{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## **3. Pondération statistique** (TF-IDF / OKapiBM25)  \n",
    "\n",
    "https://stackoverflow.com/questions/46580932/calculate-tf-idf-using-sklearn-for-n-grams-in-python  \n",
    "http://scikit-learn.sourceforge.net/stable/modules/generated/sklearn.feature_extraction.text.TfidfVectorizer.html#sklearn-feature-extraction-text-tfidfvectorizer  \n",
    "https://scikit-learn.org/stable/modules/feature_extraction.html#text-feature-extraction\n",
    "\n",
    "https://pypi.org/project/rank-bm25/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [],
   "source": [
    "path = '../04-filtrage/output/'\n",
    "acteur = 'inesss'\n",
    "tag = ''\n",
    "\n",
    "if tag:\n",
    "    csv_file = acteur + '_' + tag + '_significant-collocations.csv'\n",
    "\n",
    "else:\n",
    "    csv_file = acteur + '_significant-collocations.csv'"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### **Lire le vocabulaire** (termes retenus au prétraitement)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Terme</th>\n",
       "      <th>Structure syntaxique</th>\n",
       "      <th>Fréquence (TF)</th>\n",
       "      <th>LLR</th>\n",
       "      <th>p-value</th>\n",
       "      <th>Fréquence documentaire (DF)</th>\n",
       "      <th>isMeSHTerm</th>\n",
       "      <th>isTaxoTerm</th>\n",
       "      <th>Terme formatté</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>traitement</td>\n",
       "      <td>NOM</td>\n",
       "      <td>7872</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1218</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>traitement</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>jamp</td>\n",
       "      <td>NOM</td>\n",
       "      <td>7296</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>992</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>jamp</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>évaluation</td>\n",
       "      <td>NOM</td>\n",
       "      <td>6785</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1396</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>évaluation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>médicaments</td>\n",
       "      <td>NOM</td>\n",
       "      <td>5448</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1206</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>médicaments</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>demande</td>\n",
       "      <td>NOM</td>\n",
       "      <td>3662</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>280</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>demande</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6020</th>\n",
       "      <td>degré</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>14</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>degré</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6021</th>\n",
       "      <td>foam</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>8</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>foam</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6022</th>\n",
       "      <td>coque</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>22</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>coque</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6023</th>\n",
       "      <td>médicaments du québec</td>\n",
       "      <td>NOM PRP:det NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>88.74281960037526</td>\n",
       "      <td>4.496265284875781e-21</td>\n",
       "      <td>13</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>médicaments du québec</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6024</th>\n",
       "      <td>lmc</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>5</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>lmc</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6025 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                      Terme Structure syntaxique  Fréquence (TF)  \\\n",
       "0                traitement                  NOM            7872   \n",
       "1                      jamp                  NOM            7296   \n",
       "2                évaluation                  NOM            6785   \n",
       "3               médicaments                  NOM            5448   \n",
       "4                   demande                  NOM            3662   \n",
       "...                     ...                  ...             ...   \n",
       "6020                  degré                  NOM              16   \n",
       "6021                   foam                  NOM              16   \n",
       "6022                  coque                  NOM              16   \n",
       "6023  médicaments du québec      NOM PRP:det NOM              16   \n",
       "6024                    lmc                  NOM              16   \n",
       "\n",
       "                    LLR                p-value  Fréquence documentaire (DF)  \\\n",
       "0                     -                      -                         1218   \n",
       "1                     -                      -                          992   \n",
       "2                     -                      -                         1396   \n",
       "3                     -                      -                         1206   \n",
       "4                     -                      -                          280   \n",
       "...                 ...                    ...                          ...   \n",
       "6020                  -                      -                           14   \n",
       "6021                  -                      -                            8   \n",
       "6022                  -                      -                           22   \n",
       "6023  88.74281960037526  4.496265284875781e-21                           13   \n",
       "6024                  -                      -                            5   \n",
       "\n",
       "      isMeSHTerm  isTaxoTerm         Terme formatté  \n",
       "0          False        True             traitement  \n",
       "1          False       False                   jamp  \n",
       "2          False       False             évaluation  \n",
       "3          False        True            médicaments  \n",
       "4          False       False                demande  \n",
       "...          ...         ...                    ...  \n",
       "6020       False       False                  degré  \n",
       "6021       False       False                   foam  \n",
       "6022       False        True                  coque  \n",
       "6023       False       False  médicaments du québec  \n",
       "6024       False       False                    lmc  \n",
       "\n",
       "[6025 rows x 9 columns]"
      ]
     },
     "execution_count": 105,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from pandas import *\n",
    "\n",
    "with open(path+csv_file, encoding='utf-8') as f:\n",
    "    csv = read_csv(f).drop(columns = ['Unnamed: 0'])\n",
    "    # On va traiter les apostrophes et les parenthèses avec le underscore (\"_\") ; le tokenizer de sklearn ne les aime pas \n",
    "    csv['Terme formatté'] = csv[\"Terme\"].apply(lambda x: str(x).replace(\"'\", \"_\").replace(\"(\", \"_\").replace(\")\", \"_\").replace(\"-\", \"_\"))\n",
    "\n",
    "csv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "metadata": {},
   "outputs": [],
   "source": [
    "vocabulaire = [t.lower() for t in list(csv['Terme formatté'])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "On a un vocabulaire de 6025 formes.\n"
     ]
    }
   ],
   "source": [
    "print('On a un vocabulaire de {} formes.'.format(len(vocabulaire)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['traitement',\n",
       " 'jamp',\n",
       " 'évaluation',\n",
       " 'médicaments',\n",
       " 'demande',\n",
       " 'inesss',\n",
       " 'attente',\n",
       " 'injection',\n",
       " 'ministre',\n",
       " 'patients',\n",
       " 'médicament',\n",
       " 'cours',\n",
       " 'inscription',\n",
       " 'sodium',\n",
       " 'citrate',\n",
       " 'attente d_évaluation',\n",
       " 'cancer',\n",
       " 'angita',\n",
       " 'darunavir',\n",
       " 'calcium',\n",
       " 'lurasidone',\n",
       " 'bicarbonate',\n",
       " 'réponses',\n",
       " 'dextrose',\n",
       " 'sulfonate',\n",
       " 'bicarbonate de sodium',\n",
       " 'glycopyrrolate',\n",
       " 'cours d_évaluation',\n",
       " 'réponses rapides',\n",
       " 'covid_19',\n",
       " 'santé',\n",
       " 'indication',\n",
       " 'réponses rapides disponibles',\n",
       " 'pré_ac',\n",
       " 'services',\n",
       " 'listes',\n",
       " 'décision',\n",
       " 'québec',\n",
       " 'nom',\n",
       " 'demande en attente',\n",
       " 'coll',\n",
       " 'recommandations',\n",
       " 'adultes',\n",
       " 'projet',\n",
       " 'fabricant',\n",
       " 'cliniques',\n",
       " 'chlorhydrate',\n",
       " 'soins',\n",
       " 'forme',\n",
       " 'dépôt',\n",
       " 'pré_ac en attente',\n",
       " 'conseil',\n",
       " 'recommandation',\n",
       " 'fumarate',\n",
       " 'demande en cours',\n",
       " 'demande en cours d_évaluation',\n",
       " 'commune',\n",
       " 'dénomination commune',\n",
       " 'exception',\n",
       " 'dénomination',\n",
       " 'évaluations',\n",
       " 'maladie',\n",
       " 'listes des médicaments',\n",
       " 'canada',\n",
       " 'usage',\n",
       " 'ans',\n",
       " 'nom du fabricant',\n",
       " 'contexte',\n",
       " 'liste',\n",
       " 'teneur',\n",
       " 'apotex',\n",
       " 'recommandation de l_inesss',\n",
       " 'connaissances',\n",
       " 'quétiapine',\n",
       " 'quétiapine _fumarate de_',\n",
       " 'produits',\n",
       " 'traitements',\n",
       " 'evaluation',\n",
       " 'décision du ministre',\n",
       " 'lurasidone _chlorhydrate de_',\n",
       " 'oméga',\n",
       " 'calcium _citrate de_',\n",
       " 'bromhydrate',\n",
       " 'ag_calcium',\n",
       " 'élétriptan',\n",
       " 'ag_quetiapine',\n",
       " 'injection de glycopyrrolate',\n",
       " 'apo_eletriptan',\n",
       " 'dextrose injection',\n",
       " 'jamp lurasidone',\n",
       " 'polystyrène',\n",
       " 'sulfonate calcique',\n",
       " 'sodium pour injection',\n",
       " 'halycil',\n",
       " 'ag_calcium citrate',\n",
       " 'ag_calcium citrate liquid',\n",
       " 'jamp calcium polystyrene sulfonate',\n",
       " 'jamp calcium',\n",
       " 'jamp calcium polystyrene',\n",
       " 'citrate liquid',\n",
       " 'calcium polystyrene',\n",
       " 'bicarbonate de sodium pour injection',\n",
       " 'calcium polystyrene sulfonate',\n",
       " 'pré_ac en attente d_évaluation',\n",
       " 'données',\n",
       " 'darunavir dextrose injection',\n",
       " 'injection _jamp_',\n",
       " 'sodium pour injection _jamp_',\n",
       " 'jamp lurasidone _jamp_',\n",
       " 'apo_eletriptan _apotex_',\n",
       " 'évaluations récemment publiées',\n",
       " 'bicarbonate de sodium pour injection _jamp_',\n",
       " 'bicarbonate de sodium darunavir',\n",
       " 'dextrose halycil',\n",
       " 'bicarbonate de sodium darunavir _jamp_',\n",
       " 'sodium darunavir _jamp_',\n",
       " 'évaluations récemment',\n",
       " 'jamp calcium polystyrene sulfonate _jamp_',\n",
       " 'calcium polystyrene sulfonate _jamp_',\n",
       " 'dextrose injection _oméga_',\n",
       " 'darunavir dextrose',\n",
       " 'glycopyrrolate _jamp_',\n",
       " 'sodium darunavir',\n",
       " 'injection de glycopyrrolate _jamp_',\n",
       " 'injection _oméga_',\n",
       " 'evaluation publiée',\n",
       " 'darunavir _jamp_',\n",
       " 'citrate liquid _angita_',\n",
       " 'sulfonate _jamp_',\n",
       " 'association',\n",
       " 'adultes atteints',\n",
       " 'conditions',\n",
       " 'efficacité',\n",
       " 'demande en attente d_évaluation',\n",
       " 'attente d_un dépôt pour évaluation',\n",
       " 'attente d_un dépôt',\n",
       " 'dépôt pour évaluation',\n",
       " 'type',\n",
       " 'services sociaux',\n",
       " 'utilisation',\n",
       " 'produit',\n",
       " 'coût',\n",
       " 'résultats',\n",
       " 'risque',\n",
       " 'traitement des patients',\n",
       " 'cellules',\n",
       " 'fabricants',\n",
       " 'patients adultes',\n",
       " 'besoins',\n",
       " 'pandémie',\n",
       " 'système',\n",
       " 'clinique',\n",
       " 'enfants',\n",
       " 'patients adultes atteints',\n",
       " 'étude',\n",
       " 'études',\n",
       " 'réponse',\n",
       " 'indication reconnue',\n",
       " 'trauma',\n",
       " 'médicament d_exception',\n",
       " 'ligne',\n",
       " 'ordonnances',\n",
       " 'projet aligné',\n",
       " 'projet aligné inesss_acmts_santé canada',\n",
       " 'qualité',\n",
       " 'méthode',\n",
       " 'vie',\n",
       " 'poumon',\n",
       " 'connaissance',\n",
       " 'msss',\n",
       " 'cancer du poumon',\n",
       " 'traitement des patients adultes',\n",
       " 'traitement des patients adultes atteints',\n",
       " 'demande en attente d_un dépôt pour évaluation',\n",
       " 'demande en attente d_un dépôt',\n",
       " 'adulte',\n",
       " 'extrait',\n",
       " 'hospitalisation',\n",
       " 'produits de connaissance',\n",
       " 'auteur',\n",
       " 'mois',\n",
       " 'suivi',\n",
       " 'traitement du cancer',\n",
       " 'patients atteints',\n",
       " 'kio',\n",
       " 'projet auteur',\n",
       " 'ordonnance',\n",
       " 'réévaluation',\n",
       " 'risques',\n",
       " 'pré_ac en cours',\n",
       " 'pré_ac en cours d_évaluation',\n",
       " 'pratiques',\n",
       " 'ligne evaluation publiée',\n",
       " 'ligne evaluation',\n",
       " 'prise',\n",
       " 'extrait de l_avis au ministre',\n",
       " 'réponse rapide',\n",
       " 'établissements',\n",
       " 'trouble',\n",
       " 'injury',\n",
       " 'indications',\n",
       " 'usage optimal',\n",
       " 'analyse',\n",
       " 'médicaments d_exception',\n",
       " 'symptômes',\n",
       " 'transfert',\n",
       " 'cas',\n",
       " 'outil',\n",
       " 'sondage',\n",
       " 'ajout',\n",
       " 'ensemble',\n",
       " 'soutien',\n",
       " 'coordination',\n",
       " 'protocole',\n",
       " 'guide',\n",
       " 'traumatologie',\n",
       " 'description',\n",
       " 'évolution',\n",
       " 'pertinence',\n",
       " 'fiche',\n",
       " 'chronique',\n",
       " 'processus',\n",
       " 'besoins hospitaliers',\n",
       " 'refus',\n",
       " 'régime',\n",
       " 'dépistage',\n",
       " 'collaboration',\n",
       " 'coordination scientifique',\n",
       " 'diabète',\n",
       " 'accès',\n",
       " 'méthode de réponse',\n",
       " 'listes de médicaments',\n",
       " 'méthode de réponse rapide',\n",
       " 'projections',\n",
       " 'cancer du poumon non à petites cellules',\n",
       " 'cancérologie',\n",
       " 'durée',\n",
       " 'dose',\n",
       " 'tériflunomide',\n",
       " 'prophylaxie',\n",
       " 'description du médicament',\n",
       " 'modalités',\n",
       " 'kio autres recommandations',\n",
       " 'nom commercial',\n",
       " 'infection',\n",
       " 'prévention',\n",
       " 'rencontre',\n",
       " 'général',\n",
       " 'lymphome',\n",
       " 'merck',\n",
       " 'chimiothérapie',\n",
       " 'critères',\n",
       " 'aide',\n",
       " 'réseau',\n",
       " 'effets',\n",
       " 'risques d_hospitalisation',\n",
       " 'conditions à venir',\n",
       " 'troubles',\n",
       " 'génériques',\n",
       " 'innocuité',\n",
       " 'stade',\n",
       " 'cadre',\n",
       " 'roche',\n",
       " 'population',\n",
       " 'électronique',\n",
       " 'mesure',\n",
       " 'pembrolizumab',\n",
       " 'keytruda',\n",
       " 'adalimumab',\n",
       " 'soins palliatifs',\n",
       " 'brain',\n",
       " 'demandes',\n",
       " 'demande d_inscription',\n",
       " 'jeunes',\n",
       " 'regard',\n",
       " 'présente',\n",
       " 'dépôt électronique',\n",
       " 'pembrolizumab merck',\n",
       " 'patient',\n",
       " 'test',\n",
       " 'évaluation keytruda',\n",
       " 'hypertension',\n",
       " 'travaux',\n",
       " 'care',\n",
       " 'experts',\n",
       " 'fins',\n",
       " 'transfert de connaissances',\n",
       " 'semaines',\n",
       " 'sanis',\n",
       " 'sang',\n",
       " 'brain injury',\n",
       " 'protocole médical',\n",
       " 'traumatic',\n",
       " 'traitement adjuvant',\n",
       " 'professionnels',\n",
       " 'gène',\n",
       " 'projections des besoins hospitaliers',\n",
       " 'projections des besoins',\n",
       " 'pansement',\n",
       " 'sandoz',\n",
       " 'soins intensifs',\n",
       " 'hospitalisation et projections des besoins',\n",
       " 'hospitalisation et projections',\n",
       " 'hospitalisation et projections des besoins hospitaliers',\n",
       " 'risques d_hospitalisation et projections',\n",
       " 'raison',\n",
       " 'régime général',\n",
       " 'jours',\n",
       " 'liste des médicaments',\n",
       " 'déficit',\n",
       " 'portrait',\n",
       " 'mise',\n",
       " 'nombre',\n",
       " 'liste de médicaments',\n",
       " 'recherche',\n",
       " 'investigation',\n",
       " 'annexes',\n",
       " 'médecins',\n",
       " 'traitement des adultes',\n",
       " 'solution',\n",
       " 'atteintes',\n",
       " 'pré_ac en attente d_un dépôt pour évaluation',\n",
       " 'pré_ac en attente d_un dépôt',\n",
       " 'adultes atteints d_un cancer',\n",
       " 'asthme',\n",
       " 'tableau',\n",
       " 'inhibiteur',\n",
       " 'infections',\n",
       " 'terme',\n",
       " 'procédures',\n",
       " 'québécois',\n",
       " 'mesures',\n",
       " 'diagnostic',\n",
       " 'élaboration',\n",
       " 'biosimilaire',\n",
       " 'pratique',\n",
       " 'références',\n",
       " 'interventions',\n",
       " 'traumatic brain',\n",
       " 'jour',\n",
       " 'études cliniques',\n",
       " 'attente d_évaluation keytruda',\n",
       " 'diabète de type',\n",
       " 'groupe',\n",
       " 'traumatic brain injury',\n",
       " 'graves',\n",
       " 'formule',\n",
       " 'contexte de pandémie',\n",
       " 'analyses',\n",
       " 'ordonnance collective',\n",
       " 'évaluation des médicaments',\n",
       " 'biologie',\n",
       " 'biologie médicale',\n",
       " 'réadaptation',\n",
       " 'modification',\n",
       " 'azc',\n",
       " 'documentation',\n",
       " 'conseil a recommandé',\n",
       " 'post_covid_19',\n",
       " 'implantation',\n",
       " 'femmes',\n",
       " 'ordonnances collectives',\n",
       " 'intervention',\n",
       " 'rétablissement',\n",
       " 'principaux',\n",
       " 'échéancier',\n",
       " 'contexte de la covid_19',\n",
       " 'affections',\n",
       " 'study',\n",
       " 'intention',\n",
       " 'virus',\n",
       " 'survie',\n",
       " 'intérêt',\n",
       " 'lyme',\n",
       " 'demandes d_inscription',\n",
       " 'reprise',\n",
       " 'ministère',\n",
       " 'rapports',\n",
       " 'formule nutritive',\n",
       " 'opdivo',\n",
       " 'maladies',\n",
       " 'produit biosimilaire',\n",
       " 'produit du système',\n",
       " 'plan',\n",
       " 'aspects',\n",
       " 'réduction',\n",
       " 'ajustement',\n",
       " 'mutation',\n",
       " 'littérature',\n",
       " 'réévaluation en attente',\n",
       " 'keytruda pembrolizumab merck',\n",
       " 'produit du système du sang_ traitement',\n",
       " 'fins d_inscription',\n",
       " 'keytruda pembrolizumab',\n",
       " 'nom commercial à venir',\n",
       " 'évaluation keytruda pembrolizumab merck',\n",
       " 'évaluation keytruda pembrolizumab',\n",
       " 'traitement des patients adultes atteints d_un cancer',\n",
       " 'sang_ traitement',\n",
       " 'patients adultes atteints d_un cancer',\n",
       " 'produit du système du sang_',\n",
       " 'review',\n",
       " 'système du sang_ traitement',\n",
       " 'système du sang_',\n",
       " 'sang_',\n",
       " 'nivolumab',\n",
       " 'affections post_covid_19',\n",
       " 'phase',\n",
       " 'maladie de lyme',\n",
       " 'lien',\n",
       " 'syndrome',\n",
       " 'note',\n",
       " 'inspq',\n",
       " 'alternatives',\n",
       " 'notice',\n",
       " 'médicaments du régime',\n",
       " 'médicaments du régime général',\n",
       " 'immunoglobulines',\n",
       " 'chirurgie',\n",
       " 'santécom',\n",
       " 'sites',\n",
       " 'inhibiteurs',\n",
       " 'assurance',\n",
       " 'ventilation',\n",
       " 'états',\n",
       " 'entretien',\n",
       " 'notice santécom',\n",
       " 'ministère de la santé',\n",
       " 'conclusion',\n",
       " 'uetmis',\n",
       " 'biosimilaires',\n",
       " 'médecin',\n",
       " 'semaine',\n",
       " 'présentations',\n",
       " 'recommandation de l_inesss ajout',\n",
       " 'traitement d_entretien',\n",
       " 'lilly',\n",
       " 'hypertension artérielle',\n",
       " 'états des connaissances',\n",
       " 'chaleur',\n",
       " 'covid_19 au québec',\n",
       " 'oeuvre',\n",
       " 'placebo',\n",
       " 'treatment',\n",
       " 'influenza',\n",
       " 'temps',\n",
       " 'études cliniques en cours',\n",
       " 'approche',\n",
       " 'leucémie',\n",
       " 'épidémie',\n",
       " 'milieu',\n",
       " 'systematic',\n",
       " 'traitement du cancer du poumon',\n",
       " 'traitements en contexte',\n",
       " 'mise en oeuvre',\n",
       " 'impact',\n",
       " 'moment',\n",
       " 'ventilation assistée',\n",
       " 'tumeurs',\n",
       " 'coût de traitement',\n",
       " 'pandémie covid_19',\n",
       " 'réponse rapide dans le contexte de la covid_19',\n",
       " 'échangeur de chaleur',\n",
       " 'oeuvre de la méthode de réponse rapide',\n",
       " 'vue',\n",
       " 'élaboration et mise',\n",
       " 'méthode de réponse rapide dans le contexte',\n",
       " 'mise en oeuvre de la méthode de réponse',\n",
       " 'mise en oeuvre de la méthode',\n",
       " 'prophylaxie et traitement',\n",
       " 'échangeur',\n",
       " 'réponse rapide dans le contexte',\n",
       " 'oeuvre de la méthode de réponse',\n",
       " 'oeuvre de la méthode',\n",
       " 'élaboration et mise en oeuvre de la méthode',\n",
       " 'monothérapie',\n",
       " 'taux',\n",
       " 'mise en oeuvre de la méthode de réponse rapide',\n",
       " 'élaboration et mise en oeuvre',\n",
       " 'réponses rapides disponibles affections post_covid_19',\n",
       " 'regard sur la pandémie covid_19 au québec',\n",
       " 'pandémie covid_19 au québec',\n",
       " 'regard sur la pandémie covid_19',\n",
       " 'projections des besoins hospitaliers traitements',\n",
       " 'procédures diagnostiques',\n",
       " 'ministère de la santé et des services',\n",
       " 'démarche',\n",
       " 'réponses rapides disponibles services sociaux',\n",
       " 'réponses rapides disponibles regard',\n",
       " 'sites d_intérêt visitez',\n",
       " 'ministère de la santé et des services sociaux',\n",
       " 'traitements spécifiques',\n",
       " 'besoins hospitaliers traitements',\n",
       " 'regard sur la pandémie',\n",
       " 'traitements spécifiques à la covid_19',\n",
       " 'échangeur de chaleur sites',\n",
       " 'échangeur de chaleur sites d_intérêt',\n",
       " 'traitement ordonnances collectives',\n",
       " 'réponses rapides disponibles rétablissement',\n",
       " 'inspq visitez',\n",
       " 'intérêt visitez',\n",
       " 'niveau',\n",
       " 'contributions des uetmis soins',\n",
       " 'contributions des uetmis',\n",
       " 'contexte de la covid_19 contributions',\n",
       " 'contributions',\n",
       " 'projections des besoins hospitaliers traitements spécifiques',\n",
       " 'rapports disponibles',\n",
       " 'alternatives de traitements',\n",
       " 'réponses rapides disponibles études cliniques en cours',\n",
       " 'alternatives de traitements en contexte',\n",
       " 'réponses rapides disponibles affections',\n",
       " 'présentations cliniques',\n",
       " 'summary',\n",
       " 'rétablissement et reprise',\n",
       " 'réponses rapides disponibles investigation',\n",
       " 'réponses rapides disponibles méthode',\n",
       " 'contributions des uetmis soins intensifs',\n",
       " 'réponses rapides disponibles services',\n",
       " 'réponses rapides disponibles méthode de réponse',\n",
       " 'traitement ordonnances',\n",
       " 'prophylaxie et traitement ordonnances',\n",
       " 'réponses rapides disponibles méthode de réponse rapide',\n",
       " 'rapports disponibles présentations',\n",
       " 'chaleur sites',\n",
       " 'besoins hospitaliers traitements spécifiques',\n",
       " 'rapports disponibles présentations cliniques',\n",
       " 'alternatives de traitements en contexte de pandémie',\n",
       " 'traitements en contexte de pandémie',\n",
       " 'réponses rapides disponibles autres traitements',\n",
       " 'covid_19 longue',\n",
       " 'réponses rapides disponibles études cliniques',\n",
       " 'réponses rapides disponibles cancérologie',\n",
       " 'affections post_covid_19 _covid_19 longue_',\n",
       " 'réponses rapides disponibles études',\n",
       " 'chaleur sites d_intérêt',\n",
       " 'sites d_intérêt',\n",
       " 'plaques',\n",
       " 'appoint',\n",
       " 'constats',\n",
       " 'situation',\n",
       " 'médicaments biosimilaires',\n",
       " 'fer',\n",
       " 'pfizer',\n",
       " 'paladin',\n",
       " 'glucose',\n",
       " 'normes',\n",
       " 'dépôt électronique d_une demande d_inscription',\n",
       " 'sujets',\n",
       " 'dépôt électronique d_une demande',\n",
       " 'sol',\n",
       " 'base',\n",
       " 'évolution de l_épidémie',\n",
       " 'comprimé',\n",
       " 'pharma',\n",
       " 'épidémie de covid_19',\n",
       " 'attention',\n",
       " 'emergency',\n",
       " 'projets',\n",
       " 'santé canada',\n",
       " 'suivi de l_évolution',\n",
       " 'protocole médical national',\n",
       " 'suivi de l_évolution de l_épidémie',\n",
       " 'suivi de l_évolution de l_épidémie de covid_19',\n",
       " 'score',\n",
       " 'évolution de l_épidémie de covid_19',\n",
       " 'administration',\n",
       " 'évaluation nom',\n",
       " 'évaluation nom commercial',\n",
       " 'médicaments évalués',\n",
       " 'problèmes',\n",
       " 'protocoles',\n",
       " 'santé mentale',\n",
       " 'patients âgés',\n",
       " 'traitement des adultes atteints',\n",
       " 'bénéfices',\n",
       " 'évaluation nom commercial à venir',\n",
       " 'amélioration',\n",
       " 'développement',\n",
       " 'ministre sur les génériques',\n",
       " 'polyangéite',\n",
       " 'pembrolizumab merck traitement',\n",
       " 'réévaluation en attente d_évaluation',\n",
       " 'enfant',\n",
       " 'radiothérapie',\n",
       " 'jamp inscription',\n",
       " 'tests',\n",
       " 'gsk',\n",
       " 'lumière',\n",
       " 'conformité',\n",
       " 'besoin',\n",
       " 'années',\n",
       " 'oncologie',\n",
       " 'point',\n",
       " 'objet',\n",
       " 'augmentation',\n",
       " 'modérée',\n",
       " 'action',\n",
       " 'attente d_évaluation keytruda pembrolizumab',\n",
       " 'psoriasis',\n",
       " 'application',\n",
       " 'glycémie',\n",
       " 'egfr',\n",
       " 'échelle',\n",
       " 'long',\n",
       " 'prostate',\n",
       " 'agent',\n",
       " 'présence',\n",
       " 'bandelette',\n",
       " 'place',\n",
       " 'progression',\n",
       " 'centre',\n",
       " 'insuline',\n",
       " 'institut',\n",
       " 'metformine',\n",
       " 'effets indésirables',\n",
       " 'adolescents',\n",
       " 'paiement',\n",
       " 'doses',\n",
       " 'stylo',\n",
       " 'thérapie',\n",
       " 'processus d_évaluation',\n",
       " 'demande en attente d_évaluation keytruda',\n",
       " 'rosiglitazone',\n",
       " 'liste de médicaments du régime général',\n",
       " 'alcool',\n",
       " 'qualité de vie',\n",
       " 'liste de médicaments du régime',\n",
       " 'sclérose',\n",
       " 'centres',\n",
       " 'clientèle',\n",
       " 'familles',\n",
       " 'insuffisance',\n",
       " 'autorisation',\n",
       " 'techniques',\n",
       " 'hormone',\n",
       " 'indicateurs',\n",
       " 'indications reconnues',\n",
       " 'premarin',\n",
       " 'douleur',\n",
       " 'référence',\n",
       " 'monothérapie pour le traitement',\n",
       " 'sep',\n",
       " 'systematic review',\n",
       " 'période',\n",
       " 'modèle',\n",
       " 'protocoles médicaux',\n",
       " 'année',\n",
       " 'gestion',\n",
       " 'statut',\n",
       " 'agents',\n",
       " 'guides',\n",
       " 'colite',\n",
       " 'complications',\n",
       " 'guide d_usage optimal',\n",
       " 'organisation',\n",
       " 'colite ulcéreuse',\n",
       " 'traitement des patients atteints',\n",
       " 'liaison',\n",
       " 'guide d_usage',\n",
       " 'exception décision',\n",
       " 'exception décision du ministre',\n",
       " 'objectif',\n",
       " 'seringue',\n",
       " 'standard',\n",
       " 'consultation',\n",
       " 'informations',\n",
       " 'soulagement',\n",
       " 'ordonnance individuelle',\n",
       " 'pioglitazone',\n",
       " 'publication',\n",
       " 'continu',\n",
       " 'mutations',\n",
       " 'marie_claude',\n",
       " 'décès',\n",
       " 'sédation',\n",
       " 'coûts',\n",
       " 'remboursement',\n",
       " 'protocoles médicaux nationaux',\n",
       " 'diminution',\n",
       " 'fusion',\n",
       " 'experts consultés',\n",
       " 'éléments',\n",
       " 'travail',\n",
       " 'uvéite',\n",
       " 'sras_cov_2',\n",
       " 'services sociaux _msss_',\n",
       " 'adultes atteints d_un lymphome',\n",
       " 'abbvie',\n",
       " 'médicament d_exception décision du ministre',\n",
       " 'traitement de la colite ulcéreuse',\n",
       " 'documents',\n",
       " 'médicament d_exception décision',\n",
       " 'aspects économique',\n",
       " 'traitement de la colite',\n",
       " 'inj',\n",
       " 'protection',\n",
       " 'revue',\n",
       " 'considérations',\n",
       " 'topique',\n",
       " 'rencontre présoumission',\n",
       " 'aigüe',\n",
       " 'gonorrhoeae',\n",
       " 'endomètre',\n",
       " 'rgam',\n",
       " 'cellules métastatique',\n",
       " 'présoumission',\n",
       " 'comparaison',\n",
       " 'attente d_évaluation nom',\n",
       " 'gène ret',\n",
       " 'adultes atteints d_un cancer du poumon',\n",
       " 'abbvie traitement',\n",
       " 'asthme sévère',\n",
       " 'incertitude',\n",
       " 'point de vue',\n",
       " 'préavis',\n",
       " 'évaluation keytruda pembrolizumab merck traitement',\n",
       " 'traitement de l_uvéite',\n",
       " 'paladin traitement',\n",
       " 'attente d_évaluation nom commercial',\n",
       " 'cancer de l_endomètre',\n",
       " 'keytruda pembrolizumab merck traitement',\n",
       " 'médicaments présentés',\n",
       " 'ajout aux listes',\n",
       " 'cardiovasculaire',\n",
       " 'ministre de la santé',\n",
       " 'ministre de la santé et des services sociaux',\n",
       " 'mélanome',\n",
       " 'marcan',\n",
       " 'ajout aux listes de médicaments',\n",
       " 'ministre de la santé et des services',\n",
       " 'synthèse',\n",
       " 'mandat',\n",
       " 'rehabilitation',\n",
       " 'réalisation',\n",
       " 'répertoire',\n",
       " 'indication reconnue aux listes',\n",
       " 'hyperactivité',\n",
       " 'mcg',\n",
       " 'inscrits',\n",
       " 'version',\n",
       " 'maladie pulmonaire',\n",
       " 'guise',\n",
       " 'absence',\n",
       " 'résultat',\n",
       " 'conséquences',\n",
       " 'public',\n",
       " 'recommandation de l_inesss ajout aux listes',\n",
       " 'modification d_une indication',\n",
       " 'mode',\n",
       " 'maladie pulmonaire obstructive',\n",
       " 'décisions',\n",
       " 'caractéristiques',\n",
       " 'maladie pulmonaire obstructive chronique',\n",
       " 'iii',\n",
       " 'nouveautés',\n",
       " 'carcinome',\n",
       " 'système de santé',\n",
       " 'principaux experts consultés',\n",
       " 'liste des principaux experts consultés',\n",
       " 'principaux experts',\n",
       " 'limite',\n",
       " 'dispositifs',\n",
       " 'bgp pharma',\n",
       " 'rétention',\n",
       " 'chlamydia',\n",
       " 'modification d_une indication reconnue',\n",
       " 'groupes',\n",
       " 'liste des principaux',\n",
       " 'lésions',\n",
       " 'imagerie',\n",
       " 'liste des principaux experts',\n",
       " 'bgp',\n",
       " 'excellence',\n",
       " 'algorithme',\n",
       " 'pansements',\n",
       " 'fiches',\n",
       " 'candidose',\n",
       " 'management',\n",
       " 'biologie médicale et génomique',\n",
       " 'plaies',\n",
       " 'institut national',\n",
       " 'préavis obligatoire',\n",
       " 'système du sang',\n",
       " 'critère',\n",
       " 'tsa',\n",
       " 'évaluation scientifique',\n",
       " 'juge',\n",
       " 'refus d_inscription',\n",
       " 'fin',\n",
       " 'détresse',\n",
       " 'performance',\n",
       " 'produits du système',\n",
       " 'ppb',\n",
       " 'déficience',\n",
       " 'mucosite',\n",
       " 'fonction',\n",
       " 'ipilimumab',\n",
       " 'hospitalisations',\n",
       " 'ppe',\n",
       " 'acétate',\n",
       " 'ordonnances associées',\n",
       " 'rencontre postsoumission',\n",
       " 'traumatisme',\n",
       " 'famille',\n",
       " 'condition',\n",
       " 'utérus',\n",
       " 'postsoumission',\n",
       " 'enjeux',\n",
       " 'option',\n",
       " 'fièvre',\n",
       " 'profil',\n",
       " 'traitement de l_asthme',\n",
       " 'programme',\n",
       " 'relatives',\n",
       " 'nausées',\n",
       " 'fibrose',\n",
       " 'diabetes',\n",
       " 'cancer de la prostate',\n",
       " 'fentanyl',\n",
       " 'produits du système du sang',\n",
       " 'dermatite atopique',\n",
       " 'experts consultés autres recommandations',\n",
       " 'aide à la décision',\n",
       " 'nifédipine',\n",
       " 'dermatite',\n",
       " 'mucosite oropharyngée',\n",
       " 'guo',\n",
       " 'amgevita',\n",
       " 'adalimumab amgen',\n",
       " 'critères économique',\n",
       " 'tarification',\n",
       " 'cancers',\n",
       " 'transplantation',\n",
       " 'trouble lié',\n",
       " 'bid',\n",
       " 'chloroquine',\n",
       " 'réactif',\n",
       " 'réactif quantitatif',\n",
       " 'randomized',\n",
       " 'médicaments décision',\n",
       " 'consensus',\n",
       " 'médicaments décision du ministre',\n",
       " 'croissance',\n",
       " 'exemption',\n",
       " 'ordre',\n",
       " 'attente d_un avis de conformité',\n",
       " 'urgence',\n",
       " 'cst',\n",
       " 'naloxone',\n",
       " 'produits de santé',\n",
       " 'ensemble des critères',\n",
       " 'candidose buccale',\n",
       " 'ostéoporose',\n",
       " 'traitement du diabète',\n",
       " 'élimination',\n",
       " 'trouble lié à l_usage',\n",
       " 'calcipotriol',\n",
       " 'sédation palliative',\n",
       " 'facteurs',\n",
       " 'évaluation des médicaments aux fins',\n",
       " 'davc',\n",
       " 'médicaments aux fins d_inscription',\n",
       " 'évaluation des médicaments aux fins d_inscription',\n",
       " 'médicaments aux fins',\n",
       " 'quality',\n",
       " 'références utilisées',\n",
       " 'antidiabétique',\n",
       " 'natalizumab',\n",
       " 'ensemble des critères prévus',\n",
       " 'élimination fécale',\n",
       " 'critères prévus',\n",
       " 'liste établissements',\n",
       " 'formulation',\n",
       " 'jamp inscription inscrire',\n",
       " 'vitamine',\n",
       " 'détection',\n",
       " 'continuum',\n",
       " 'médicaments evaluation',\n",
       " 'documentation scientifique',\n",
       " 'proches',\n",
       " 'âge',\n",
       " 'listes des médicaments evaluation',\n",
       " 'médicaments evaluation publiée',\n",
       " 'classe',\n",
       " 'preuve',\n",
       " 'insuffisance cardiaque',\n",
       " 'santé naturels',\n",
       " 'produits de santé naturels',\n",
       " 'rencontre présoumission avec les fabricants',\n",
       " 'sédation palliative continue',\n",
       " 'mortalité',\n",
       " 'dexcom',\n",
       " 'présoumission avec les fabricants',\n",
       " 'modifications',\n",
       " 'postsoumission avec les fabricants',\n",
       " 'rencontre postsoumission avec les fabricants',\n",
       " 'troubles neurocognitifs',\n",
       " 'pertes',\n",
       " 'évaluation aux fins d_inscription',\n",
       " 'fiche synthèse',\n",
       " 'trastuzumab',\n",
       " 'technologies',\n",
       " 'évaluation aux fins',\n",
       " 'usage d_alcool',\n",
       " 'trouble lié à l_usage d_alcool',\n",
       " 'infections urinaires',\n",
       " 'pharmacien',\n",
       " 'candidose buccale chez l_adulte',\n",
       " 'institut national d_excellence en santé',\n",
       " 'listes de médicaments décision',\n",
       " 'excellence en santé',\n",
       " 'traitement au fer',\n",
       " 'listes de médicaments décision du ministre',\n",
       " 'cliniciens',\n",
       " 'institut national d_excellence',\n",
       " 'associations',\n",
       " 'pertes vaginales',\n",
       " 'laboratoire',\n",
       " 'rétention urinaire',\n",
       " 'surveillance',\n",
       " 'présent',\n",
       " 'fabricants avis aux fabricants',\n",
       " 'outil de transfert',\n",
       " 'médecins signataires',\n",
       " 'med',\n",
       " 'préavis obligatoire demandé aux fabricants',\n",
       " 'préavis obligatoire demandé',\n",
       " 'signataires',\n",
       " 'fer intraveineux',\n",
       " 'modalités d_évaluation',\n",
       " 'fibrose kystique',\n",
       " 'outil de transfert de connaissances',\n",
       " 'femme',\n",
       " 'fabricants rencontre',\n",
       " 'pompe',\n",
       " 'comité',\n",
       " 'traitement d_appoint',\n",
       " 'traitement au fer intraveineux',\n",
       " 'exon',\n",
       " 'conditions décision',\n",
       " 'fer intraveineux chez l_adulte',\n",
       " 'frais',\n",
       " 'traitement au fer intraveineux chez l_adulte',\n",
       " 'rétention urinaire aigüe',\n",
       " 'demande d_exemption',\n",
       " 'conditions décision du ministre',\n",
       " 'intervenants',\n",
       " 'pertes vaginales inhabituelles',\n",
       " 'traitement de la fibrose',\n",
       " 'glaucome',\n",
       " 'recommandation de l_inesss médicaments',\n",
       " 'estrogènes',\n",
       " 'rédaction',\n",
       " 'cpnpc',\n",
       " 'thyroïde',\n",
       " 'aide médicale',\n",
       " 'aide médicale à mourir',\n",
       " 'associés',\n",
       " 'domicile',\n",
       " 'corticothérapie',\n",
       " 'écoulement',\n",
       " 'prise de décision',\n",
       " 'écoulement urétral',\n",
       " 'modes',\n",
       " 'dermatite atopique modérée',\n",
       " 'fresenius',\n",
       " 'efficacy',\n",
       " 'professionnels de la santé',\n",
       " 'algorithmes',\n",
       " 'renseignements',\n",
       " 'différence',\n",
       " 'médicaments génériques',\n",
       " 'professionnel',\n",
       " 'ordonnance individuelle d_ajustement',\n",
       " 'lénalidomide',\n",
       " 'itss',\n",
       " 'heures',\n",
       " 'eampoc',\n",
       " 'gonadotrophines',\n",
       " 'insomnie',\n",
       " 'modalités d_évaluation des médicaments',\n",
       " 'institut national d_excellence en santé et en services',\n",
       " 'conséquence',\n",
       " 'excellence en santé et en services sociaux',\n",
       " 'technologie',\n",
       " 'congrès',\n",
       " 'excellence en santé et en services',\n",
       " 'inscription de médicaments',\n",
       " 'dernières',\n",
       " 'res',\n",
       " 'taro',\n",
       " 'interféron',\n",
       " 'essais',\n",
       " 'trouble déficitaire',\n",
       " 'traitement de la dermatite',\n",
       " 'dupixent',\n",
       " 'nucala',\n",
       " 'gabarits',\n",
       " 'choix',\n",
       " ...]"
      ]
     },
     "execution_count": 108,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vocabulaire"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### **Lire le corpus**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os, shutil, re\n",
    "from pathlib import Path\n",
    "from os import path\n",
    "from pandas import *\n",
    "\n",
    "base_path = '../03-corpus/2-data/1-fr/'\n",
    "if tag:\n",
    "    base_path = path.join(base_path, acteur, acteur + '_' + tag + '.csv')\n",
    "\n",
    "else:\n",
    "    base_path = path.join(base_path, acteur +  '.csv')\n",
    "        \n",
    "with open(base_path, \"r\", encoding = \"UTF-8\") as f:\n",
    "    data = read_csv(base_path, sep=',')\n",
    "    text = data['text'].tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "On a donc un corpus de 2035 documents.\n"
     ]
    }
   ],
   "source": [
    "text = text[:round(len(text))]\n",
    "\n",
    "nb_docs = len(text)\n",
    "\n",
    "print(\"On a donc un corpus de {} documents.\".format(nb_docs))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### **Nettoyage**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "metadata": {},
   "outputs": [],
   "source": [
    "corpus = [str(t).strip('\\n').lower().replace('’', '\\'') for t in text]\n",
    "    \n",
    "punct = '[!#$%&•►*+,;<=>?@[\\]^_{|}~©«»—“”–—]'\n",
    "spaces = '\\s+'\n",
    "postals = '([a-zA-Z]+\\d+|\\d+[a-zA-Z]+)+'\n",
    "phones = '\\d{3}\\s\\d{3}-\\d{4}' #très simple (trop)\n",
    "\n",
    "corpus = [str(t).strip('\\n').lower().replace('’', '\\'') for t in corpus]\n",
    "corpus = [re.sub(spaces, ' ', t) for t in corpus]\n",
    "corpus = [re.sub(punct, ' ', t).replace(\"' \", \"'\" ) for t in corpus]\n",
    "corpus = [re.sub(phones, ' STOP ', t) for t in corpus]\n",
    "corpus = [re.sub(postals, ' STOP ', t) for t in corpus]\n",
    "corpus = [t.replace(\"  \", \" \" ) for t in corpus]\n",
    "corpus = [t.replace(\"'\", \"_\").replace(\"(\", \"_\").replace(\")\", \"_\").replace(\"-\", \"_\") for t in corpus]\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "On va commencer par utiliser le CountVectorizer pour valider que l'implémentation de sklearn arrive bien au même compte que nous "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "\n",
    "vectorizer = CountVectorizer(vocabulary=vocabulaire, ngram_range=(1,10), token_pattern='\\w+')\n",
    "X = vectorizer.fit_transform(corpus)\n",
    "vectorizer.get_feature_names_out()\n",
    "\n",
    "features_names = vectorizer.get_feature_names_out()\n",
    "corpus_index = [corpus.index(n) for n in corpus]\n",
    "\n",
    "import pandas as pd\n",
    "df = pd.DataFrame(X.T.todense(), index=features_names, columns=corpus_index).transpose()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Terme</th>\n",
       "      <th>Structure syntaxique</th>\n",
       "      <th>Fréquence (TF)</th>\n",
       "      <th>LLR</th>\n",
       "      <th>p-value</th>\n",
       "      <th>Fréquence documentaire (DF)</th>\n",
       "      <th>isMeSHTerm</th>\n",
       "      <th>isTaxoTerm</th>\n",
       "      <th>Terme formatté</th>\n",
       "      <th>TF (sklearn)</th>\n",
       "      <th>DF (sklearn)</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>traitement</td>\n",
       "      <td>NOM</td>\n",
       "      <td>7872</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1218</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>traitement</td>\n",
       "      <td>7864</td>\n",
       "      <td>1180</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>jamp</td>\n",
       "      <td>NOM</td>\n",
       "      <td>7296</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>992</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>jamp</td>\n",
       "      <td>2556</td>\n",
       "      <td>992</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>évaluation</td>\n",
       "      <td>NOM</td>\n",
       "      <td>6785</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1396</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>évaluation</td>\n",
       "      <td>1694</td>\n",
       "      <td>324</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>médicaments</td>\n",
       "      <td>NOM</td>\n",
       "      <td>5448</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1206</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>médicaments</td>\n",
       "      <td>5451</td>\n",
       "      <td>1206</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>demande</td>\n",
       "      <td>NOM</td>\n",
       "      <td>3662</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>280</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>demande</td>\n",
       "      <td>3662</td>\n",
       "      <td>240</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6020</th>\n",
       "      <td>degré</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>14</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>degré</td>\n",
       "      <td>16</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6021</th>\n",
       "      <td>foam</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>8</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>foam</td>\n",
       "      <td>16</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6022</th>\n",
       "      <td>coque</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>22</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>coque</td>\n",
       "      <td>16</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6023</th>\n",
       "      <td>médicaments du québec</td>\n",
       "      <td>NOM PRP:det NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>88.74281960037526</td>\n",
       "      <td>4.496265284875781e-21</td>\n",
       "      <td>13</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>médicaments du québec</td>\n",
       "      <td>16</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6024</th>\n",
       "      <td>lmc</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>5</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>lmc</td>\n",
       "      <td>14</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6025 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                      Terme Structure syntaxique  Fréquence (TF)  \\\n",
       "0                traitement                  NOM            7872   \n",
       "1                      jamp                  NOM            7296   \n",
       "2                évaluation                  NOM            6785   \n",
       "3               médicaments                  NOM            5448   \n",
       "4                   demande                  NOM            3662   \n",
       "...                     ...                  ...             ...   \n",
       "6020                  degré                  NOM              16   \n",
       "6021                   foam                  NOM              16   \n",
       "6022                  coque                  NOM              16   \n",
       "6023  médicaments du québec      NOM PRP:det NOM              16   \n",
       "6024                    lmc                  NOM              16   \n",
       "\n",
       "                    LLR                p-value  Fréquence documentaire (DF)  \\\n",
       "0                     -                      -                         1218   \n",
       "1                     -                      -                          992   \n",
       "2                     -                      -                         1396   \n",
       "3                     -                      -                         1206   \n",
       "4                     -                      -                          280   \n",
       "...                 ...                    ...                          ...   \n",
       "6020                  -                      -                           14   \n",
       "6021                  -                      -                            8   \n",
       "6022                  -                      -                           22   \n",
       "6023  88.74281960037526  4.496265284875781e-21                           13   \n",
       "6024                  -                      -                            5   \n",
       "\n",
       "      isMeSHTerm  isTaxoTerm         Terme formatté  TF (sklearn)  \\\n",
       "0          False        True             traitement          7864   \n",
       "1          False       False                   jamp          2556   \n",
       "2          False       False             évaluation          1694   \n",
       "3          False        True            médicaments          5451   \n",
       "4          False       False                demande          3662   \n",
       "...          ...         ...                    ...           ...   \n",
       "6020       False       False                  degré            16   \n",
       "6021       False       False                   foam            16   \n",
       "6022       False        True                  coque            16   \n",
       "6023       False       False  médicaments du québec            16   \n",
       "6024       False       False                    lmc            14   \n",
       "\n",
       "      DF (sklearn)  \n",
       "0             1180  \n",
       "1              992  \n",
       "2              324  \n",
       "3             1206  \n",
       "4              240  \n",
       "...            ...  \n",
       "6020            14  \n",
       "6021             8  \n",
       "6022            12  \n",
       "6023            13  \n",
       "6024             2  \n",
       "\n",
       "[6025 rows x 11 columns]"
      ]
     },
     "execution_count": 113,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csv['TF (sklearn)'] = 0\n",
    "for t in vocabulaire:\n",
    "    csv.loc[csv['Terme formatté'] == t, 'TF (sklearn)'] = df[t].sum()\n",
    "\n",
    "\n",
    "csv['DF (sklearn)'] = 0\n",
    "for t in vocabulaire:\n",
    "    freqdoc = len(df[df[t] != 0])\n",
    "    csv.loc[csv['Terme formatté'] == t, 'DF (sklearn)'] = freqdoc\n",
    "csv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from nltk import RegexpTokenizer\n",
    "\n",
    "#toknizer = RegexpTokenizer()\n",
    "\n",
    "# max_df : ignore words that appear in 85% of documents, \n",
    "# min df:  ignore words that appear in less than 1% of documents \n",
    "# vocabulary = vocabulaire\n",
    "\n",
    "# Sans utiliser le vocabulaire\n",
    "# tfidf = TfidfVectorizer(min_df=0.1, stop_words=None, ngram_range=(2,4), max_df=0.85, use_idf=True)\n",
    "\n",
    "# vocabulary = vocabulaire\n",
    "tfidf_vectorizer = TfidfVectorizer(vocabulary=vocabulaire, ngram_range=(1,10), lowercase=False, token_pattern='\\w+')\n",
    "tfidf = tfidf_vectorizer.fit_transform(corpus)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "metadata": {},
   "outputs": [],
   "source": [
    "features_names = tfidf_vectorizer.get_feature_names_out()\n",
    "corpus_index = [corpus.index(n) for n in corpus]\n",
    "\n",
    "import pandas as pd\n",
    "df = pd.DataFrame(tfidf.T.todense(), index=features_names, columns=corpus_index).transpose()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [],
   "source": [
    "terms_tfidf = {term: df[term].max() for term in df}\n",
    "zeros = {term : value for term, value in terms_tfidf.items() if terms_tfidf[term] == 0}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'bromhydrate': 0.0,\n",
       " 'sulfonate calcique': 0.0,\n",
       " 'auteur': 0.0,\n",
       " 'projet auteur': 0.0,\n",
       " 'évaluation keytruda': 0.0,\n",
       " 'hospitalisation et projections des besoins': 0.0,\n",
       " 'hospitalisation et projections': 0.0,\n",
       " 'hospitalisation et projections des besoins hospitaliers': 0.0,\n",
       " 'évaluation keytruda pembrolizumab merck': 0.0,\n",
       " 'évaluation keytruda pembrolizumab': 0.0,\n",
       " 'entretien': 0.0,\n",
       " 'inspq visitez': 0.0,\n",
       " 'intérêt visitez': 0.0,\n",
       " 'covid_19 longue': 0.0,\n",
       " 'évolution de l_épidémie': 0.0,\n",
       " 'épidémie de covid_19': 0.0,\n",
       " 'évolution de l_épidémie de covid_19': 0.0,\n",
       " 'alcool': 0.0,\n",
       " 'exception décision': 0.0,\n",
       " 'exception décision du ministre': 0.0,\n",
       " 'endomètre': 0.0,\n",
       " 'asthme sévère': 0.0,\n",
       " 'évaluation keytruda pembrolizumab merck traitement': 0.0,\n",
       " 'utérus': 0.0,\n",
       " 'aide à la décision': 0.0,\n",
       " 'ensemble des critères': 0.0,\n",
       " 'ensemble des critères prévus': 0.0,\n",
       " 'usage d_alcool': 0.0,\n",
       " 'excellence en santé': 0.0,\n",
       " 'excellence en santé et en services sociaux': 0.0,\n",
       " 'excellence en santé et en services': 0.0,\n",
       " 'inscription de médicaments': 0.0,\n",
       " 'atrophie': 0.0,\n",
       " 'immunodéficience': 0.0,\n",
       " 'inscription adhésion au dépôt': 0.0,\n",
       " 'inscription adhésion au dépôt électronique': 0.0,\n",
       " 'immunodéficience humaine': 0.0,\n",
       " 'inscription adhésion au dépôt électronique d_une demande': 0.0,\n",
       " 'usage d_alcool troubles neurocognitifs': 0.0,\n",
       " 'usage d_alcool troubles': 0.0,\n",
       " 'alcool troubles': 0.0,\n",
       " 'inscription médicaments': 0.0,\n",
       " 'alcool troubles neurocognitifs document complémentaire': 0.0,\n",
       " 'évaluation modalités d_évaluation des médicaments': 0.0,\n",
       " 'évaluation modalités d_évaluation': 0.0,\n",
       " 'asthme sévère de type': 0.0,\n",
       " 'évaluation modalités': 0.0,\n",
       " 'alcool troubles neurocognitifs': 0.0,\n",
       " 'ipp': 0.0,\n",
       " 'évaluation nucala': 0.0,\n",
       " 'évaluation foquest méthylphénidate': 0.0,\n",
       " 'évaluation foquest': 0.0,\n",
       " 'exemption de la méthode': 0.0,\n",
       " 'inscription médicaments en attente': 0.0,\n",
       " 'exception évaluation des médicaments biosimilaires': 0.0,\n",
       " 'exception évaluation des médicaments': 0.0,\n",
       " 'exception évaluation': 0.0,\n",
       " 'ajustement professionnels': 0.0,\n",
       " 'ajustement professionnels impliqués protocole': 0.0,\n",
       " 'atrophie vulvovaginale': 0.0,\n",
       " 'inscription avis au ministre': 0.0,\n",
       " 'ajustement professionnels impliqués': 0.0,\n",
       " 'entretien du déficit grave': 0.0,\n",
       " 'évaluation opdivo': 0.0,\n",
       " 'uvéite non infectieuse': 0.0,\n",
       " 'entretien du déficit': 0.0,\n",
       " 'endomètre pré_ac': 0.0,\n",
       " 'endomètre pré_ac en cours': 0.0,\n",
       " 'endomètre pré_ac en cours d_évaluation': 0.0,\n",
       " 'évaluation trikafta': 0.0,\n",
       " 'évaluation amgevita adalimumab amgen': 0.0,\n",
       " 'évaluation amgevita': 0.0,\n",
       " 'évaluation amgevita adalimumab': 0.0,\n",
       " 'évaluation vraylar cariprazine': 0.0,\n",
       " 'évaluation vraylar cariprazine abbvie traitement': 0.0,\n",
       " 'évaluation vraylar cariprazine abbvie': 0.0,\n",
       " 'évaluation vraylar': 0.0,\n",
       " 'assurance maladie': 0.0,\n",
       " 'évaluation ultomiris ravulizumab': 0.0,\n",
       " 'évaluation ultomiris': 0.0,\n",
       " 'assurance maladie du québec': 0.0,\n",
       " 'inesss recommande': 0.0,\n",
       " 'incertitude existante': 0.0,\n",
       " 'hospitalisation pour les personnes infectées par le sras_cov_2': 0.0,\n",
       " 'hospitalisation pour les personnes infectées': 0.0,\n",
       " 'intervention en santé': 0.0,\n",
       " 'origine': 0.0,\n",
       " 'autisme': 0.0,\n",
       " 'assurance médicaments': 0.0,\n",
       " 'œdème': 0.0,\n",
       " 'antigène': 0.0,\n",
       " 'inscription aux listes': 0.0,\n",
       " 'accès vasculaire': 0.0,\n",
       " 'objet d_une évaluation': 0.0,\n",
       " 'inesss estime': 0.0,\n",
       " 'inesss met': 0.0,\n",
       " 'nivolumab b.m.s.': 0.0,\n",
       " 'n.nordisk': 0.0,\n",
       " 'inscription aux listes des médicaments': 0.0,\n",
       " 'oxydation des acides gras à longue chaîne': 0.0,\n",
       " 'oxydation des acides gras': 0.0,\n",
       " 'furoate': 0.0,\n",
       " 'échelle edss': 0.0,\n",
       " 'oxydation': 0.0,\n",
       " 'oxydation des acides': 0.0,\n",
       " 'inesss met en lumière': 0.0,\n",
       " 'objet d_une évaluation scientifique': 0.0,\n",
       " 'œsophage': 0.0,\n",
       " 'entretien d_appoint': 0.0,\n",
       " 'aetmis': 0.0,\n",
       " 'inesss a pour mandat': 0.0,\n",
       " 'assurance médicament': 0.0,\n",
       " 'hôte': 0.0,\n",
       " 'évaluation zeposia ozanimod': 0.0,\n",
       " 'ozanimod b.m.s.': 0.0,\n",
       " 'évaluation zeposia': 0.0,\n",
       " 'évaluation myinfla colchicine': 0.0,\n",
       " 'infections bactériennes aiguës de la peau et des structures cutanées': 0.0,\n",
       " 'infections bactériennes aiguës de la peau': 0.0,\n",
       " 'infections bactériennes aiguës': 0.0,\n",
       " 'évaluation trikafta élexacaftor': 0.0,\n",
       " 'évaluation myinfla': 0.0,\n",
       " 'évaluation tepmetko tepotinib': 0.0,\n",
       " 'évaluation xpovio': 0.0,\n",
       " 'évaluation xpovio sélinexor': 0.0,\n",
       " 'évaluation hyrimoz': 0.0,\n",
       " 'évaluation xpovio sélinexor forus': 0.0,\n",
       " 'exception evaluation publiée': 0.0,\n",
       " 'exception evaluation': 0.0,\n",
       " 'appoint du lupus': 0.0,\n",
       " 'oedème maculaire diabétique': 0.0,\n",
       " 'évaluation tepmetko': 0.0,\n",
       " 'utérus intact avec intolérance à l_acétate': 0.0,\n",
       " 'pegol n.nordisk traitement prophylactique': 0.0,\n",
       " 'pegol n.nordisk traitement': 0.0,\n",
       " 'utérus intact': 0.0,\n",
       " 'utérus intact avec intolérance': 0.0,\n",
       " 'oedème': 0.0,\n",
       " 'ptta': 0.0,\n",
       " 'entretien de l_asthme éosinophile': 0.0,\n",
       " 'entretien de l_asthme': 0.0,\n",
       " 'oedème maculaire': 0.0,\n",
       " 'évaluation scemblix': 0.0,\n",
       " 'évaluation libtayo cémiplimab sanofiaven traitement': 0.0,\n",
       " 'évaluation libtayo cémiplimab sanofiaven': 0.0,\n",
       " 'évaluation libtayo': 0.0,\n",
       " 'évaluation nucala mépolizumab gsk traitement': 0.0,\n",
       " 'évaluation nucala mépolizumab gsk': 0.0,\n",
       " 'évaluation nucala mépolizumab': 0.0,\n",
       " 'évaluation libtayo cémiplimab': 0.0,\n",
       " 'évaluation hyrimoz adalimumab': 0.0,\n",
       " 'évaluation hyrimoz adalimumab sandoz': 0.0,\n",
       " 'évaluation wakix': 0.0,\n",
       " 'évaluation wakix pitolisant': 0.0,\n",
       " 'évaluation wakix pitolisant paladin': 0.0,\n",
       " 'association nivolumab': 0.0,\n",
       " 'évaluation opdivo et yervoy': 0.0,\n",
       " 'ipilimumab b.m.s.': 0.0,\n",
       " 'évaluation bryhali halobétasol bauschhealth': 0.0,\n",
       " 'évaluation bryhali halobétasol': 0.0,\n",
       " 'évaluation bryhali': 0.0,\n",
       " 'évaluation bryhali halobétasol bauschhealth soulagement': 0.0,\n",
       " 'atrophie vulvovaginale postménopausique': 0.0,\n",
       " 'insertion': 0.0,\n",
       " 'opdivo nivolumab b.m.s.': 0.0,\n",
       " 'appoint du lupus érythémateux disséminé': 0.0,\n",
       " 'évaluation opdivo nivolumab': 0.0,\n",
       " 'évaluation opdivo nivolumab b.m.s.': 0.0,\n",
       " 'appoint du lupus érythémateux': 0.0,\n",
       " 'hôte chez les patients': 0.0,\n",
       " 'évaluation dayvigo': 0.0,\n",
       " 'évaluation dayvigo lemborexant': 0.0,\n",
       " 'évaluation jakavi': 0.0,\n",
       " 'infection à clostridium difficile': 0.0,\n",
       " 'traitement des adultes atteints d_une infection à clostridium difficile': 0.0,\n",
       " 'insertion de l_exon': 0.0,\n",
       " 'assurance médicament l iste': 0.0,\n",
       " 'médicaments ─ établissements': 0.0,\n",
       " 'iste des médicaments ─ établissements': 0.0,\n",
       " 'adultes atteints d_une infection à clostridium difficile': 0.0,\n",
       " 'pegol n.nordisk': 0.0,\n",
       " 'oedème maculaire diabétique _omd_': 0.0,\n",
       " 'évaluation nubeqa': 0.0,\n",
       " 'cvb': 0.0,\n",
       " 'évaluation jardiance empagliflozine': 0.0,\n",
       " 'évaluation jardiance': 0.0,\n",
       " 'évaluation nypozi filgrastim tanvex': 0.0,\n",
       " 'acétylcystéine acétylcystéine': 0.0,\n",
       " 'évaluation gavreto pralsetinib': 0.0,\n",
       " 'évaluation nypozi': 0.0,\n",
       " 'évaluation nypozi filgrastim': 0.0,\n",
       " 'cdt': 0.0,\n",
       " 'évaluation nucala mepolizumab': 0.0,\n",
       " 'évaluation gavreto': 0.0,\n",
       " 'évaluation zemaira inhibiteur': 0.0,\n",
       " 'évaluation zemaira': 0.0,\n",
       " 'évaluation rybrevant': 0.0,\n",
       " 'évaluation du médicament réfère': 0.0,\n",
       " 'évaluation nucala mepolizumab gsk traitement': 0.0,\n",
       " 'évaluation nucala mepolizumab gsk': 0.0,\n",
       " 'monohydrate': 0.0,\n",
       " 'nourrissons ou enfants': 0.0,\n",
       " 'évaluation kimmtrak': 0.0,\n",
       " 'autorisation permettant la publication': 0.0,\n",
       " 'évaluation jemperli': 0.0,\n",
       " 'évaluation prolastin_c': 0.0,\n",
       " 'évaluation kimmtrak tebentafusp': 0.0,\n",
       " 'immunodéficience humaine l_évaluation': 0.0,\n",
       " 'évaluation prolastin_c liquid': 0.0,\n",
       " 'hyperkaliémie chez les patients atteints': 0.0,\n",
       " 'hyperkaliémie chez les patients': 0.0,\n",
       " 'évaluation kimmtrak tebentafusp medison': 0.0,\n",
       " 'autorisation permettant': 0.0,\n",
       " 'évaluation rybrevant amivantamab': 0.0,\n",
       " 'âge pré_ac': 0.0,\n",
       " 'évaluation jemperli dostarlimab': 0.0,\n",
       " 'appoint au traitement standard chez les adultes': 0.0,\n",
       " 'hémostase': 0.0,\n",
       " 'évaluation jemperli dostarlimab gsk': 0.0,\n",
       " 'appoint au traitement standard': 0.0,\n",
       " 'œdème maculaire diabétique pré_ac': 0.0,\n",
       " 'œdème maculaire diabétique': 0.0,\n",
       " 'œdème maculaire': 0.0,\n",
       " 'âge pré_ac en cours': 0.0,\n",
       " 'âge pré_ac en cours d_évaluation': 0.0,\n",
       " 'entretien de l_asthme éosinophile sévère': 0.0,\n",
       " 'évaluation glassia inhibiteur': 0.0,\n",
       " 'évaluation cosentyx sécukinumab novartis': 0.0,\n",
       " 'évaluation glassia': 0.0,\n",
       " 'évaluation cosentyx sécukinumab': 0.0,\n",
       " 'évaluation cosentyx': 0.0,\n",
       " 'asthme éosinophile sévère': 0.0,\n",
       " 'utérus persistant': 0.0,\n",
       " 'omd': 0.0,\n",
       " 'nonacog beta pegol n.nordisk traitement': 0.0,\n",
       " 'nonacog beta pegol n.nordisk': 0.0,\n",
       " 'objet d_une évaluation scientifique par l_inesss': 0.0,\n",
       " 'évaluation en mode': 0.0,\n",
       " 'évaluation en mode continu': 0.0,\n",
       " 'œdème maculaire diabétique pré_ac en attente': 0.0,\n",
       " 'appoint au traitement': 0.0,\n",
       " 'évaluation rozlytrek': 0.0,\n",
       " 'évaluation jemperli dostarlimab gsk traitement': 0.0,\n",
       " 'évaluation rozlytrek entrectinib': 0.0,\n",
       " 'évaluation en mode continu par l_inesss': 0.0,\n",
       " 'asthme sévère pré_ac en attente': 0.0,\n",
       " 'insuffisance cardiaque pré_ac en attente': 0.0,\n",
       " 'insuffisance cardiaque pré_ac': 0.0,\n",
       " 'évaluation vyepti': 0.0,\n",
       " 'évaluation vyepti eptinezumab': 0.0,\n",
       " 'évaluation vyepti eptinezumab lundbeck': 0.0,\n",
       " 'évaluation mvasi': 0.0,\n",
       " 'évaluation prolastin_c liquid inhibiteur': 0.0,\n",
       " 'asthme sévère pré_ac': 0.0,\n",
       " 'évaluation vyepti eptinezumab lundbeck traitement': 0.0,\n",
       " 'évaluation mvasi bévacizumab': 0.0,\n",
       " 'antigène leucocytaire': 0.0,\n",
       " 'antigène leucocytaire humain': 0.0,\n",
       " 'enfant pré_ac en attente d_évaluation': 0.0,\n",
       " 'enfant pré_ac': 0.0,\n",
       " 'évaluation mvasi bévacizumab amgen': 0.0,\n",
       " 'évaluation mvasi bévacizumab amgen traitement': 0.0,\n",
       " 'enfant pré_ac en attente': 0.0,\n",
       " 'ostéoporose pré_ac': 0.0,\n",
       " 'ostéoporose pré_ac en attente': 0.0,\n",
       " 'ostéoporose pré_ac en attente d_évaluation': 0.0,\n",
       " 'toag_lc': 0.0,\n",
       " 'asthme éosinophile': 0.0,\n",
       " 'entretien d_appoint chez les adultes': 0.0,\n",
       " 'appoint chez les adultes': 0.0,\n",
       " 'appoint chez les adultes et les adolescents': 0.0,\n",
       " 'angioedème': 0.0,\n",
       " 'angioedème héréditaire _aoh_': 0.0,\n",
       " 'aoh': 0.0,\n",
       " 'angioedème héréditaire': 0.0,\n",
       " 'évaluation orladeyo': 0.0,\n",
       " 'évaluation ngenla': 0.0,\n",
       " 'évaluation amgevita adalimumab amgen traitement': 0.0,\n",
       " 'évaluation oncaspar pegaspargase': 0.0,\n",
       " 'évaluation hulio': 0.0,\n",
       " 'évaluation oncaspar pegaspargase servier traitement': 0.0,\n",
       " 'évaluation addnutriv agent de suppléance': 0.0,\n",
       " 'évaluation oncaspar pegaspargase servier': 0.0,\n",
       " 'évaluation addnutriv': 0.0,\n",
       " 'évaluation addnutriv agent': 0.0,\n",
       " 'évaluation dojolvi': 0.0,\n",
       " 'évaluation ngenla somatrogon': 0.0,\n",
       " 'évaluation xydalba dalbavancine': 0.0,\n",
       " 'évaluation saphnelo anifrolumab azc traitement': 0.0,\n",
       " 'évaluation dojolvi triheptanoïne ultragenyx traitement': 0.0,\n",
       " 'furoate monohydraté': 0.0,\n",
       " 'acétylcystéine acétylcystéine sandoz': 0.0,\n",
       " 'évaluation xydalba dalbavancine paladin': 0.0,\n",
       " 'évaluation hulio adalimumab': 0.0,\n",
       " 'évaluation intrarosa': 0.0,\n",
       " 'évaluation saphnelo': 0.0,\n",
       " 'évaluation hulio adalimumab bgp': 0.0,\n",
       " 'évaluation intrarosa prasterone': 0.0,\n",
       " 'évaluation xydalba': 0.0,\n",
       " 'évaluation rinvoq': 0.0,\n",
       " 'évaluation rinvoq upadacitinib abbvie': 0.0,\n",
       " 'évaluation rinvoq upadacitinib': 0.0,\n",
       " 'évaluation oncaspar': 0.0,\n",
       " 'évaluation saphnelo anifrolumab': 0.0,\n",
       " 'évaluation dojolvi triheptanoïne': 0.0,\n",
       " 'évaluation dojolvi triheptanoïne ultragenyx': 0.0,\n",
       " 'évaluation intrarosa prasterone lupin': 0.0,\n",
       " 'évaluation saphnelo anifrolumab azc': 0.0,\n",
       " 'évaluation osphena ospémifène': 0.0,\n",
       " 'évaluation osphena': 0.0,\n",
       " 'évaluation osphena ospémifène duchesnay': 0.0,\n",
       " 'âge pré_ac en cours d_évaluation rozlytrek': 0.0,\n",
       " 'évaluation minjuvi tafasitamab': 0.0,\n",
       " 'évaluation minjuvi': 0.0,\n",
       " 'ostéoporose pré_ac en attente d_évaluation orladeyo': 0.0,\n",
       " 'endomètre pré_ac en cours d_évaluation cosentyx': 0.0,\n",
       " 'inesss émet': 0.0,\n",
       " 'organes solides': 0.0,\n",
       " 'autorisation initiale': 0.0,\n",
       " 'attention du pharmacien communautaire': 0.0,\n",
       " 'attention du pharmacien': 0.0,\n",
       " 'anatomopathologie': 0.0,\n",
       " 'xinafoate': 0.0,\n",
       " 'propionate': 0.0,\n",
       " 'autisme _tsa_': 0.0,\n",
       " 'amélioration continue': 0.0,\n",
       " 'pma': 0.0,\n",
       " 'association lopinavir': 0.0,\n",
       " 'œil': 0.0,\n",
       " 'évidence d_un effet bénéfique': 0.0,\n",
       " 'icc': 0.0,\n",
       " 'inscription à la liste': 0.0,\n",
       " 'congrès et colloques': 0.0,\n",
       " 'acquisition': 0.0,\n",
       " 'colloques en traumatologie': 0.0,\n",
       " 'congrès et colloques en traumatologie': 0.0,\n",
       " 'inesss a développé': 0.0,\n",
       " 'influenza chez l_enfant': 0.0,\n",
       " 'aps': 0.0,\n",
       " 'exception de la liste': 0.0,\n",
       " 'inesss a évalué': 0.0,\n",
       " 'oms': 0.0,\n",
       " 'adulte dans le contexte': 0.0,\n",
       " 'influenza chez l_enfant et l_adulte dans le contexte': 0.0,\n",
       " 'influenza chez l_enfant et l_adulte': 0.0,\n",
       " 'exception de la liste de médicaments': 0.0,\n",
       " 'exception des listes': 0.0,\n",
       " 'protéines de lait ou de soya': 0.0,\n",
       " 'soya': 0.0,\n",
       " 'allergie aux protéines de lait ou de soya': 0.0,\n",
       " 'adulte dans le contexte de la covid_19': 0.0,\n",
       " 'ensemble du système': 0.0,\n",
       " 'inscription à venir': 0.0,\n",
       " 'ensemble du système de santé': 0.0,\n",
       " 'allergie aux protéines de lait': 0.0,\n",
       " 'inesss est conscient': 0.0,\n",
       " 'faites_nous': 0.0,\n",
       " 'analyse des besoins des familles': 0.0,\n",
       " 'lymphome hodgkin': 0.0,\n",
       " 'exception de la liste de médicaments du régime général': 0.0,\n",
       " 'exception de la liste de médicaments du régime': 0.0,\n",
       " 'exception à la section régulière': 0.0,\n",
       " 'évaluation diagnostique des troubles': 0.0,\n",
       " 'évaluation en traumatologie': 0.0,\n",
       " 'amélioration continue de la qualité': 0.0,\n",
       " 'évaluation en traumatologie et en soins critiques': 0.0,\n",
       " 'évaluation en traumatologie et en soins': 0.0,\n",
       " 'efficacité clinique': 0.0,\n",
       " 'exercice du collège': 0.0,\n",
       " 'exercice du collège des médecins': 0.0,\n",
       " 'usage des médicaments': 0.0,\n",
       " 'anesthésie générale': 0.0,\n",
       " 'usage de l_association': 0.0,\n",
       " 'émicizumab': 0.0,\n",
       " 'inscription à la liste du rgam': 0.0,\n",
       " 'ovaire': 0.0,\n",
       " 'évidence d_un effet bénéfique par l_absence': 0.0,\n",
       " 'évaluation des produits du système du sang': 0.0,\n",
       " 'évaluation des produits du système': 0.0,\n",
       " 'exercice du collège des médecins du québec': 0.0,\n",
       " 'évaluation des produits': 0.0,\n",
       " 'usage de l_association lopinavir': 0.0,\n",
       " 'insulinothérapie': 0.0,\n",
       " 'urgence sanitaire': 0.0,\n",
       " 'innocuité cardiovasculaire': 0.0,\n",
       " 'inscription à la liste du rgam décision': 0.0,\n",
       " 'évolution des pratiques en oncologie': 0.0,\n",
       " 'évolution des pratiques': 0.0,\n",
       " 'association carboplatine': 0.0,\n",
       " 'association d_une tzd': 0.0,\n",
       " 'utilisation des tests': 0.0,\n",
       " 'assistance ventriculaire': 0.0,\n",
       " 'autonomie fonctionnelle': 0.0,\n",
       " 'oxaliplatine': 0.0,\n",
       " 'exception à la section régulière décision': 0.0,\n",
       " 'res en l_équipe de projet auteur': 0.0,\n",
       " 'évaluation diagnostique des troubles neurodéveloppementaux chez les enfants': 0.0,\n",
       " 'hypertension pulmonaire': 0.0,\n",
       " 'inesss d_élaborer': 0.0,\n",
       " 'inesss le mandat': 0.0,\n",
       " 'ensemble des données': 0.0,\n",
       " 'économie de la santé': 0.0,\n",
       " 'usage des opioïdes': 0.0,\n",
       " 'évolution des pratiques en oncologie _cepo_': 0.0,\n",
       " 'ordre des pharmaciens du québec': 0.0,\n",
       " 'helicobacter': 0.0,\n",
       " 'évaluation des médicaments et des technologies': 0.0,\n",
       " 'hcg': 0.0,\n",
       " 'juge qu_': 0.0,\n",
       " 'inesss a procédé': 0.0,\n",
       " 'helicobacter pylori': 0.0,\n",
       " 'ensemble des documents': 0.0,\n",
       " 'exigence d_un essai préalable avec un immunosuppresseur': 0.0,\n",
       " 'exigence d_un essai préalable': 0.0,\n",
       " 'usage optimal _guo_': 0.0,\n",
       " 'efficacité soit modifié': 0.0,\n",
       " 'équilibre bénéfices_risques': 0.0,\n",
       " 'assurance médicaments du québec': 0.0,\n",
       " 'inesss a entrepris': 0.0,\n",
       " 'inesss a élaboré': 0.0}"
      ]
     },
     "execution_count": 117,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "zeros"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "6.970954356846473"
      ]
     },
     "execution_count": 118,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(zeros) / len(vocabulaire) *100"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'traitement': 0.23369636532326207,\n",
       " 'jamp': 0.29924686605391876,\n",
       " 'évaluation': 0.20741661056128932,\n",
       " 'médicaments': 0.3981305740253018,\n",
       " 'demande': 0.5580812780469357,\n",
       " 'inesss': 0.5529704133634528,\n",
       " 'attente': 0.34497126734932826,\n",
       " 'injection': 0.2569514183782643,\n",
       " 'ministre': 0.40365828329161973,\n",
       " 'patients': 0.21635323821345812,\n",
       " 'médicament': 0.29438295880067566,\n",
       " 'cours': 0.14865292382697187,\n",
       " 'inscription': 0.15309853058123454,\n",
       " 'sodium': 0.28981644539900886,\n",
       " 'citrate': 0.08590160639011464,\n",
       " 'attente d_évaluation': 0.2964632267509891,\n",
       " 'cancer': 0.5095657182967378,\n",
       " 'angita': 0.03674036534465795,\n",
       " 'darunavir': 0.2871619287714037,\n",
       " 'calcium': 0.5756092052559373,\n",
       " 'lurasidone': 0.17342763328232366,\n",
       " 'bicarbonate': 0.17363255382174503,\n",
       " 'réponses': 0.4692707467706064,\n",
       " 'dextrose': 0.17363255382174503,\n",
       " 'sulfonate': 0.08681627691087251,\n",
       " 'bicarbonate de sodium': 0.17363255382174503,\n",
       " 'glycopyrrolate': 0.17363255382174503,\n",
       " 'cours d_évaluation': 0.2594076785489053,\n",
       " 'réponses rapides': 0.477123670692439,\n",
       " 'covid_19': 0.5504366635452947,\n",
       " 'santé': 0.3040510697406075,\n",
       " 'indication': 0.19551933179897638,\n",
       " 'réponses rapides disponibles': 0.42941130362319513,\n",
       " 'pré_ac': 0.23869965475779004,\n",
       " 'services': 0.3927786709072175,\n",
       " 'listes': 0.25459241939600824,\n",
       " 'décision': 0.21601776024796346,\n",
       " 'québec': 0.19279361937531445,\n",
       " 'nom': 0.08480593199944458,\n",
       " 'demande en attente': 0.19764215116732606,\n",
       " 'coll': 0.41766835310476647,\n",
       " 'recommandations': 0.1368591358506286,\n",
       " 'adultes': 0.18096986914776333,\n",
       " 'projet': 0.47412178929476884,\n",
       " 'fabricant': 0.10155093540511893,\n",
       " 'cliniques': 0.1936130976803758,\n",
       " 'chlorhydrate': 0.06860021255453846,\n",
       " 'soins': 0.310387798901902,\n",
       " 'forme': 0.12689792059706415,\n",
       " 'dépôt': 0.43896659034737634,\n",
       " 'pré_ac en attente': 0.1729368822714103,\n",
       " 'conseil': 0.38534703738995946,\n",
       " 'recommandation': 0.3297627911647669,\n",
       " 'fumarate': 0.04749953749265081,\n",
       " 'demande en cours': 0.1584305284102368,\n",
       " 'demande en cours d_évaluation': 0.1584305284102368,\n",
       " 'commune': 0.0849539358394948,\n",
       " 'dénomination commune': 0.08540059424109869,\n",
       " 'exception': 0.10909312899742216,\n",
       " 'dénomination': 0.08530099143102597,\n",
       " 'évaluations': 0.08475669458126373,\n",
       " 'maladie': 0.3565291082919169,\n",
       " 'listes des médicaments': 0.23437229452581818,\n",
       " 'canada': 0.19203738515367255,\n",
       " 'usage': 0.5935719394951011,\n",
       " 'ans': 0.24192920603100151,\n",
       " 'nom du fabricant': 0.08560039708088553,\n",
       " 'contexte': 0.204817240932048,\n",
       " 'liste': 0.28702474095867725,\n",
       " 'teneur': 0.14430584965392285,\n",
       " 'apotex': 0.05785373736637102,\n",
       " 'recommandation de l_inesss': 0.13952042386696897,\n",
       " 'connaissances': 0.22818871057882892,\n",
       " 'quétiapine': 0.08661156590180126,\n",
       " 'quétiapine _fumarate de_': 0.08661156590180126,\n",
       " 'produits': 0.428895335349547,\n",
       " 'traitements': 0.3916016984088624,\n",
       " 'evaluation': 0.08722823058305822,\n",
       " 'décision du ministre': 0.08590160639011464,\n",
       " 'lurasidone _chlorhydrate de_': 0.08671381664116183,\n",
       " 'oméga': 0.026585352403994032,\n",
       " 'calcium _citrate de_': 0.14107675287314791,\n",
       " 'bromhydrate': 0.0,\n",
       " 'ag_calcium': 0.08671381664116183,\n",
       " 'élétriptan': 0.08681627691087251,\n",
       " 'ag_quetiapine': 0.08681627691087251,\n",
       " 'injection de glycopyrrolate': 0.08681627691087251,\n",
       " 'apo_eletriptan': 0.08681627691087251,\n",
       " 'dextrose injection': 0.08681627691087251,\n",
       " 'jamp lurasidone': 0.08681627691087251,\n",
       " 'polystyrène': 0.08681627691087251,\n",
       " 'sulfonate calcique': 0.0,\n",
       " 'sodium pour injection': 0.08681627691087251,\n",
       " 'halycil': 0.08681627691087251,\n",
       " 'ag_calcium citrate': 0.08681627691087251,\n",
       " 'ag_calcium citrate liquid': 0.08681627691087251,\n",
       " 'jamp calcium polystyrene sulfonate': 0.08681627691087251,\n",
       " 'jamp calcium': 0.08681627691087251,\n",
       " 'jamp calcium polystyrene': 0.08681627691087251,\n",
       " 'citrate liquid': 0.08681627691087251,\n",
       " 'calcium polystyrene': 0.08681627691087251,\n",
       " 'bicarbonate de sodium pour injection': 0.08681627691087251,\n",
       " 'calcium polystyrene sulfonate': 0.08681627691087251,\n",
       " 'pré_ac en attente d_évaluation': 0.13587897892753667,\n",
       " 'données': 0.24778716905486892,\n",
       " 'darunavir dextrose injection': 0.08816772658860206,\n",
       " 'injection _jamp_': 0.08816772658860206,\n",
       " 'sodium pour injection _jamp_': 0.08816772658860206,\n",
       " 'jamp lurasidone _jamp_': 0.08816772658860206,\n",
       " 'apo_eletriptan _apotex_': 0.08816772658860206,\n",
       " 'évaluations récemment publiées': 0.08816772658860206,\n",
       " 'bicarbonate de sodium pour injection _jamp_': 0.08816772658860206,\n",
       " 'bicarbonate de sodium darunavir': 0.08816772658860206,\n",
       " 'dextrose halycil': 0.08816772658860206,\n",
       " 'bicarbonate de sodium darunavir _jamp_': 0.08816772658860206,\n",
       " 'sodium darunavir _jamp_': 0.08816772658860206,\n",
       " 'évaluations récemment': 0.08816772658860206,\n",
       " 'jamp calcium polystyrene sulfonate _jamp_': 0.08816772658860206,\n",
       " 'calcium polystyrene sulfonate _jamp_': 0.08816772658860206,\n",
       " 'dextrose injection _oméga_': 0.08816772658860206,\n",
       " 'darunavir dextrose': 0.08816772658860206,\n",
       " 'glycopyrrolate _jamp_': 0.08816772658860206,\n",
       " 'sodium darunavir': 0.08816772658860206,\n",
       " 'injection de glycopyrrolate _jamp_': 0.08816772658860206,\n",
       " 'injection _oméga_': 0.08816772658860206,\n",
       " 'evaluation publiée': 0.08816772658860206,\n",
       " 'darunavir _jamp_': 0.08816772658860206,\n",
       " 'citrate liquid _angita_': 0.08816772658860206,\n",
       " 'sulfonate _jamp_': 0.08816772658860206,\n",
       " 'association': 0.3069138041101071,\n",
       " 'adultes atteints': 0.1849446518307392,\n",
       " 'conditions': 0.2153294297395903,\n",
       " 'efficacité': 0.22789879397402363,\n",
       " 'demande en attente d_évaluation': 0.12352634447957879,\n",
       " 'attente d_un dépôt pour évaluation': 0.12352634447957879,\n",
       " 'attente d_un dépôt': 0.12352634447957879,\n",
       " 'dépôt pour évaluation': 0.12352634447957879,\n",
       " 'type': 0.45530043746863924,\n",
       " 'services sociaux': 0.35737980249078816,\n",
       " 'utilisation': 0.20692124764429426,\n",
       " 'produit': 0.3782851300423401,\n",
       " 'coût': 0.2958103089923085,\n",
       " 'résultats': 0.2911755287248604,\n",
       " 'risque': 0.3156509721546755,\n",
       " 'traitement des patients': 0.16015655865190917,\n",
       " 'cellules': 0.38096794492921565,\n",
       " 'fabricants': 0.6551918569854741,\n",
       " 'patients adultes': 0.16048193830383373,\n",
       " 'besoins': 0.19013703119031392,\n",
       " 'pandémie': 0.4370010181425507,\n",
       " 'système': 0.2985333945792275,\n",
       " 'clinique': 0.1718868685501446,\n",
       " 'enfants': 0.31193534765433417,\n",
       " 'patients adultes atteints': 0.1645019094776746,\n",
       " 'étude': 0.30473791178080284,\n",
       " 'études': 0.19861016704505113,\n",
       " 'réponse': 0.2681935552166463,\n",
       " 'indication reconnue': 0.23999820304998482,\n",
       " 'trauma': 0.40286838667681335,\n",
       " 'médicament d_exception': 0.22050197871194963,\n",
       " 'ligne': 0.12570065582855677,\n",
       " 'ordonnances': 0.22007447150834458,\n",
       " 'projet aligné': 0.006176317223978939,\n",
       " 'projet aligné inesss_acmts_santé canada': 0.006176317223978939,\n",
       " 'qualité': 0.33133693307471956,\n",
       " 'méthode': 0.2715330838333706,\n",
       " 'vie': 0.3738067841727798,\n",
       " 'poumon': 0.36256430735063017,\n",
       " 'connaissance': 0.491920879843773,\n",
       " 'msss': 0.189250389045432,\n",
       " 'cancer du poumon': 0.3650713217803546,\n",
       " 'traitement des patients adultes': 0.07344604761778155,\n",
       " 'traitement des patients adultes atteints': 0.07344604761778155,\n",
       " 'demande en attente d_un dépôt pour évaluation': 0.07411580668774727,\n",
       " 'demande en attente d_un dépôt': 0.07411580668774727,\n",
       " 'adulte': 0.2955298350120922,\n",
       " 'extrait': 0.18290717833335188,\n",
       " 'hospitalisation': 0.2255508862864798,\n",
       " 'produits de connaissance': 0.4971227724671914,\n",
       " 'auteur': 0.0,\n",
       " 'mois': 0.43114846443224897,\n",
       " 'suivi': 0.19563884185408215,\n",
       " 'traitement du cancer': 0.19325276091353247,\n",
       " 'patients atteints': 0.19000111169694164,\n",
       " 'kio': 0.17620148487156115,\n",
       " 'projet auteur': 0.0,\n",
       " 'ordonnance': 0.39289667550839596,\n",
       " 'réévaluation': 0.20270026537261931,\n",
       " 'risques': 0.18109245122089226,\n",
       " 'pré_ac en cours': 0.06793948946376833,\n",
       " 'pré_ac en cours d_évaluation': 0.06793948946376833,\n",
       " 'pratiques': 0.2441148174042227,\n",
       " 'ligne evaluation publiée': 0.12214520674449997,\n",
       " 'ligne evaluation': 0.12214520674449997,\n",
       " 'prise': 0.3031038369184203,\n",
       " 'extrait de l_avis au ministre': 0.16669532196007616,\n",
       " 'réponse rapide': 0.29763007726481344,\n",
       " 'établissements': 0.20576616878720205,\n",
       " 'trouble': 0.23343758776591517,\n",
       " 'injury': 0.332691105034037,\n",
       " 'indications': 0.6843242750533561,\n",
       " 'usage optimal': 0.5885624064519912,\n",
       " 'analyse': 0.22870047596835352,\n",
       " 'médicaments d_exception': 0.24827020965408458,\n",
       " 'symptômes': 0.3364389773360257,\n",
       " 'transfert': 0.189476215810322,\n",
       " 'cas': 0.3032221361540489,\n",
       " 'outil': 0.2584037083965797,\n",
       " 'sondage': 0.1193108461204297,\n",
       " 'ajout': 0.1305944277615663,\n",
       " 'ensemble': 0.15231943375284507,\n",
       " 'soutien': 0.22812125977973222,\n",
       " 'coordination': 0.1167452301542929,\n",
       " 'protocole': 0.4202102906369749,\n",
       " 'guide': 0.30068491094075994,\n",
       " 'traumatologie': 0.6321431916422053,\n",
       " 'description': 0.10001604275182098,\n",
       " 'évolution': 0.28337087280686457,\n",
       " 'pertinence': 0.15960418093223866,\n",
       " 'fiche': 0.400408528665863,\n",
       " 'chronique': 0.27849655971566073,\n",
       " 'processus': 0.2540678985562901,\n",
       " 'besoins hospitaliers': 0.2135602161313374,\n",
       " 'refus': 0.21319542444936704,\n",
       " 'régime': 0.1951537126710611,\n",
       " 'dépistage': 0.56260606193778,\n",
       " 'collaboration': 0.20209780368199057,\n",
       " 'coordination scientifique': 0.11840181350463855,\n",
       " 'diabète': 0.3431191596704677,\n",
       " 'accès': 0.23212224598799872,\n",
       " 'méthode de réponse': 0.17343413459739457,\n",
       " 'listes de médicaments': 0.22912864441430916,\n",
       " 'méthode de réponse rapide': 0.17343413459739457,\n",
       " 'projections': 0.33715527765178166,\n",
       " 'cancer du poumon non à petites cellules': 0.16208104363735995,\n",
       " 'cancérologie': 0.6512604720079617,\n",
       " 'durée': 0.28108832446905646,\n",
       " 'dose': 0.2979268271339005,\n",
       " 'tériflunomide': 0.05611201470878099,\n",
       " 'prophylaxie': 0.2314605590513958,\n",
       " 'description du médicament': 0.10477654513781653,\n",
       " 'modalités': 0.2978536490066637,\n",
       " 'kio autres recommandations': 0.12020113317466787,\n",
       " 'nom commercial': 0.04773038741694766,\n",
       " 'infection': 0.321806032169433,\n",
       " 'prévention': 0.19196694152268284,\n",
       " 'rencontre': 0.6451230008081085,\n",
       " 'général': 0.19169343502454705,\n",
       " 'lymphome': 0.36351171943467236,\n",
       " 'merck': 0.17382965542086865,\n",
       " 'chimiothérapie': 0.5668110192323421,\n",
       " 'critères': 0.10571610083143937,\n",
       " 'aide': 0.11504434207088277,\n",
       " 'réseau': 0.32879008398622517,\n",
       " 'effets': 0.2563854178461006,\n",
       " 'risques d_hospitalisation': 0.15867354474142392,\n",
       " 'conditions à venir': 0.08805770621685116,\n",
       " 'troubles': 0.3238980102170219,\n",
       " 'génériques': 0.40642545766631066,\n",
       " 'innocuité': 0.19097876100732805,\n",
       " 'stade': 0.19261331507319276,\n",
       " 'cadre': 0.20332473377679805,\n",
       " 'roche': 0.15375154007190153,\n",
       " 'population': 0.2521062835603366,\n",
       " 'électronique': 0.3503043452330722,\n",
       " 'mesure': 0.20117386460572043,\n",
       " 'pembrolizumab': 0.14930176220845343,\n",
       " 'keytruda': 0.45523932065643263,\n",
       " 'adalimumab': 0.14685023585724075,\n",
       " 'soins palliatifs': 0.46480606347969583,\n",
       " 'brain': 0.2532803252385867,\n",
       " 'demandes': 0.18394821048694432,\n",
       " 'demande d_inscription': 0.28919373415757477,\n",
       " 'jeunes': 0.5924104034607948,\n",
       " 'regard': 0.1557239259248474,\n",
       " 'présente': 0.20375149334841644,\n",
       " 'dépôt électronique': 0.25682834813151595,\n",
       " 'pembrolizumab merck': 0.049410537791831514,\n",
       " 'patient': 0.18719684985409069,\n",
       " 'test': 0.3868735668182056,\n",
       " 'évaluation keytruda': 0.0,\n",
       " 'hypertension': 0.20570274766676333,\n",
       " 'travaux': 0.1625268565439596,\n",
       " 'care': 0.2206516719020201,\n",
       " 'experts': 0.1403657115757503,\n",
       " 'fins': 0.2759903229658558,\n",
       " 'transfert de connaissances': 0.18340650799800792,\n",
       " 'semaines': 0.46933191645350075,\n",
       " 'sanis': 0.04901481573913627,\n",
       " 'sang': 0.2922034985771784,\n",
       " 'brain injury': 0.226087782731216,\n",
       " 'protocole médical': 0.31334484585904576,\n",
       " 'traumatic': 0.3014503769749547,\n",
       " 'traitement adjuvant': 0.322259905908378,\n",
       " 'professionnels': 0.18961733545030013,\n",
       " 'gène': 0.16864223541438272,\n",
       " 'projections des besoins hospitaliers': 0.12160234937659274,\n",
       " 'projections des besoins': 0.12160234937659274,\n",
       " 'pansement': 0.6017990172332022,\n",
       " 'sandoz': 0.39210241173008753,\n",
       " 'soins intensifs': 0.351568528020494,\n",
       " 'hospitalisation et projections des besoins': 0.0,\n",
       " 'hospitalisation et projections': 0.0,\n",
       " 'hospitalisation et projections des besoins hospitaliers': 0.0,\n",
       " 'risques d_hospitalisation et projections': 0.12160234937659274,\n",
       " 'raison': 0.14833926011355458,\n",
       " 'régime général': 0.2090320434220738,\n",
       " 'jours': 0.26979281658632176,\n",
       " 'liste des médicaments': 0.27602298659564994,\n",
       " 'déficit': 0.2971973589367709,\n",
       " 'portrait': 0.3483814809547503,\n",
       " 'mise': 0.44857571462068907,\n",
       " 'nombre': 0.21817885852726224,\n",
       " 'liste de médicaments': 0.22562584660305016,\n",
       " 'recherche': 0.43915037817347263,\n",
       " 'investigation': 0.05239332186664023,\n",
       " 'annexes': 0.2640502710136675,\n",
       " 'médecins': 0.23066092903651292,\n",
       " 'traitement des adultes': 0.036723023808890774,\n",
       " 'solution': 0.36649662054875554,\n",
       " 'atteintes': 0.16947141849314,\n",
       " 'pré_ac en attente d_un dépôt pour évaluation': 0.037057903343873634,\n",
       " 'pré_ac en attente d_un dépôt': 0.037057903343873634,\n",
       " 'adultes atteints d_un cancer': 0.037057903343873634,\n",
       " 'asthme': 0.20501604202517998,\n",
       " 'tableau': 0.16623856642417356,\n",
       " 'inhibiteur': 0.19722466434771166,\n",
       " 'infections': 0.36909095417985976,\n",
       " 'terme': 0.28081370861883276,\n",
       " 'procédures': 0.07157948186031404,\n",
       " 'québécois': 0.1747345360924791,\n",
       " 'mesures': 0.39048032721322545,\n",
       " 'diagnostic': 0.28854141364264324,\n",
       " 'élaboration': 0.08719482696841792,\n",
       " 'biosimilaire': 0.3681781699227314,\n",
       " 'pratique': 0.24966240341634227,\n",
       " 'références': 0.087874546418596,\n",
       " 'interventions': 0.2995632203698052,\n",
       " 'traumatic brain': 0.226087782731216,\n",
       " 'jour': 0.4799734405930157,\n",
       " 'études cliniques': 0.1119400637230712,\n",
       " 'attente d_évaluation keytruda': 0.037057903343873634,\n",
       " 'diabète de type': 0.3243935433651698,\n",
       " 'groupe': 0.36478740728759274,\n",
       " 'traumatic brain injury': 0.226087782731216,\n",
       " 'graves': 0.25241775686913914,\n",
       " 'formule': 0.3332377520029006,\n",
       " 'contexte de pandémie': 0.11728774842475506,\n",
       " 'analyses': 0.28207107856331926,\n",
       " 'ordonnance collective': 0.25069436894224295,\n",
       " 'évaluation des médicaments': 0.11811893911428921,\n",
       " 'biologie': 0.48669031494908976,\n",
       " 'biologie médicale': 0.48669031494908976,\n",
       " 'réadaptation': 0.3631292762331958,\n",
       " 'modification': 0.17805908587033936,\n",
       " 'azc': 0.1760223581574175,\n",
       " 'documentation': 0.12276503026746059,\n",
       " 'conseil a recommandé': 0.11572684242384383,\n",
       " 'post_covid_19': 0.463692589973626,\n",
       " 'implantation': 0.12455085800183577,\n",
       " 'femmes': 0.4142032212425161,\n",
       " 'ordonnances collectives': 0.14897475940430543,\n",
       " 'intervention': 0.3279478254963261,\n",
       " 'rétablissement': 0.2850943464430784,\n",
       " 'principaux': 0.08907482692250622,\n",
       " 'échéancier': 0.2816118737938616,\n",
       " 'contexte de la covid_19': 0.2325584686230045,\n",
       " 'affections': 0.27959848297775236,\n",
       " 'study': 0.15264679303930515,\n",
       " 'intention': 0.354356458975857,\n",
       " 'virus': 0.26711719185529564,\n",
       " 'survie': 0.374291862146398,\n",
       " 'intérêt': 0.12276026090571601,\n",
       " 'lyme': 0.5624751863282456,\n",
       " 'demandes d_inscription': 0.1415325297225845,\n",
       " 'reprise': 0.13037464512605967,\n",
       " 'ministère': 0.20562809712970279,\n",
       " 'rapports': 0.0979328886645333,\n",
       " 'formule nutritive': 0.23236054806538636,\n",
       " 'opdivo': 0.42981501119338494,\n",
       " 'maladies': 0.42995389023093955,\n",
       " 'produit biosimilaire': 0.14622260284688046,\n",
       " 'produit du système': 0.11249356499978312,\n",
       " 'plan': 0.37086669482576723,\n",
       " 'aspects': 0.15267982167603017,\n",
       " 'réduction': 0.1465883462336557,\n",
       " 'ajustement': 0.21518402333660333,\n",
       " 'mutation': 0.3515015280040832,\n",
       " 'littérature': 0.26360049540786773,\n",
       " 'réévaluation en attente': 0.030881586119894697,\n",
       " 'keytruda pembrolizumab merck': 0.030881586119894697,\n",
       " 'produit du système du sang_ traitement': 0.030881586119894697,\n",
       " 'fins d_inscription': 0.25851660355368244,\n",
       " 'keytruda pembrolizumab': 0.030881586119894697,\n",
       " 'nom commercial à venir': 0.030881586119894697,\n",
       " 'évaluation keytruda pembrolizumab merck': 0.0,\n",
       " 'évaluation keytruda pembrolizumab': 0.0,\n",
       " 'traitement des patients adultes atteints d_un cancer': 0.030881586119894697,\n",
       " 'sang_ traitement': 0.030881586119894697,\n",
       " 'patients adultes atteints d_un cancer': 0.030881586119894697,\n",
       " 'produit du système du sang_': 0.030881586119894697,\n",
       " 'review': 0.090504446736049,\n",
       " 'système du sang_ traitement': 0.030881586119894697,\n",
       " 'système du sang_': 0.030881586119894697,\n",
       " 'sang_': 0.030881586119894697,\n",
       " 'nivolumab': 0.38606929647970273,\n",
       " 'affections post_covid_19': 0.2837969751489182,\n",
       " 'phase': 0.31352452196962666,\n",
       " 'maladie de lyme': 0.5624751863282456,\n",
       " 'lien': 0.15864649046005103,\n",
       " 'syndrome': 0.46810288162023983,\n",
       " 'note': 0.11247474636341893,\n",
       " 'inspq': 0.012959753118997861,\n",
       " 'alternatives': 0.15572049438817648,\n",
       " 'notice': 0.23376306717710107,\n",
       " 'médicaments du régime': 0.2189717815105361,\n",
       " 'médicaments du régime général': 0.2189717815105361,\n",
       " 'immunoglobulines': 0.4323108478560879,\n",
       " 'chirurgie': 0.24194147978193425,\n",
       " 'santécom': 0.11971048183085622,\n",
       " 'sites': 0.0952215721490131,\n",
       " 'inhibiteurs': 0.38882956321958756,\n",
       " 'assurance': 0.09795920746528998,\n",
       " 'ventilation': 0.1552138753135264,\n",
       " 'états': 0.17801392042317404,\n",
       " 'entretien': 0.0,\n",
       " 'notice santécom': 0.120782035421425,\n",
       " 'ministère de la santé': 0.10463197706974238,\n",
       " 'conclusion': 0.07925889737173908,\n",
       " 'uetmis': 0.06921461749163238,\n",
       " 'biosimilaires': 0.39639669932483407,\n",
       " 'médecin': 0.2929253069024176,\n",
       " 'semaine': 0.36745903275917213,\n",
       " 'présentations': 0.057717667290319526,\n",
       " 'recommandation de l_inesss ajout': 0.1305346144852146,\n",
       " 'traitement d_entretien': 0.3747644667288536,\n",
       " 'lilly': 0.1846006100889887,\n",
       " 'hypertension artérielle': 0.18789891868137998,\n",
       " 'états des connaissances': 0.18014174675649006,\n",
       " 'chaleur': 0.09318565541966235,\n",
       " 'covid_19 au québec': 0.12450366756502841,\n",
       " 'oeuvre': 0.08732692073705763,\n",
       " 'placebo': 0.3377967143052582,\n",
       " 'treatment': 0.14746381400900377,\n",
       " 'influenza': 0.25832835782416264,\n",
       " 'temps': 0.16715961077371458,\n",
       " 'études cliniques en cours': 0.0824265807045348,\n",
       " 'approche': 0.14678375620712578,\n",
       " 'leucémie': 0.29168816627475075,\n",
       " 'épidémie': 0.030915097430031274,\n",
       " 'milieu': 0.4346159806957683,\n",
       " 'systematic': 0.07615035092452169,\n",
       " 'traitement du cancer du poumon': 0.2333690780830552,\n",
       " 'traitements en contexte': 0.08186941458307938,\n",
       " 'mise en oeuvre': 0.08772724236977326,\n",
       " 'impact': 0.1579481098736949,\n",
       " 'moment': 0.1540715467930134,\n",
       " 'ventilation assistée': 0.09375668924552648,\n",
       " 'tumeurs': 0.2536302052434525,\n",
       " 'coût de traitement': 0.17178588657214205,\n",
       " 'pandémie covid_19': 0.06927499009091483,\n",
       " 'réponse rapide dans le contexte de la covid_19': 0.08786205273162095,\n",
       " 'échangeur de chaleur': 0.09375668924552648,\n",
       " 'oeuvre de la méthode de réponse rapide': 0.08786205273162095,\n",
       " 'vue': 0.17457074946457132,\n",
       " 'élaboration et mise': 0.08786205273162095,\n",
       " 'méthode de réponse rapide dans le contexte': 0.08786205273162095,\n",
       " 'mise en oeuvre de la méthode de réponse': 0.08786205273162095,\n",
       " 'mise en oeuvre de la méthode': 0.08786205273162095,\n",
       " 'prophylaxie et traitement': 0.0824265807045348,\n",
       " 'échangeur': 0.09375668924552648,\n",
       " 'réponse rapide dans le contexte': 0.08786205273162095,\n",
       " 'oeuvre de la méthode de réponse': 0.08786205273162095,\n",
       " 'oeuvre de la méthode': 0.08786205273162095,\n",
       " 'élaboration et mise en oeuvre de la méthode': 0.08786205273162095,\n",
       " 'monothérapie': 0.16221361862451428,\n",
       " 'taux': 0.2490575379897087,\n",
       " 'mise en oeuvre de la méthode de réponse rapide': 0.08786205273162095,\n",
       " 'élaboration et mise en oeuvre': 0.08786205273162095,\n",
       " 'réponses rapides disponibles affections post_covid_19': 0.0477123670692439,\n",
       " 'regard sur la pandémie covid_19 au québec': 0.0477123670692439,\n",
       " 'pandémie covid_19 au québec': 0.0477123670692439,\n",
       " 'regard sur la pandémie covid_19': 0.0477123670692439,\n",
       " 'projections des besoins hospitaliers traitements': 0.0477123670692439,\n",
       " 'procédures diagnostiques': 0.0477123670692439,\n",
       " 'ministère de la santé et des services': 0.10623098139395948,\n",
       " 'démarche': 0.14028036556159326,\n",
       " 'réponses rapides disponibles services sociaux': 0.0477123670692439,\n",
       " 'réponses rapides disponibles regard': 0.0477123670692439,\n",
       " 'sites d_intérêt visitez': 0.0477123670692439,\n",
       " 'ministère de la santé et des services sociaux': 0.10623098139395948,\n",
       " 'traitements spécifiques': 0.0477123670692439,\n",
       " 'besoins hospitaliers traitements': 0.0477123670692439,\n",
       " 'regard sur la pandémie': 0.0477123670692439,\n",
       " 'traitements spécifiques à la covid_19': 0.0477123670692439,\n",
       " 'échangeur de chaleur sites': 0.0477123670692439,\n",
       " 'échangeur de chaleur sites d_intérêt': 0.0477123670692439,\n",
       " 'traitement ordonnances collectives': 0.0477123670692439,\n",
       " 'réponses rapides disponibles rétablissement': 0.0477123670692439,\n",
       " 'inspq visitez': 0.0,\n",
       " 'intérêt visitez': 0.0,\n",
       " 'niveau': 0.16750081105698245,\n",
       " 'contributions des uetmis soins': 0.0477123670692439,\n",
       " 'contributions des uetmis': 0.0477123670692439,\n",
       " 'contexte de la covid_19 contributions': 0.0477123670692439,\n",
       " 'contributions': 0.0477123670692439,\n",
       " 'projections des besoins hospitaliers traitements spécifiques': 0.0477123670692439,\n",
       " 'rapports disponibles': 0.0477123670692439,\n",
       " 'alternatives de traitements': 0.0477123670692439,\n",
       " 'réponses rapides disponibles études cliniques en cours': 0.0477123670692439,\n",
       " 'alternatives de traitements en contexte': 0.0477123670692439,\n",
       " 'réponses rapides disponibles affections': 0.0477123670692439,\n",
       " 'présentations cliniques': 0.0477123670692439,\n",
       " 'summary': 0.2268177222294722,\n",
       " 'rétablissement et reprise': 0.0477123670692439,\n",
       " 'réponses rapides disponibles investigation': 0.0477123670692439,\n",
       " 'réponses rapides disponibles méthode': 0.0477123670692439,\n",
       " 'contributions des uetmis soins intensifs': 0.0477123670692439,\n",
       " 'réponses rapides disponibles services': 0.0477123670692439,\n",
       " 'réponses rapides disponibles méthode de réponse': 0.0477123670692439,\n",
       " 'traitement ordonnances': 0.0477123670692439,\n",
       " 'prophylaxie et traitement ordonnances': 0.0477123670692439,\n",
       " 'réponses rapides disponibles méthode de réponse rapide': 0.0477123670692439,\n",
       " 'rapports disponibles présentations': 0.0477123670692439,\n",
       " 'chaleur sites': 0.0477123670692439,\n",
       " 'besoins hospitaliers traitements spécifiques': 0.0477123670692439,\n",
       " 'rapports disponibles présentations cliniques': 0.0477123670692439,\n",
       " 'alternatives de traitements en contexte de pandémie': 0.0477123670692439,\n",
       " 'traitements en contexte de pandémie': 0.0477123670692439,\n",
       " 'réponses rapides disponibles autres traitements': 0.0477123670692439,\n",
       " 'covid_19 longue': 0.0,\n",
       " 'réponses rapides disponibles études cliniques': 0.0477123670692439,\n",
       " 'réponses rapides disponibles cancérologie': 0.0477123670692439,\n",
       " 'affections post_covid_19 _covid_19 longue_': 0.0477123670692439,\n",
       " 'réponses rapides disponibles études': 0.0477123670692439,\n",
       " 'chaleur sites d_intérêt': 0.0477123670692439,\n",
       " 'sites d_intérêt': 0.0477123670692439,\n",
       " 'plaques': 0.27975144181871836,\n",
       " 'appoint': 0.006176317223978939,\n",
       " 'constats': 0.1304853020068804,\n",
       " 'situation': 0.26488500807817983,\n",
       " 'médicaments biosimilaires': 0.2776118246096055,\n",
       " 'fer': 0.45314903362794123,\n",
       " 'pfizer': 0.17461178258578325,\n",
       " 'paladin': 0.17499651005595074,\n",
       " 'glucose': 0.4736850834814347,\n",
       " 'normes': 0.47883239271776723,\n",
       " 'dépôt électronique d_une demande d_inscription': 0.16661846491698779,\n",
       " 'sujets': 0.29134270960793557,\n",
       " 'dépôt électronique d_une demande': 0.16661846491698779,\n",
       " 'sol': 0.5204947298120611,\n",
       " 'base': 0.2053012786876187,\n",
       " 'évolution de l_épidémie': 0.0,\n",
       " 'comprimé': 0.2002038626682269,\n",
       " 'pharma': 0.18517790378063406,\n",
       " 'épidémie de covid_19': 0.0,\n",
       " 'attention': 0.13001107889780428,\n",
       " 'emergency': 0.31726854467255206,\n",
       " 'projets': 0.24944930609045488,\n",
       " 'santé canada': 0.24444742514684462,\n",
       " 'suivi de l_évolution': 0.3498817500018663,\n",
       " 'protocole médical national': 0.29961604090524313,\n",
       " 'suivi de l_évolution de l_épidémie': 0.3477612545473095,\n",
       " 'suivi de l_évolution de l_épidémie de covid_19': 0.3477612545473095,\n",
       " 'score': 0.15089917626902785,\n",
       " 'évolution de l_épidémie de covid_19': 0.0,\n",
       " 'administration': 0.2851529092998622,\n",
       " 'évaluation nom': 0.006359987534101222,\n",
       " 'évaluation nom commercial': 0.006359987534101222,\n",
       " 'médicaments évalués': 0.03089492141728654,\n",
       " 'problèmes': 0.279438002895088,\n",
       " 'protocoles': 0.23140080182904077,\n",
       " 'santé mentale': 0.6806158093561243,\n",
       " 'patients âgés': 0.18311709219544853,\n",
       " 'traitement des adultes atteints': 0.035918413005476636,\n",
       " 'bénéfices': 0.16019575911202713,\n",
       " 'évaluation nom commercial à venir': 0.006359987534101222,\n",
       " 'amélioration': 0.20450164977082488,\n",
       " 'développement': 0.22935308626410456,\n",
       " 'ministre sur les génériques': 0.7508013042934888,\n",
       " 'polyangéite': 0.024705268895915757,\n",
       " 'pembrolizumab merck traitement': 0.024705268895915757,\n",
       " 'réévaluation en attente d_évaluation': 0.024705268895915757,\n",
       " 'enfant': 0.10482230370231105,\n",
       " 'radiothérapie': 0.39603236614938475,\n",
       " 'jamp inscription': 0.030907355773994824,\n",
       " 'tests': 0.5673567395109362,\n",
       " 'gsk': 0.15846288716622892,\n",
       " 'lumière': 0.09966530338630934,\n",
       " 'conformité': 0.2989218651762325,\n",
       " 'besoin': 0.12836294776308213,\n",
       " 'années': 0.2651479112109066,\n",
       " 'oncologie': 0.18022446131530645,\n",
       " 'point': 0.12640619143636278,\n",
       " 'objet': 0.08437469677333831,\n",
       " 'augmentation': 0.300874095625356,\n",
       " 'modérée': 0.21176643588506305,\n",
       " 'action': 0.4033516162506063,\n",
       " 'attente d_évaluation keytruda pembrolizumab': 0.024705268895915757,\n",
       " 'psoriasis': 0.4317493608039756,\n",
       " 'application': 0.18101422824789773,\n",
       " 'glycémie': 0.2626197643962532,\n",
       " 'egfr': 0.2377689016509828,\n",
       " 'échelle': 0.18552961007502108,\n",
       " 'long': 0.23350634718722665,\n",
       " 'prostate': 0.3706047037634581,\n",
       " 'agent': 0.19406426557751832,\n",
       " 'présence': 0.1659136938864789,\n",
       " 'bandelette': 0.28936863151269193,\n",
       " 'place': 0.15900963707941615,\n",
       " 'progression': 0.17733602225796752,\n",
       " 'centre': 0.2045789683517475,\n",
       " 'insuline': 0.28149402559088865,\n",
       " 'institut': 0.11089703501134564,\n",
       " 'metformine': 0.46840308128689656,\n",
       " 'effets indésirables': 0.1947531110997438,\n",
       " 'adolescents': 0.13868817555362797,\n",
       " 'paiement': 0.25752676761694065,\n",
       " 'doses': 0.30901423172473824,\n",
       " 'stylo': 0.43625723231404334,\n",
       " 'thérapie': 0.25300918178455134,\n",
       " 'processus d_évaluation': 0.22982782286546272,\n",
       " 'demande en attente d_évaluation keytruda': 0.024705268895915757,\n",
       " 'rosiglitazone': 0.4882747000897025,\n",
       " 'liste de médicaments du régime général': 0.24368175910668005,\n",
       " 'alcool': 0.0,\n",
       " 'qualité de vie': 0.1588238545699941,\n",
       " 'liste de médicaments du régime': 0.24368175910668005,\n",
       " 'sclérose': 0.20155269893002978,\n",
       " 'centres': 0.2873204480145146,\n",
       " 'clientèle': 0.3392071103687929,\n",
       " 'familles': 0.4481615198560952,\n",
       " 'insuffisance': 0.1957636609993391,\n",
       " 'autorisation': 0.08502198456475132,\n",
       " 'techniques': 0.21713678102473236,\n",
       " 'hormone': 0.21382904613628226,\n",
       " 'indicateurs': 0.39393525804918206,\n",
       " 'indications reconnues': 0.24960960935827303,\n",
       " 'premarin': 0.3500106482651657,\n",
       " 'douleur': 0.4208133804076063,\n",
       " 'référence': 0.24401491086533822,\n",
       " 'monothérapie pour le traitement': 0.16864223541438272,\n",
       " 'sep': 0.3732660623639383,\n",
       " 'systematic review': 0.07386897668075904,\n",
       " 'période': 0.19975075275927093,\n",
       " 'modèle': 0.18307683447153586,\n",
       " 'protocoles médicaux': 0.24338031980315267,\n",
       " 'année': 0.13669885890945718,\n",
       " 'gestion': 0.2927157477827044,\n",
       " 'statut': 0.21810168028520524,\n",
       " 'agents': 0.25569984840968923,\n",
       " 'guides': 0.4280267501371803,\n",
       " 'colite': 0.1716500213920134,\n",
       " 'complications': 0.1748033961077111,\n",
       " 'guide d_usage optimal': 0.2982347799247735,\n",
       " 'organisation': 0.18661676120768292,\n",
       " 'colite ulcéreuse': 0.17295354170142113,\n",
       " 'traitement des patients atteints': 0.1396115195409193,\n",
       " 'liaison': 0.20574591878299614,\n",
       " 'guide d_usage': 0.2982347799247735,\n",
       " 'exception décision': 0.0,\n",
       " 'exception décision du ministre': 0.0,\n",
       " 'objectif': 0.08912683156364565,\n",
       " 'seringue': 0.06672005765962372,\n",
       " 'standard': 0.14567135480396778,\n",
       " 'consultation': 0.34274954344793546,\n",
       " 'informations': 0.13521063619690696,\n",
       " 'soulagement': 0.14926897543248285,\n",
       " 'ordonnance individuelle': 0.18580995663214078,\n",
       " 'pioglitazone': 0.4439025822908598,\n",
       " 'publication': 0.3156683900402506,\n",
       " 'continu': 0.26771951629257534,\n",
       " 'mutations': 0.07090469970958212,\n",
       " 'marie_claude': 0.13305604728212697,\n",
       " 'décès': 0.28735710896318395,\n",
       " 'sédation': 0.5037961348145578,\n",
       " 'coûts': 0.17112347577384718,\n",
       " 'remboursement': 0.35235830587231737,\n",
       " 'protocoles médicaux nationaux': 0.18633036203955658,\n",
       " 'diminution': 0.17132028370752644,\n",
       " 'fusion': 0.057858895938531246,\n",
       " 'experts consultés': 0.08171523203230453,\n",
       " 'éléments': 0.1329029828034239,\n",
       " 'travail': 0.21209495512586354,\n",
       " 'uvéite': 0.057624019088976526,\n",
       " 'sras_cov_2': 0.48785981464365363,\n",
       " 'services sociaux _msss_': 0.1170789477847433,\n",
       " 'adultes atteints d_un lymphome': 0.09865431868181217,\n",
       " 'abbvie': 0.0244500832204968,\n",
       " 'médicament d_exception décision du ministre': 0.14698757527237644,\n",
       " 'traitement de la colite ulcéreuse': 0.17866982175635499,\n",
       " 'documents': 0.25797512738065537,\n",
       " 'médicament d_exception décision': 0.14698757527237644,\n",
       " 'aspects économique': 0.083224050631465,\n",
       " 'traitement de la colite': 0.17866982175635499,\n",
       " 'inj': 0.5849448656068823,\n",
       " 'protection': 0.35240650166600956,\n",
       " 'revue': 0.20952401927818418,\n",
       " 'considérations': 0.19639810099306554,\n",
       " 'topique': 0.4218473309673781,\n",
       " 'rencontre présoumission': 0.2548016438092679,\n",
       " 'aigüe': 0.17979427827225938,\n",
       " 'gonorrhoeae': 0.26855382820934737,\n",
       " 'endomètre': 0.0,\n",
       " 'rgam': 0.2638329814680295,\n",
       " 'cellules métastatique': 0.05161602697008434,\n",
       " 'présoumission': 0.2548016438092679,\n",
       " 'comparaison': 0.11598241468581837,\n",
       " 'attente d_évaluation nom': 0.02442349711591029,\n",
       " 'gène ret': 0.018528951671936817,\n",
       " 'adultes atteints d_un cancer du poumon': 0.018528951671936817,\n",
       " 'abbvie traitement': 0.018528951671936817,\n",
       " 'asthme sévère': 0.0,\n",
       " 'incertitude': 0.1271034512495199,\n",
       " 'point de vue': 0.12904099329247576,\n",
       " 'préavis': 0.30754564239070814,\n",
       " 'évaluation keytruda pembrolizumab merck traitement': 0.0,\n",
       " 'traitement de l_uvéite': 0.018528951671936817,\n",
       " 'paladin traitement': 0.018528951671936817,\n",
       " 'attente d_évaluation nom commercial': 0.02442349711591029,\n",
       " 'cancer de l_endomètre': 0.018528951671936817,\n",
       " 'keytruda pembrolizumab merck traitement': 0.018528951671936817,\n",
       " 'médicaments présentés': 0.018528951671936817,\n",
       " 'ajout aux listes': 0.14679341110393812,\n",
       " 'cardiovasculaire': 0.43425857668780105,\n",
       " 'ministre de la santé': 0.1673384273768813,\n",
       " 'ministre de la santé et des services sociaux': 0.1678213837697428,\n",
       " 'mélanome': 0.1704352586849657,\n",
       " 'marcan': 0.04280491707882014,\n",
       " 'ajout aux listes de médicaments': 0.14738996436282112,\n",
       " 'ministre de la santé et des services': 0.1678213837697428,\n",
       " 'synthèse': 0.1705114377824651,\n",
       " 'mandat': 0.14423648201469197,\n",
       " 'rehabilitation': 0.1365298726022547,\n",
       " 'réalisation': 0.20651573487422406,\n",
       " 'répertoire': 0.418448670445927,\n",
       " 'indication reconnue aux listes': 0.31456998564126537,\n",
       " 'hyperactivité': 0.15178399459123015,\n",
       " 'mcg': 0.4563460001244919,\n",
       " 'inscrits': 0.12248877033837594,\n",
       " 'version': 0.20404515462297065,\n",
       " 'maladie pulmonaire': 0.24375131796920874,\n",
       " 'guise': 0.659977171642937,\n",
       " 'absence': 0.1944013737840984,\n",
       " 'résultat': 0.1730103368403389,\n",
       " 'conséquences': 0.15152584997479454,\n",
       " 'public': 0.19437110061109047,\n",
       " 'recommandation de l_inesss ajout aux listes': 0.1486108920187904,\n",
       " 'modification d_une indication': 0.14528272821494712,\n",
       " 'mode': 0.21768751884672097,\n",
       " 'maladie pulmonaire obstructive': 0.24485525655294138,\n",
       " 'décisions': 0.28785892949308184,\n",
       " 'caractéristiques': 0.18722219664687495,\n",
       " 'maladie pulmonaire obstructive chronique': 0.24485525655294138,\n",
       " 'iii': 0.3187373863921979,\n",
       " 'nouveautés': 0.2678034641835188,\n",
       " 'carcinome': 0.1728922729427877,\n",
       " 'système de santé': 0.15119147841726502,\n",
       " 'principaux experts consultés': 0.05655000831202635,\n",
       " 'liste des principaux experts consultés': 0.05655000831202635,\n",
       " 'principaux experts': 0.05655000831202635,\n",
       " 'limite': 0.15920551590235626,\n",
       " 'dispositifs': 0.3645295023300523,\n",
       " 'bgp pharma': 0.018451353948659235,\n",
       " 'rétention': 0.1829465035117373,\n",
       " 'chlamydia': 0.30203603601665446,\n",
       " 'modification d_une indication reconnue': 0.14592406219831877,\n",
       " 'groupes': 0.19855518565644417,\n",
       " 'liste des principaux': 0.05655000831202635,\n",
       " 'lésions': 0.3803860916314195,\n",
       " 'imagerie': 0.2603586739862976,\n",
       " 'liste des principaux experts': 0.05655000831202635,\n",
       " 'bgp': 0.018451353948659235,\n",
       " 'excellence': 0.05078606032030619,\n",
       " 'algorithme': 0.5227031530141817,\n",
       " 'pansements': 0.6781234278499981,\n",
       " 'fiches': 0.15632775799805126,\n",
       " 'candidose': 0.43104850332439665,\n",
       " 'management': 0.33971201563594544,\n",
       " 'biologie médicale et génomique': 0.29633454512792506,\n",
       " 'plaies': 0.325077820710967,\n",
       " 'institut national': 0.08346425846312222,\n",
       " 'préavis obligatoire': 0.17780490311166647,\n",
       " 'système du sang': 0.4036354861327812,\n",
       " 'critère': 0.18327733184057893,\n",
       " 'tsa': 0.424098930765565,\n",
       " 'évaluation scientifique': 0.07334229648825166,\n",
       " 'juge': 0.07416783380028381,\n",
       " 'refus d_inscription': 0.16647342024343023,\n",
       " 'fin': 0.32202774850563615,\n",
       " 'détresse': 0.3494631827175081,\n",
       " 'performance': 0.4085236409265451,\n",
       " 'produits du système': 0.4036354861327812,\n",
       " 'ppb': 0.4737428052443046,\n",
       " 'déficience': 0.488903199875013,\n",
       " 'mucosite': 0.40130486413327743,\n",
       " 'fonction': 0.11695667573322122,\n",
       " 'ipilimumab': 0.396224056483388,\n",
       " 'hospitalisations': 0.39509536657878347,\n",
       " 'ppe': 0.3086188781744942,\n",
       " 'acétate': 0.00887111901564439,\n",
       " 'ordonnances associées': 0.18633036203955658,\n",
       " 'rencontre postsoumission': 0.1617486221783091,\n",
       " 'traumatisme': 0.19558735037014324,\n",
       " 'famille': 0.2490869798100239,\n",
       " 'condition': 0.16920798008125,\n",
       " 'utérus': 0.0,\n",
       " 'postsoumission': 0.1617486221783091,\n",
       " 'enjeux': 0.1615858545710275,\n",
       " 'option': 0.1833628993445611,\n",
       " 'fièvre': 0.19259473784624964,\n",
       " 'profil': 0.18226475116502616,\n",
       " 'traitement de l_asthme': 0.2708535587733567,\n",
       " 'programme': 0.32143136685109047,\n",
       " 'relatives': 0.15529872376807224,\n",
       " 'nausées': 0.36590028942830066,\n",
       " 'fibrose': 0.23097665766738104,\n",
       " 'diabetes': 0.308375185217906,\n",
       " 'cancer de la prostate': 0.27497483929494626,\n",
       " 'fentanyl': 0.25688916703642733,\n",
       " 'produits du système du sang': 0.4036354861327812,\n",
       " 'dermatite atopique': 0.3581443632222723,\n",
       " 'experts consultés autres recommandations': 0.057114331130922034,\n",
       " 'aide à la décision': 0.0,\n",
       " 'nifédipine': 0.16452165498279137,\n",
       " 'dermatite': 0.3581443632222723,\n",
       " 'mucosite oropharyngée': 0.40562253382080493,\n",
       " 'guo': 0.4263354946046018,\n",
       " 'amgevita': 0.018370853870576836,\n",
       " 'adalimumab amgen': 0.018370853870576836,\n",
       " 'critères économique': 0.0869907661612959,\n",
       " 'tarification': 0.1631894497096523,\n",
       " 'cancers': 0.3880192774470874,\n",
       " 'transplantation': 0.6440281086374402,\n",
       " 'trouble lié': 0.14411400695627205,\n",
       " 'bid': 0.8327992113814122,\n",
       " 'chloroquine': 0.3065064532911625,\n",
       " 'réactif': 0.15669872973630358,\n",
       " 'réactif quantitatif': 0.15669872973630358,\n",
       " 'randomized': 0.14044895500485408,\n",
       " 'médicaments décision': 0.15320948497285977,\n",
       " 'consensus': 0.1569585633905432,\n",
       " 'médicaments décision du ministre': 0.15320948497285977,\n",
       " 'croissance': 0.47929257224972477,\n",
       " 'exemption': 0.25271105248803466,\n",
       " 'ordre': 0.09631917400593147,\n",
       " 'attente d_un avis de conformité': 0.13213042793219984,\n",
       " 'urgence': 0.07724042455249312,\n",
       " 'cst': 0.5150453033111756,\n",
       " 'naloxone': 0.4017324122719153,\n",
       " 'produits de santé': 0.362496063279235,\n",
       " 'ensemble des critères': 0.0,\n",
       " 'candidose buccale': 0.43338042225944956,\n",
       " 'ostéoporose': 0.13670906014719064,\n",
       " 'traitement du diabète': 0.17661722429161678,\n",
       " 'élimination': 0.400244267097271,\n",
       " 'trouble lié à l_usage': 0.14524251886696157,\n",
       " 'calcipotriol': 0.47586057829732475,\n",
       " 'sédation palliative': 0.31340398451849,\n",
       " 'facteurs': 0.17242543283911416,\n",
       " 'évaluation des médicaments aux fins': 0.09830237276478872,\n",
       " 'davc': 0.4894986613525576,\n",
       " 'médicaments aux fins d_inscription': 0.2142198472325798,\n",
       " 'évaluation des médicaments aux fins d_inscription': 0.09830237276478872,\n",
       " 'médicaments aux fins': 0.2142198472325798,\n",
       " 'quality': 0.3623129860756573,\n",
       " 'références utilisées': 0.04764809348423433,\n",
       " 'antidiabétique': 0.2889368254850078,\n",
       " 'natalizumab': 0.7739578503046228,\n",
       " 'ensemble des critères prévus': 0.0,\n",
       " 'élimination fécale': 0.400244267097271,\n",
       " 'critères prévus': 0.05834514804735156,\n",
       " 'liste établissements': 0.2832696708362435,\n",
       " 'formulation': 0.2925971016375176,\n",
       " 'jamp inscription inscrire': 0.024834232094850736,\n",
       " 'vitamine': 0.47512001340569,\n",
       " 'détection': 0.35850478492772797,\n",
       " 'continuum': 0.4807072890311854,\n",
       " 'médicaments evaluation': 0.17446105818162877,\n",
       " 'documentation scientifique': 0.07171668449928842,\n",
       " 'proches': 0.24676377705474506,\n",
       " 'âge': 0.22156536685419065,\n",
       " 'listes des médicaments evaluation': 0.17446105818162877,\n",
       " 'médicaments evaluation publiée': 0.17446105818162877,\n",
       " 'classe': 0.13246679924155116,\n",
       " 'preuve': 0.2576310015521911,\n",
       " 'insuffisance cardiaque': 0.24215422344758492,\n",
       " 'santé naturels': 0.36735772789551663,\n",
       " 'produits de santé naturels': 0.36735772789551663,\n",
       " 'rencontre présoumission avec les fabricants': 0.1631894497096523,\n",
       " 'sédation palliative continue': 0.28568558705090524,\n",
       " 'mortalité': 0.38144070211927333,\n",
       " 'dexcom': 0.23405121190677086,\n",
       " 'présoumission avec les fabricants': 0.1631894497096523,\n",
       " 'modifications': 0.15401214077697967,\n",
       " 'postsoumission avec les fabricants': 0.10224444491806306,\n",
       " 'rencontre postsoumission avec les fabricants': 0.10224444491806306,\n",
       " 'troubles neurocognitifs': 0.12096566750943093,\n",
       " 'pertes': 0.2831703868664685,\n",
       " 'évaluation aux fins d_inscription': 0.1414983257419194,\n",
       " 'fiche synthèse': 0.1834539360390243,\n",
       " 'trastuzumab': 0.3104555419828367,\n",
       " 'technologies': 0.4966258559860386,\n",
       " 'évaluation aux fins': 0.1414983257419194,\n",
       " 'usage d_alcool': 0.0,\n",
       " 'trouble lié à l_usage d_alcool': 0.14680519422203464,\n",
       " 'infections urinaires': 0.347035261544776,\n",
       " 'pharmacien': 0.1664232848777094,\n",
       " 'candidose buccale chez l_adulte': 0.31518576164323603,\n",
       " 'institut national d_excellence en santé': 0.06913514961386366,\n",
       " 'listes de médicaments décision': 0.15610045377811727,\n",
       " 'excellence en santé': 0.0,\n",
       " 'traitement au fer': 0.33097569010765104,\n",
       " 'listes de médicaments décision du ministre': 0.15610045377811727,\n",
       " 'cliniciens': 0.24084175466169777,\n",
       " 'institut national d_excellence': 0.06913514961386366,\n",
       " 'associations': 0.3464146770862858,\n",
       " 'pertes vaginales': 0.28466468174080894,\n",
       " 'laboratoire': 0.23818789987531355,\n",
       " 'rétention urinaire': 0.18534064127869695,\n",
       " 'surveillance': 0.42596367945514335,\n",
       " 'présent': 0.1339293028183422,\n",
       " 'fabricants avis aux fabricants': 0.10224444491806306,\n",
       " 'outil de transfert': 0.1315907952380347,\n",
       " 'médecins signataires': 0.21682533458594266,\n",
       " 'med': 0.08693851369601346,\n",
       " 'préavis obligatoire demandé aux fabricants': 0.10224444491806306,\n",
       " 'préavis obligatoire demandé': 0.10224444491806306,\n",
       " 'signataires': 0.21682533458594266,\n",
       " 'fer intraveineux': 0.29420061342902315,\n",
       " 'modalités d_évaluation': 0.16762071414790164,\n",
       " 'fibrose kystique': 0.24376157125980533,\n",
       " 'outil de transfert de connaissances': 0.13427785652874552,\n",
       " 'femme': 0.12662698999246358,\n",
       " 'fabricants rencontre': 0.1631894497096523,\n",
       " 'pompe': 0.15448943180885477,\n",
       " 'comité': 0.12736025644089996,\n",
       " 'traitement d_appoint': 0.20214731910523612,\n",
       " 'traitement au fer intraveineux': 0.25742553675039526,\n",
       " 'exon': 0.18933864978842108,\n",
       " 'conditions décision': 0.17687413910830224,\n",
       " 'fer intraveineux chez l_adulte': 0.25742553675039526,\n",
       " 'frais': 0.740501928936481,\n",
       " 'traitement au fer intraveineux chez l_adulte': 0.25742553675039526,\n",
       " 'rétention urinaire aigüe': 0.1868404022384097,\n",
       " 'demande d_exemption': 0.2492963728704997,\n",
       " 'conditions décision du ministre': 0.17687413910830224,\n",
       " 'intervenants': 0.13263085642882474,\n",
       " 'pertes vaginales inhabituelles': 0.28696816452439305,\n",
       " 'traitement de la fibrose': 0.1489616948140163,\n",
       " 'glaucome': 0.4606421796457712,\n",
       " 'recommandation de l_inesss médicaments': 0.1760577531063043,\n",
       " 'estrogènes': 0.485120953514216,\n",
       " 'rédaction': 0.07674764895884749,\n",
       " 'cpnpc': 0.3468251261642973,\n",
       " 'thyroïde': 0.13139642712176422,\n",
       " 'aide médicale': 0.09533703624685218,\n",
       " 'aide médicale à mourir': 0.09533703624685218,\n",
       " 'associés': 0.1577700846746626,\n",
       " 'domicile': 0.37221803831797207,\n",
       " 'corticothérapie': 0.26718860399574984,\n",
       " 'écoulement': 0.27853498015718736,\n",
       " 'prise de décision': 0.22780377561981474,\n",
       " 'écoulement urétral': 0.27853498015718736,\n",
       " 'modes': 0.2771556879733515,\n",
       " 'dermatite atopique modérée': 0.21488661793336336,\n",
       " 'fresenius': 0.14814487223842698,\n",
       " 'efficacy': 0.09731527705301724,\n",
       " 'professionnels de la santé': 0.11245999251480131,\n",
       " 'algorithmes': 0.7883593772238339,\n",
       " 'renseignements': 0.09808941581061695,\n",
       " 'différence': 0.15465150717039794,\n",
       " 'médicaments génériques': 0.11942328021707957,\n",
       " 'professionnel': 0.40694977336331356,\n",
       " 'ordonnance individuelle d_ajustement': 0.08557871108066224,\n",
       " 'lénalidomide': 0.036689928924702984,\n",
       " 'itss': 0.15228404163064835,\n",
       " 'heures': 0.3377753664155193,\n",
       " 'eampoc': 0.21059600069180137,\n",
       " 'gonadotrophines': 0.41122868566409476,\n",
       " 'insomnie': 0.18146350909284606,\n",
       " 'modalités d_évaluation des médicaments': 0.17072529211165735,\n",
       " 'institut national d_excellence en santé et en services': 0.06913514961386366,\n",
       " 'conséquence': 0.09805342392450613,\n",
       " 'excellence en santé et en services sociaux': 0.0,\n",
       " 'technologie': 0.296635809932369,\n",
       " 'congrès': 0.07368193363013101,\n",
       " 'excellence en santé et en services': 0.0,\n",
       " 'inscription de médicaments': 0.0,\n",
       " 'dernières': 0.11756888142592463,\n",
       " 'res': 0.2907942863537504,\n",
       " 'taro': 0.024322210487182,\n",
       " 'interféron': 0.19779777577374708,\n",
       " 'essais': 0.169485483590439,\n",
       " 'trouble déficitaire': 0.21252591393926704,\n",
       " 'traitement de la dermatite': 0.14325774528890892,\n",
       " 'dupixent': 0.0244952244391206,\n",
       " 'nucala': 0.42595708001230526,\n",
       " 'gabarits': 0.07973794143470629,\n",
       " 'choix': 0.15287486311558837,\n",
       " ...}"
      ]
     },
     "execution_count": 119,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "terms_tfidf"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "metadata": {},
   "outputs": [],
   "source": [
    "terms_weighted = DataFrame(terms_tfidf.items(), columns=['Terme formatté', 'TF-IDF'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Terme formatté</th>\n",
       "      <th>TF-IDF</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5854</th>\n",
       "      <td>venofer</td>\n",
       "      <td>0.857335</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4835</th>\n",
       "      <td>préservateur</td>\n",
       "      <td>0.844618</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4931</th>\n",
       "      <td>vag</td>\n",
       "      <td>0.836657</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>835</th>\n",
       "      <td>bid</td>\n",
       "      <td>0.832799</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5052</th>\n",
       "      <td>fulvestrant</td>\n",
       "      <td>0.832582</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4904</th>\n",
       "      <td>évaluation diagnostique des troubles</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5636</th>\n",
       "      <td>hypertension pulmonaire</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2878</th>\n",
       "      <td>évaluation gavreto</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4910</th>\n",
       "      <td>évaluation en traumatologie</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>660</th>\n",
       "      <td>exception décision</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6025 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                            Terme formatté    TF-IDF\n",
       "5854                               venofer  0.857335\n",
       "4835                          préservateur  0.844618\n",
       "4931                                   vag  0.836657\n",
       "835                                    bid  0.832799\n",
       "5052                           fulvestrant  0.832582\n",
       "...                                    ...       ...\n",
       "4904  évaluation diagnostique des troubles  0.000000\n",
       "5636               hypertension pulmonaire  0.000000\n",
       "2878                    évaluation gavreto  0.000000\n",
       "4910           évaluation en traumatologie  0.000000\n",
       "660                     exception décision  0.000000\n",
       "\n",
       "[6025 rows x 2 columns]"
      ]
     },
     "execution_count": 121,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "terms_weighted.sort_values([\"TF-IDF\"], \n",
    "                    axis=0,\n",
    "                    ascending=[False], \n",
    "                    inplace=True)\n",
    "\n",
    "terms_weighted = terms_weighted.drop_duplicates(keep='first')\n",
    "terms_weighted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Terme</th>\n",
       "      <th>Structure syntaxique</th>\n",
       "      <th>Fréquence (TF)</th>\n",
       "      <th>LLR</th>\n",
       "      <th>p-value</th>\n",
       "      <th>Fréquence documentaire (DF)</th>\n",
       "      <th>isMeSHTerm</th>\n",
       "      <th>isTaxoTerm</th>\n",
       "      <th>Terme formatté</th>\n",
       "      <th>TF (sklearn)</th>\n",
       "      <th>DF (sklearn)</th>\n",
       "      <th>TF-IDF</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>traitement</td>\n",
       "      <td>NOM</td>\n",
       "      <td>7872</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1218</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>traitement</td>\n",
       "      <td>7864</td>\n",
       "      <td>1180</td>\n",
       "      <td>0.233696</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>jamp</td>\n",
       "      <td>NOM</td>\n",
       "      <td>7296</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>992</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>jamp</td>\n",
       "      <td>2556</td>\n",
       "      <td>992</td>\n",
       "      <td>0.299247</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>évaluation</td>\n",
       "      <td>NOM</td>\n",
       "      <td>6785</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1396</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>évaluation</td>\n",
       "      <td>1694</td>\n",
       "      <td>324</td>\n",
       "      <td>0.207417</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>médicaments</td>\n",
       "      <td>NOM</td>\n",
       "      <td>5448</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1206</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>médicaments</td>\n",
       "      <td>5451</td>\n",
       "      <td>1206</td>\n",
       "      <td>0.398131</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>demande</td>\n",
       "      <td>NOM</td>\n",
       "      <td>3662</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>280</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>demande</td>\n",
       "      <td>3662</td>\n",
       "      <td>240</td>\n",
       "      <td>0.558081</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6020</th>\n",
       "      <td>degré</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>14</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>degré</td>\n",
       "      <td>16</td>\n",
       "      <td>14</td>\n",
       "      <td>0.143549</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6021</th>\n",
       "      <td>foam</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>8</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>foam</td>\n",
       "      <td>16</td>\n",
       "      <td>8</td>\n",
       "      <td>0.486611</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6022</th>\n",
       "      <td>coque</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>22</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>coque</td>\n",
       "      <td>16</td>\n",
       "      <td>12</td>\n",
       "      <td>0.448285</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6023</th>\n",
       "      <td>médicaments du québec</td>\n",
       "      <td>NOM PRP:det NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>88.74281960037526</td>\n",
       "      <td>4.496265284875781e-21</td>\n",
       "      <td>13</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>médicaments du québec</td>\n",
       "      <td>16</td>\n",
       "      <td>13</td>\n",
       "      <td>0.119791</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6024</th>\n",
       "      <td>lmc</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>5</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>lmc</td>\n",
       "      <td>14</td>\n",
       "      <td>2</td>\n",
       "      <td>0.396506</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6025 rows × 12 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                      Terme Structure syntaxique  Fréquence (TF)  \\\n",
       "0                traitement                  NOM            7872   \n",
       "1                      jamp                  NOM            7296   \n",
       "2                évaluation                  NOM            6785   \n",
       "3               médicaments                  NOM            5448   \n",
       "4                   demande                  NOM            3662   \n",
       "...                     ...                  ...             ...   \n",
       "6020                  degré                  NOM              16   \n",
       "6021                   foam                  NOM              16   \n",
       "6022                  coque                  NOM              16   \n",
       "6023  médicaments du québec      NOM PRP:det NOM              16   \n",
       "6024                    lmc                  NOM              16   \n",
       "\n",
       "                    LLR                p-value  Fréquence documentaire (DF)  \\\n",
       "0                     -                      -                         1218   \n",
       "1                     -                      -                          992   \n",
       "2                     -                      -                         1396   \n",
       "3                     -                      -                         1206   \n",
       "4                     -                      -                          280   \n",
       "...                 ...                    ...                          ...   \n",
       "6020                  -                      -                           14   \n",
       "6021                  -                      -                            8   \n",
       "6022                  -                      -                           22   \n",
       "6023  88.74281960037526  4.496265284875781e-21                           13   \n",
       "6024                  -                      -                            5   \n",
       "\n",
       "      isMeSHTerm  isTaxoTerm         Terme formatté  TF (sklearn)  \\\n",
       "0          False        True             traitement          7864   \n",
       "1          False       False                   jamp          2556   \n",
       "2          False       False             évaluation          1694   \n",
       "3          False        True            médicaments          5451   \n",
       "4          False       False                demande          3662   \n",
       "...          ...         ...                    ...           ...   \n",
       "6020       False       False                  degré            16   \n",
       "6021       False       False                   foam            16   \n",
       "6022       False        True                  coque            16   \n",
       "6023       False       False  médicaments du québec            16   \n",
       "6024       False       False                    lmc            14   \n",
       "\n",
       "      DF (sklearn)    TF-IDF  \n",
       "0             1180  0.233696  \n",
       "1              992  0.299247  \n",
       "2              324  0.207417  \n",
       "3             1206  0.398131  \n",
       "4              240  0.558081  \n",
       "...            ...       ...  \n",
       "6020            14  0.143549  \n",
       "6021             8  0.486611  \n",
       "6022            12  0.448285  \n",
       "6023            13  0.119791  \n",
       "6024             2  0.396506  \n",
       "\n",
       "[6025 rows x 12 columns]"
      ]
     },
     "execution_count": 122,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "terms_weighted = pd.merge(csv, terms_weighted, on='Terme formatté').drop_duplicates(\n",
    "  subset = ['Terme', 'Fréquence (TF)'],\n",
    "  keep = 'first').reset_index(drop = True)\n",
    "\n",
    "terms_weighted"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## **OKapi BM25**\n",
    "https://hal.archives-ouvertes.fr/hal-00760158 "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {},
   "outputs": [],
   "source": [
    "from rank_bm25 import BM25Okapi"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {},
   "outputs": [],
   "source": [
    "from nltk.tokenize import RegexpTokenizer\n",
    "tokenizer = RegexpTokenizer(\"(\\w+\\'|\\w+-\\w+|\\(|\\)|\\w+)\")\n",
    "\n",
    "bm25 = BM25Okapi([tokenizer.tokenize(t) for t in corpus])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['traitement',\n",
       " 'jamp',\n",
       " 'évaluation',\n",
       " 'médicaments',\n",
       " 'demande',\n",
       " 'inesss',\n",
       " 'attente',\n",
       " 'injection',\n",
       " 'ministre',\n",
       " 'patients',\n",
       " 'médicament',\n",
       " 'cours',\n",
       " 'inscription',\n",
       " 'sodium',\n",
       " 'citrate',\n",
       " \"attente d'évaluation\",\n",
       " 'cancer',\n",
       " 'angita',\n",
       " 'darunavir',\n",
       " 'calcium',\n",
       " 'lurasidone',\n",
       " 'bicarbonate',\n",
       " 'réponses',\n",
       " 'dextrose',\n",
       " 'sulfonate',\n",
       " 'bicarbonate de sodium',\n",
       " 'glycopyrrolate',\n",
       " \"cours d'évaluation\",\n",
       " 'réponses rapides',\n",
       " 'covid-19',\n",
       " 'santé',\n",
       " 'indication',\n",
       " 'réponses rapides disponibles',\n",
       " 'pré-ac',\n",
       " 'services',\n",
       " 'listes',\n",
       " 'décision',\n",
       " 'québec',\n",
       " 'nom',\n",
       " 'demande en attente',\n",
       " 'coll',\n",
       " 'recommandations',\n",
       " 'adultes',\n",
       " 'projet',\n",
       " 'fabricant',\n",
       " 'cliniques',\n",
       " 'chlorhydrate',\n",
       " 'soins',\n",
       " 'forme',\n",
       " 'dépôt',\n",
       " 'pré-ac en attente',\n",
       " 'conseil',\n",
       " 'recommandation',\n",
       " 'fumarate',\n",
       " 'demande en cours',\n",
       " \"demande en cours d'évaluation\",\n",
       " 'commune',\n",
       " 'dénomination commune',\n",
       " 'exception',\n",
       " 'dénomination',\n",
       " 'évaluations',\n",
       " 'maladie',\n",
       " 'listes des médicaments',\n",
       " 'canada',\n",
       " 'usage',\n",
       " 'ans',\n",
       " 'nom du fabricant',\n",
       " 'contexte',\n",
       " 'liste',\n",
       " 'teneur',\n",
       " 'apotex',\n",
       " \"recommandation de l'inesss\",\n",
       " 'connaissances',\n",
       " 'quétiapine',\n",
       " 'quétiapine (fumarate de)',\n",
       " 'produits',\n",
       " 'traitements',\n",
       " 'evaluation',\n",
       " 'décision du ministre',\n",
       " 'lurasidone (chlorhydrate de)',\n",
       " 'oméga',\n",
       " 'calcium (citrate de)',\n",
       " 'bromhydrate',\n",
       " 'ag-calcium',\n",
       " 'élétriptan',\n",
       " 'ag-quetiapine',\n",
       " 'injection de glycopyrrolate',\n",
       " 'apo-eletriptan',\n",
       " 'dextrose injection',\n",
       " 'jamp lurasidone',\n",
       " 'polystyrène',\n",
       " 'sulfonate calcique',\n",
       " 'sodium pour injection',\n",
       " 'halycil',\n",
       " 'ag-calcium citrate',\n",
       " 'ag-calcium citrate liquid',\n",
       " 'jamp calcium polystyrene sulfonate',\n",
       " 'jamp calcium',\n",
       " 'jamp calcium polystyrene',\n",
       " 'citrate liquid',\n",
       " 'calcium polystyrene',\n",
       " 'bicarbonate de sodium pour injection',\n",
       " 'calcium polystyrene sulfonate',\n",
       " \"pré-ac en attente d'évaluation\",\n",
       " 'données',\n",
       " 'darunavir dextrose injection',\n",
       " 'injection (jamp)',\n",
       " 'sodium pour injection (jamp)',\n",
       " 'jamp lurasidone (jamp)',\n",
       " 'apo-eletriptan (apotex)',\n",
       " 'évaluations récemment publiées',\n",
       " 'bicarbonate de sodium pour injection (jamp)',\n",
       " 'bicarbonate de sodium darunavir',\n",
       " 'dextrose halycil',\n",
       " 'bicarbonate de sodium darunavir (jamp)',\n",
       " 'sodium darunavir (jamp)',\n",
       " 'évaluations récemment',\n",
       " 'jamp calcium polystyrene sulfonate (jamp)',\n",
       " 'calcium polystyrene sulfonate (jamp)',\n",
       " 'dextrose injection (oméga)',\n",
       " 'darunavir dextrose',\n",
       " 'glycopyrrolate (jamp)',\n",
       " 'sodium darunavir',\n",
       " 'injection de glycopyrrolate (jamp)',\n",
       " 'injection (oméga)',\n",
       " 'evaluation publiée',\n",
       " 'darunavir (jamp)',\n",
       " 'citrate liquid (angita)',\n",
       " 'sulfonate (jamp)',\n",
       " 'association',\n",
       " 'adultes atteints',\n",
       " 'conditions',\n",
       " 'efficacité',\n",
       " \"demande en attente d'évaluation\",\n",
       " \"attente d'un dépôt pour évaluation\",\n",
       " \"attente d'un dépôt\",\n",
       " 'dépôt pour évaluation',\n",
       " 'type',\n",
       " 'services sociaux',\n",
       " 'utilisation',\n",
       " 'produit',\n",
       " 'coût',\n",
       " 'résultats',\n",
       " 'risque',\n",
       " 'traitement des patients',\n",
       " 'cellules',\n",
       " 'fabricants',\n",
       " 'patients adultes',\n",
       " 'besoins',\n",
       " 'pandémie',\n",
       " 'système',\n",
       " 'clinique',\n",
       " 'enfants',\n",
       " 'patients adultes atteints',\n",
       " 'étude',\n",
       " 'études',\n",
       " 'réponse',\n",
       " 'indication reconnue',\n",
       " 'trauma',\n",
       " \"médicament d'exception\",\n",
       " 'ligne',\n",
       " 'ordonnances',\n",
       " 'projet aligné',\n",
       " 'projet aligné inesss-acmts-santé canada',\n",
       " 'qualité',\n",
       " 'méthode',\n",
       " 'vie',\n",
       " 'poumon',\n",
       " 'connaissance',\n",
       " 'msss',\n",
       " 'cancer du poumon',\n",
       " 'traitement des patients adultes',\n",
       " 'traitement des patients adultes atteints',\n",
       " \"demande en attente d'un dépôt pour évaluation\",\n",
       " \"demande en attente d'un dépôt\",\n",
       " 'adulte',\n",
       " 'extrait',\n",
       " 'hospitalisation',\n",
       " 'produits de connaissance',\n",
       " 'auteur',\n",
       " 'mois',\n",
       " 'suivi',\n",
       " 'traitement du cancer',\n",
       " 'patients atteints',\n",
       " 'kio',\n",
       " 'projet auteur',\n",
       " 'ordonnance',\n",
       " 'réévaluation',\n",
       " 'risques',\n",
       " 'pré-ac en cours',\n",
       " \"pré-ac en cours d'évaluation\",\n",
       " 'pratiques',\n",
       " 'ligne evaluation publiée',\n",
       " 'ligne evaluation',\n",
       " 'prise',\n",
       " \"extrait de l'avis au ministre\",\n",
       " 'réponse rapide',\n",
       " 'établissements',\n",
       " 'trouble',\n",
       " 'injury',\n",
       " 'indications',\n",
       " 'usage optimal',\n",
       " 'analyse',\n",
       " \"médicaments d'exception\",\n",
       " 'symptômes',\n",
       " 'transfert',\n",
       " 'cas',\n",
       " 'outil',\n",
       " 'sondage',\n",
       " 'ajout',\n",
       " 'ensemble',\n",
       " 'soutien',\n",
       " 'coordination',\n",
       " 'protocole',\n",
       " 'guide',\n",
       " 'traumatologie',\n",
       " 'description',\n",
       " 'évolution',\n",
       " 'pertinence',\n",
       " 'fiche',\n",
       " 'chronique',\n",
       " 'processus',\n",
       " 'besoins hospitaliers',\n",
       " 'refus',\n",
       " 'régime',\n",
       " 'dépistage',\n",
       " 'collaboration',\n",
       " 'coordination scientifique',\n",
       " 'diabète',\n",
       " 'accès',\n",
       " 'méthode de réponse',\n",
       " 'listes de médicaments',\n",
       " 'méthode de réponse rapide',\n",
       " 'projections',\n",
       " 'cancer du poumon non à petites cellules',\n",
       " 'cancérologie',\n",
       " 'durée',\n",
       " 'dose',\n",
       " 'tériflunomide',\n",
       " 'prophylaxie',\n",
       " 'description du médicament',\n",
       " 'modalités',\n",
       " 'kio autres recommandations',\n",
       " 'nom commercial',\n",
       " 'infection',\n",
       " 'prévention',\n",
       " 'rencontre',\n",
       " 'général',\n",
       " 'lymphome',\n",
       " 'merck',\n",
       " 'chimiothérapie',\n",
       " 'critères',\n",
       " 'aide',\n",
       " 'réseau',\n",
       " 'effets',\n",
       " \"risques d'hospitalisation\",\n",
       " 'conditions à venir',\n",
       " 'troubles',\n",
       " 'génériques',\n",
       " 'innocuité',\n",
       " 'stade',\n",
       " 'cadre',\n",
       " 'roche',\n",
       " 'population',\n",
       " 'électronique',\n",
       " 'mesure',\n",
       " 'pembrolizumab',\n",
       " 'keytruda',\n",
       " 'adalimumab',\n",
       " 'soins palliatifs',\n",
       " 'brain',\n",
       " 'demandes',\n",
       " \"demande d'inscription\",\n",
       " 'jeunes',\n",
       " 'regard',\n",
       " 'présente',\n",
       " 'dépôt électronique',\n",
       " 'pembrolizumab merck',\n",
       " 'patient',\n",
       " 'test',\n",
       " 'évaluation keytruda',\n",
       " 'hypertension',\n",
       " 'travaux',\n",
       " 'care',\n",
       " 'experts',\n",
       " 'fins',\n",
       " 'transfert de connaissances',\n",
       " 'semaines',\n",
       " 'sanis',\n",
       " 'sang',\n",
       " 'brain injury',\n",
       " 'protocole médical',\n",
       " 'traumatic',\n",
       " 'traitement adjuvant',\n",
       " 'professionnels',\n",
       " 'gène',\n",
       " 'projections des besoins hospitaliers',\n",
       " 'projections des besoins',\n",
       " 'pansement',\n",
       " 'sandoz',\n",
       " 'soins intensifs',\n",
       " 'hospitalisation et projections des besoins',\n",
       " 'hospitalisation et projections',\n",
       " 'hospitalisation et projections des besoins hospitaliers',\n",
       " \"risques d'hospitalisation et projections\",\n",
       " 'raison',\n",
       " 'régime général',\n",
       " 'jours',\n",
       " 'liste des médicaments',\n",
       " 'déficit',\n",
       " 'portrait',\n",
       " 'mise',\n",
       " 'nombre',\n",
       " 'liste de médicaments',\n",
       " 'recherche',\n",
       " 'investigation',\n",
       " 'annexes',\n",
       " 'médecins',\n",
       " 'traitement des adultes',\n",
       " 'solution',\n",
       " 'atteintes',\n",
       " \"pré-ac en attente d'un dépôt pour évaluation\",\n",
       " \"pré-ac en attente d'un dépôt\",\n",
       " \"adultes atteints d'un cancer\",\n",
       " 'asthme',\n",
       " 'tableau',\n",
       " 'inhibiteur',\n",
       " 'infections',\n",
       " 'terme',\n",
       " 'procédures',\n",
       " 'québécois',\n",
       " 'mesures',\n",
       " 'diagnostic',\n",
       " 'élaboration',\n",
       " 'biosimilaire',\n",
       " 'pratique',\n",
       " 'références',\n",
       " 'interventions',\n",
       " 'traumatic brain',\n",
       " 'jour',\n",
       " 'études cliniques',\n",
       " \"attente d'évaluation keytruda\",\n",
       " 'diabète de type',\n",
       " 'groupe',\n",
       " 'traumatic brain injury',\n",
       " 'graves',\n",
       " 'formule',\n",
       " 'contexte de pandémie',\n",
       " 'analyses',\n",
       " 'ordonnance collective',\n",
       " 'évaluation des médicaments',\n",
       " 'biologie',\n",
       " 'biologie médicale',\n",
       " 'réadaptation',\n",
       " 'modification',\n",
       " 'azc',\n",
       " 'documentation',\n",
       " 'conseil a recommandé',\n",
       " 'post-covid-19',\n",
       " 'implantation',\n",
       " 'femmes',\n",
       " 'ordonnances collectives',\n",
       " 'intervention',\n",
       " 'rétablissement',\n",
       " 'principaux',\n",
       " 'échéancier',\n",
       " 'contexte de la covid-19',\n",
       " 'affections',\n",
       " 'study',\n",
       " 'intention',\n",
       " 'virus',\n",
       " 'survie',\n",
       " 'intérêt',\n",
       " 'lyme',\n",
       " \"demandes d'inscription\",\n",
       " 'reprise',\n",
       " 'ministère',\n",
       " 'rapports',\n",
       " 'formule nutritive',\n",
       " 'opdivo',\n",
       " 'maladies',\n",
       " 'produit biosimilaire',\n",
       " 'produit du système',\n",
       " 'plan',\n",
       " 'aspects',\n",
       " 'réduction',\n",
       " 'ajustement',\n",
       " 'mutation',\n",
       " 'littérature',\n",
       " 'réévaluation en attente',\n",
       " 'keytruda pembrolizumab merck',\n",
       " 'produit du système du sang- traitement',\n",
       " \"fins d'inscription\",\n",
       " 'keytruda pembrolizumab',\n",
       " 'nom commercial à venir',\n",
       " 'évaluation keytruda pembrolizumab merck',\n",
       " 'évaluation keytruda pembrolizumab',\n",
       " \"traitement des patients adultes atteints d'un cancer\",\n",
       " 'sang- traitement',\n",
       " \"patients adultes atteints d'un cancer\",\n",
       " 'produit du système du sang-',\n",
       " 'review',\n",
       " 'système du sang- traitement',\n",
       " 'système du sang-',\n",
       " 'sang-',\n",
       " 'nivolumab',\n",
       " 'affections post-covid-19',\n",
       " 'phase',\n",
       " 'maladie de lyme',\n",
       " 'lien',\n",
       " 'syndrome',\n",
       " 'note',\n",
       " 'inspq',\n",
       " 'alternatives',\n",
       " 'notice',\n",
       " 'médicaments du régime',\n",
       " 'médicaments du régime général',\n",
       " 'immunoglobulines',\n",
       " 'chirurgie',\n",
       " 'santécom',\n",
       " 'sites',\n",
       " 'inhibiteurs',\n",
       " 'assurance',\n",
       " 'ventilation',\n",
       " 'états',\n",
       " 'entretien',\n",
       " 'notice santécom',\n",
       " 'ministère de la santé',\n",
       " 'conclusion',\n",
       " 'uetmis',\n",
       " 'biosimilaires',\n",
       " 'médecin',\n",
       " 'semaine',\n",
       " 'présentations',\n",
       " \"recommandation de l'inesss ajout\",\n",
       " \"traitement d'entretien\",\n",
       " 'lilly',\n",
       " 'hypertension artérielle',\n",
       " 'états des connaissances',\n",
       " 'chaleur',\n",
       " 'covid-19 au québec',\n",
       " 'oeuvre',\n",
       " 'placebo',\n",
       " 'treatment',\n",
       " 'influenza',\n",
       " 'temps',\n",
       " 'études cliniques en cours',\n",
       " 'approche',\n",
       " 'leucémie',\n",
       " 'épidémie',\n",
       " 'milieu',\n",
       " 'systematic',\n",
       " 'traitement du cancer du poumon',\n",
       " 'traitements en contexte',\n",
       " 'mise en oeuvre',\n",
       " 'impact',\n",
       " 'moment',\n",
       " 'ventilation assistée',\n",
       " 'tumeurs',\n",
       " 'coût de traitement',\n",
       " 'pandémie covid-19',\n",
       " 'réponse rapide dans le contexte de la covid-19',\n",
       " 'échangeur de chaleur',\n",
       " 'oeuvre de la méthode de réponse rapide',\n",
       " 'vue',\n",
       " 'élaboration et mise',\n",
       " 'méthode de réponse rapide dans le contexte',\n",
       " 'mise en oeuvre de la méthode de réponse',\n",
       " 'mise en oeuvre de la méthode',\n",
       " 'prophylaxie et traitement',\n",
       " 'échangeur',\n",
       " 'réponse rapide dans le contexte',\n",
       " 'oeuvre de la méthode de réponse',\n",
       " 'oeuvre de la méthode',\n",
       " 'élaboration et mise en oeuvre de la méthode',\n",
       " 'monothérapie',\n",
       " 'taux',\n",
       " 'mise en oeuvre de la méthode de réponse rapide',\n",
       " 'élaboration et mise en oeuvre',\n",
       " 'réponses rapides disponibles affections post-covid-19',\n",
       " 'regard sur la pandémie covid-19 au québec',\n",
       " 'pandémie covid-19 au québec',\n",
       " 'regard sur la pandémie covid-19',\n",
       " 'projections des besoins hospitaliers traitements',\n",
       " 'procédures diagnostiques',\n",
       " 'ministère de la santé et des services',\n",
       " 'démarche',\n",
       " 'réponses rapides disponibles services sociaux',\n",
       " 'réponses rapides disponibles regard',\n",
       " \"sites d'intérêt visitez\",\n",
       " 'ministère de la santé et des services sociaux',\n",
       " 'traitements spécifiques',\n",
       " 'besoins hospitaliers traitements',\n",
       " 'regard sur la pandémie',\n",
       " 'traitements spécifiques à la covid-19',\n",
       " 'échangeur de chaleur sites',\n",
       " \"échangeur de chaleur sites d'intérêt\",\n",
       " 'traitement ordonnances collectives',\n",
       " 'réponses rapides disponibles rétablissement',\n",
       " 'inspq visitez',\n",
       " 'intérêt visitez',\n",
       " 'niveau',\n",
       " 'contributions des uetmis soins',\n",
       " 'contributions des uetmis',\n",
       " 'contexte de la covid-19 contributions',\n",
       " 'contributions',\n",
       " 'projections des besoins hospitaliers traitements spécifiques',\n",
       " 'rapports disponibles',\n",
       " 'alternatives de traitements',\n",
       " 'réponses rapides disponibles études cliniques en cours',\n",
       " 'alternatives de traitements en contexte',\n",
       " 'réponses rapides disponibles affections',\n",
       " 'présentations cliniques',\n",
       " 'summary',\n",
       " 'rétablissement et reprise',\n",
       " 'réponses rapides disponibles investigation',\n",
       " 'réponses rapides disponibles méthode',\n",
       " 'contributions des uetmis soins intensifs',\n",
       " 'réponses rapides disponibles services',\n",
       " 'réponses rapides disponibles méthode de réponse',\n",
       " 'traitement ordonnances',\n",
       " 'prophylaxie et traitement ordonnances',\n",
       " 'réponses rapides disponibles méthode de réponse rapide',\n",
       " 'rapports disponibles présentations',\n",
       " 'chaleur sites',\n",
       " 'besoins hospitaliers traitements spécifiques',\n",
       " 'rapports disponibles présentations cliniques',\n",
       " 'alternatives de traitements en contexte de pandémie',\n",
       " 'traitements en contexte de pandémie',\n",
       " 'réponses rapides disponibles autres traitements',\n",
       " 'covid-19 longue',\n",
       " 'réponses rapides disponibles études cliniques',\n",
       " 'réponses rapides disponibles cancérologie',\n",
       " 'affections post-covid-19 (covid-19 longue)',\n",
       " 'réponses rapides disponibles études',\n",
       " \"chaleur sites d'intérêt\",\n",
       " \"sites d'intérêt\",\n",
       " 'plaques',\n",
       " 'appoint',\n",
       " 'constats',\n",
       " 'situation',\n",
       " 'médicaments biosimilaires',\n",
       " 'fer',\n",
       " 'pfizer',\n",
       " 'paladin',\n",
       " 'glucose',\n",
       " 'normes',\n",
       " \"dépôt électronique d'une demande d'inscription\",\n",
       " 'sujets',\n",
       " \"dépôt électronique d'une demande\",\n",
       " 'sol',\n",
       " 'base',\n",
       " \"évolution de l'épidémie\",\n",
       " 'comprimé',\n",
       " 'pharma',\n",
       " 'épidémie de covid-19',\n",
       " 'attention',\n",
       " 'emergency',\n",
       " 'projets',\n",
       " 'santé canada',\n",
       " \"suivi de l'évolution\",\n",
       " 'protocole médical national',\n",
       " \"suivi de l'évolution de l'épidémie\",\n",
       " \"suivi de l'évolution de l'épidémie de covid-19\",\n",
       " 'score',\n",
       " \"évolution de l'épidémie de covid-19\",\n",
       " 'administration',\n",
       " 'évaluation nom',\n",
       " 'évaluation nom commercial',\n",
       " 'médicaments évalués',\n",
       " 'problèmes',\n",
       " 'protocoles',\n",
       " 'santé mentale',\n",
       " 'patients âgés',\n",
       " 'traitement des adultes atteints',\n",
       " 'bénéfices',\n",
       " 'évaluation nom commercial à venir',\n",
       " 'amélioration',\n",
       " 'développement',\n",
       " 'ministre sur les génériques',\n",
       " 'polyangéite',\n",
       " 'pembrolizumab merck traitement',\n",
       " \"réévaluation en attente d'évaluation\",\n",
       " 'enfant',\n",
       " 'radiothérapie',\n",
       " 'jamp inscription',\n",
       " 'tests',\n",
       " 'gsk',\n",
       " 'lumière',\n",
       " 'conformité',\n",
       " 'besoin',\n",
       " 'années',\n",
       " 'oncologie',\n",
       " 'point',\n",
       " 'objet',\n",
       " 'augmentation',\n",
       " 'modérée',\n",
       " 'action',\n",
       " \"attente d'évaluation keytruda pembrolizumab\",\n",
       " 'psoriasis',\n",
       " 'application',\n",
       " 'glycémie',\n",
       " 'egfr',\n",
       " 'échelle',\n",
       " 'long',\n",
       " 'prostate',\n",
       " 'agent',\n",
       " 'présence',\n",
       " 'bandelette',\n",
       " 'place',\n",
       " 'progression',\n",
       " 'centre',\n",
       " 'insuline',\n",
       " 'institut',\n",
       " 'metformine',\n",
       " 'effets indésirables',\n",
       " 'adolescents',\n",
       " 'paiement',\n",
       " 'doses',\n",
       " 'stylo',\n",
       " 'thérapie',\n",
       " \"processus d'évaluation\",\n",
       " \"demande en attente d'évaluation keytruda\",\n",
       " 'rosiglitazone',\n",
       " 'liste de médicaments du régime général',\n",
       " 'alcool',\n",
       " 'qualité de vie',\n",
       " 'liste de médicaments du régime',\n",
       " 'sclérose',\n",
       " 'centres',\n",
       " 'clientèle',\n",
       " 'familles',\n",
       " 'insuffisance',\n",
       " 'autorisation',\n",
       " 'techniques',\n",
       " 'hormone',\n",
       " 'indicateurs',\n",
       " 'indications reconnues',\n",
       " 'premarin',\n",
       " 'douleur',\n",
       " 'référence',\n",
       " 'monothérapie pour le traitement',\n",
       " 'sep',\n",
       " 'systematic review',\n",
       " 'période',\n",
       " 'modèle',\n",
       " 'protocoles médicaux',\n",
       " 'année',\n",
       " 'gestion',\n",
       " 'statut',\n",
       " 'agents',\n",
       " 'guides',\n",
       " 'colite',\n",
       " 'complications',\n",
       " \"guide d'usage optimal\",\n",
       " 'organisation',\n",
       " 'colite ulcéreuse',\n",
       " 'traitement des patients atteints',\n",
       " 'liaison',\n",
       " \"guide d'usage\",\n",
       " 'exception décision',\n",
       " 'exception décision du ministre',\n",
       " 'objectif',\n",
       " 'seringue',\n",
       " 'standard',\n",
       " 'consultation',\n",
       " 'informations',\n",
       " 'soulagement',\n",
       " 'ordonnance individuelle',\n",
       " 'pioglitazone',\n",
       " 'publication',\n",
       " 'continu',\n",
       " 'mutations',\n",
       " 'marie-claude',\n",
       " 'décès',\n",
       " 'sédation',\n",
       " 'coûts',\n",
       " 'remboursement',\n",
       " 'protocoles médicaux nationaux',\n",
       " 'diminution',\n",
       " 'fusion',\n",
       " 'experts consultés',\n",
       " 'éléments',\n",
       " 'travail',\n",
       " 'uvéite',\n",
       " 'sras-cov-2',\n",
       " 'services sociaux (msss)',\n",
       " \"adultes atteints d'un lymphome\",\n",
       " 'abbvie',\n",
       " \"médicament d'exception décision du ministre\",\n",
       " 'traitement de la colite ulcéreuse',\n",
       " 'documents',\n",
       " \"médicament d'exception décision\",\n",
       " 'aspects économique',\n",
       " 'traitement de la colite',\n",
       " 'inj',\n",
       " 'protection',\n",
       " 'revue',\n",
       " 'considérations',\n",
       " 'topique',\n",
       " 'rencontre présoumission',\n",
       " 'aigüe',\n",
       " 'gonorrhoeae',\n",
       " 'endomètre',\n",
       " 'rgam',\n",
       " 'cellules métastatique',\n",
       " 'présoumission',\n",
       " 'comparaison',\n",
       " \"attente d'évaluation nom\",\n",
       " 'gène ret',\n",
       " \"adultes atteints d'un cancer du poumon\",\n",
       " 'abbvie traitement',\n",
       " 'asthme sévère',\n",
       " 'incertitude',\n",
       " 'point de vue',\n",
       " 'préavis',\n",
       " 'évaluation keytruda pembrolizumab merck traitement',\n",
       " \"traitement de l'uvéite\",\n",
       " 'paladin traitement',\n",
       " \"attente d'évaluation nom commercial\",\n",
       " \"cancer de l'endomètre\",\n",
       " 'keytruda pembrolizumab merck traitement',\n",
       " 'médicaments présentés',\n",
       " 'ajout aux listes',\n",
       " 'cardiovasculaire',\n",
       " 'ministre de la santé',\n",
       " 'ministre de la santé et des services sociaux',\n",
       " 'mélanome',\n",
       " 'marcan',\n",
       " 'ajout aux listes de médicaments',\n",
       " 'ministre de la santé et des services',\n",
       " 'synthèse',\n",
       " 'mandat',\n",
       " 'rehabilitation',\n",
       " 'réalisation',\n",
       " 'répertoire',\n",
       " 'indication reconnue aux listes',\n",
       " 'hyperactivité',\n",
       " 'mcg',\n",
       " 'inscrits',\n",
       " 'version',\n",
       " 'maladie pulmonaire',\n",
       " 'guise',\n",
       " 'absence',\n",
       " 'résultat',\n",
       " 'conséquences',\n",
       " 'public',\n",
       " \"recommandation de l'inesss ajout aux listes\",\n",
       " \"modification d'une indication\",\n",
       " 'mode',\n",
       " 'maladie pulmonaire obstructive',\n",
       " 'décisions',\n",
       " 'caractéristiques',\n",
       " 'maladie pulmonaire obstructive chronique',\n",
       " 'iii',\n",
       " 'nouveautés',\n",
       " 'carcinome',\n",
       " 'système de santé',\n",
       " 'principaux experts consultés',\n",
       " 'liste des principaux experts consultés',\n",
       " 'principaux experts',\n",
       " 'limite',\n",
       " 'dispositifs',\n",
       " 'bgp pharma',\n",
       " 'rétention',\n",
       " 'chlamydia',\n",
       " \"modification d'une indication reconnue\",\n",
       " 'groupes',\n",
       " 'liste des principaux',\n",
       " 'lésions',\n",
       " 'imagerie',\n",
       " 'liste des principaux experts',\n",
       " 'bgp',\n",
       " 'excellence',\n",
       " 'algorithme',\n",
       " 'pansements',\n",
       " 'fiches',\n",
       " 'candidose',\n",
       " 'management',\n",
       " 'biologie médicale et génomique',\n",
       " 'plaies',\n",
       " 'institut national',\n",
       " 'préavis obligatoire',\n",
       " 'système du sang',\n",
       " 'critère',\n",
       " 'tsa',\n",
       " 'évaluation scientifique',\n",
       " 'juge',\n",
       " \"refus d'inscription\",\n",
       " 'fin',\n",
       " 'détresse',\n",
       " 'performance',\n",
       " 'produits du système',\n",
       " 'ppb',\n",
       " 'déficience',\n",
       " 'mucosite',\n",
       " 'fonction',\n",
       " 'ipilimumab',\n",
       " 'hospitalisations',\n",
       " 'ppe',\n",
       " 'acétate',\n",
       " 'ordonnances associées',\n",
       " 'rencontre postsoumission',\n",
       " 'traumatisme',\n",
       " 'famille',\n",
       " 'condition',\n",
       " 'utérus',\n",
       " 'postsoumission',\n",
       " 'enjeux',\n",
       " 'option',\n",
       " 'fièvre',\n",
       " 'profil',\n",
       " \"traitement de l'asthme\",\n",
       " 'programme',\n",
       " 'relatives',\n",
       " 'nausées',\n",
       " 'fibrose',\n",
       " 'diabetes',\n",
       " 'cancer de la prostate',\n",
       " 'fentanyl',\n",
       " 'produits du système du sang',\n",
       " 'dermatite atopique',\n",
       " 'experts consultés autres recommandations',\n",
       " 'aide à la décision',\n",
       " 'nifédipine',\n",
       " 'dermatite',\n",
       " 'mucosite oropharyngée',\n",
       " 'guo',\n",
       " 'amgevita',\n",
       " 'adalimumab amgen',\n",
       " 'critères économique',\n",
       " 'tarification',\n",
       " 'cancers',\n",
       " 'transplantation',\n",
       " 'trouble lié',\n",
       " 'bid',\n",
       " 'chloroquine',\n",
       " 'réactif',\n",
       " 'réactif quantitatif',\n",
       " 'randomized',\n",
       " 'médicaments décision',\n",
       " 'consensus',\n",
       " 'médicaments décision du ministre',\n",
       " 'croissance',\n",
       " 'exemption',\n",
       " 'ordre',\n",
       " \"attente d'un avis de conformité\",\n",
       " 'urgence',\n",
       " 'cst',\n",
       " 'naloxone',\n",
       " 'produits de santé',\n",
       " 'ensemble des critères',\n",
       " 'candidose buccale',\n",
       " 'ostéoporose',\n",
       " 'traitement du diabète',\n",
       " 'élimination',\n",
       " \"trouble lié à l'usage\",\n",
       " 'calcipotriol',\n",
       " 'sédation palliative',\n",
       " 'facteurs',\n",
       " 'évaluation des médicaments aux fins',\n",
       " 'davc',\n",
       " \"médicaments aux fins d'inscription\",\n",
       " \"évaluation des médicaments aux fins d'inscription\",\n",
       " 'médicaments aux fins',\n",
       " 'quality',\n",
       " 'références utilisées',\n",
       " 'antidiabétique',\n",
       " 'natalizumab',\n",
       " 'ensemble des critères prévus',\n",
       " 'élimination fécale',\n",
       " 'critères prévus',\n",
       " 'liste établissements',\n",
       " 'formulation',\n",
       " 'jamp inscription inscrire',\n",
       " 'vitamine',\n",
       " 'détection',\n",
       " 'continuum',\n",
       " 'médicaments evaluation',\n",
       " 'documentation scientifique',\n",
       " 'proches',\n",
       " 'âge',\n",
       " 'listes des médicaments evaluation',\n",
       " 'médicaments evaluation publiée',\n",
       " 'classe',\n",
       " 'preuve',\n",
       " 'insuffisance cardiaque',\n",
       " 'santé naturels',\n",
       " 'produits de santé naturels',\n",
       " 'rencontre présoumission avec les fabricants',\n",
       " 'sédation palliative continue',\n",
       " 'mortalité',\n",
       " 'dexcom',\n",
       " 'présoumission avec les fabricants',\n",
       " 'modifications',\n",
       " 'postsoumission avec les fabricants',\n",
       " 'rencontre postsoumission avec les fabricants',\n",
       " 'troubles neurocognitifs',\n",
       " 'pertes',\n",
       " \"évaluation aux fins d'inscription\",\n",
       " 'fiche synthèse',\n",
       " 'trastuzumab',\n",
       " 'technologies',\n",
       " 'évaluation aux fins',\n",
       " \"usage d'alcool\",\n",
       " \"trouble lié à l'usage d'alcool\",\n",
       " 'infections urinaires',\n",
       " 'pharmacien',\n",
       " \"candidose buccale chez l'adulte\",\n",
       " \"institut national d'excellence en santé\",\n",
       " 'listes de médicaments décision',\n",
       " 'excellence en santé',\n",
       " 'traitement au fer',\n",
       " 'listes de médicaments décision du ministre',\n",
       " 'cliniciens',\n",
       " \"institut national d'excellence\",\n",
       " 'associations',\n",
       " 'pertes vaginales',\n",
       " 'laboratoire',\n",
       " 'rétention urinaire',\n",
       " 'surveillance',\n",
       " 'présent',\n",
       " 'fabricants avis aux fabricants',\n",
       " 'outil de transfert',\n",
       " 'médecins signataires',\n",
       " 'med',\n",
       " 'préavis obligatoire demandé aux fabricants',\n",
       " 'préavis obligatoire demandé',\n",
       " 'signataires',\n",
       " 'fer intraveineux',\n",
       " \"modalités d'évaluation\",\n",
       " 'fibrose kystique',\n",
       " 'outil de transfert de connaissances',\n",
       " 'femme',\n",
       " 'fabricants rencontre',\n",
       " 'pompe',\n",
       " 'comité',\n",
       " \"traitement d'appoint\",\n",
       " 'traitement au fer intraveineux',\n",
       " 'exon',\n",
       " 'conditions décision',\n",
       " \"fer intraveineux chez l'adulte\",\n",
       " 'frais',\n",
       " \"traitement au fer intraveineux chez l'adulte\",\n",
       " 'rétention urinaire aigüe',\n",
       " \"demande d'exemption\",\n",
       " 'conditions décision du ministre',\n",
       " 'intervenants',\n",
       " 'pertes vaginales inhabituelles',\n",
       " 'traitement de la fibrose',\n",
       " 'glaucome',\n",
       " \"recommandation de l'inesss médicaments\",\n",
       " 'estrogènes',\n",
       " 'rédaction',\n",
       " 'cpnpc',\n",
       " 'thyroïde',\n",
       " 'aide médicale',\n",
       " 'aide médicale à mourir',\n",
       " 'associés',\n",
       " 'domicile',\n",
       " 'corticothérapie',\n",
       " 'écoulement',\n",
       " 'prise de décision',\n",
       " 'écoulement urétral',\n",
       " 'modes',\n",
       " 'dermatite atopique modérée',\n",
       " 'fresenius',\n",
       " 'efficacy',\n",
       " 'professionnels de la santé',\n",
       " 'algorithmes',\n",
       " 'renseignements',\n",
       " 'différence',\n",
       " 'médicaments génériques',\n",
       " 'professionnel',\n",
       " \"ordonnance individuelle d'ajustement\",\n",
       " 'lénalidomide',\n",
       " 'itss',\n",
       " 'heures',\n",
       " 'eampoc',\n",
       " 'gonadotrophines',\n",
       " 'insomnie',\n",
       " \"modalités d'évaluation des médicaments\",\n",
       " \"institut national d'excellence en santé et en services\",\n",
       " 'conséquence',\n",
       " 'excellence en santé et en services sociaux',\n",
       " 'technologie',\n",
       " 'congrès',\n",
       " 'excellence en santé et en services',\n",
       " 'inscription de médicaments',\n",
       " 'dernières',\n",
       " 'res',\n",
       " 'taro',\n",
       " 'interféron',\n",
       " 'essais',\n",
       " 'trouble déficitaire',\n",
       " 'traitement de la dermatite',\n",
       " 'dupixent',\n",
       " 'nucala',\n",
       " 'gabarits',\n",
       " 'choix',\n",
       " ...]"
      ]
     },
     "execution_count": 125,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vocabulaire = csv[\"Terme\"].dropna().tolist()\n",
    "\n",
    "vocabulaire"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "metadata": {},
   "outputs": [],
   "source": [
    "#tokenizer = RegexpTokenizer(r\"\\w\\'|\\w+\")\n",
    "## Revoir ça\n",
    "tokenized_queries = [tokenizer.tokenize(str(t)) for t in vocabulaire]\n",
    "\n",
    "features_names = [t for t in set(vocabulaire)]\n",
    "corpus_index = [corpus.index(n) for n in corpus]\n",
    "\n",
    "tab = [bm25.get_scores(query) for query in tokenized_queries]\n",
    "df = pd.DataFrame(tab, index=features_names, columns=corpus_index).transpose()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6025\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[['traitement'],\n",
       " ['jamp'],\n",
       " ['évaluation'],\n",
       " ['médicaments'],\n",
       " ['demande'],\n",
       " ['inesss'],\n",
       " ['attente'],\n",
       " ['injection'],\n",
       " ['ministre'],\n",
       " ['patients'],\n",
       " ['médicament'],\n",
       " ['cours'],\n",
       " ['inscription'],\n",
       " ['sodium'],\n",
       " ['citrate'],\n",
       " ['attente', \"d'\", 'évaluation'],\n",
       " ['cancer'],\n",
       " ['angita'],\n",
       " ['darunavir'],\n",
       " ['calcium'],\n",
       " ['lurasidone'],\n",
       " ['bicarbonate'],\n",
       " ['réponses'],\n",
       " ['dextrose'],\n",
       " ['sulfonate'],\n",
       " ['bicarbonate', 'de', 'sodium'],\n",
       " ['glycopyrrolate'],\n",
       " ['cours', \"d'\", 'évaluation'],\n",
       " ['réponses', 'rapides'],\n",
       " ['covid-19'],\n",
       " ['santé'],\n",
       " ['indication'],\n",
       " ['réponses', 'rapides', 'disponibles'],\n",
       " ['pré-ac'],\n",
       " ['services'],\n",
       " ['listes'],\n",
       " ['décision'],\n",
       " ['québec'],\n",
       " ['nom'],\n",
       " ['demande', 'en', 'attente'],\n",
       " ['coll'],\n",
       " ['recommandations'],\n",
       " ['adultes'],\n",
       " ['projet'],\n",
       " ['fabricant'],\n",
       " ['cliniques'],\n",
       " ['chlorhydrate'],\n",
       " ['soins'],\n",
       " ['forme'],\n",
       " ['dépôt'],\n",
       " ['pré-ac', 'en', 'attente'],\n",
       " ['conseil'],\n",
       " ['recommandation'],\n",
       " ['fumarate'],\n",
       " ['demande', 'en', 'cours'],\n",
       " ['demande', 'en', 'cours', \"d'\", 'évaluation'],\n",
       " ['commune'],\n",
       " ['dénomination', 'commune'],\n",
       " ['exception'],\n",
       " ['dénomination'],\n",
       " ['évaluations'],\n",
       " ['maladie'],\n",
       " ['listes', 'des', 'médicaments'],\n",
       " ['canada'],\n",
       " ['usage'],\n",
       " ['ans'],\n",
       " ['nom', 'du', 'fabricant'],\n",
       " ['contexte'],\n",
       " ['liste'],\n",
       " ['teneur'],\n",
       " ['apotex'],\n",
       " ['recommandation', 'de', \"l'\", 'inesss'],\n",
       " ['connaissances'],\n",
       " ['quétiapine'],\n",
       " ['quétiapine', '(', 'fumarate', 'de', ')'],\n",
       " ['produits'],\n",
       " ['traitements'],\n",
       " ['evaluation'],\n",
       " ['décision', 'du', 'ministre'],\n",
       " ['lurasidone', '(', 'chlorhydrate', 'de', ')'],\n",
       " ['oméga'],\n",
       " ['calcium', '(', 'citrate', 'de', ')'],\n",
       " ['bromhydrate'],\n",
       " ['ag-calcium'],\n",
       " ['élétriptan'],\n",
       " ['ag-quetiapine'],\n",
       " ['injection', 'de', 'glycopyrrolate'],\n",
       " ['apo-eletriptan'],\n",
       " ['dextrose', 'injection'],\n",
       " ['jamp', 'lurasidone'],\n",
       " ['polystyrène'],\n",
       " ['sulfonate', 'calcique'],\n",
       " ['sodium', 'pour', 'injection'],\n",
       " ['halycil'],\n",
       " ['ag-calcium', 'citrate'],\n",
       " ['ag-calcium', 'citrate', 'liquid'],\n",
       " ['jamp', 'calcium', 'polystyrene', 'sulfonate'],\n",
       " ['jamp', 'calcium'],\n",
       " ['jamp', 'calcium', 'polystyrene'],\n",
       " ['citrate', 'liquid'],\n",
       " ['calcium', 'polystyrene'],\n",
       " ['bicarbonate', 'de', 'sodium', 'pour', 'injection'],\n",
       " ['calcium', 'polystyrene', 'sulfonate'],\n",
       " ['pré-ac', 'en', 'attente', \"d'\", 'évaluation'],\n",
       " ['données'],\n",
       " ['darunavir', 'dextrose', 'injection'],\n",
       " ['injection', '(', 'jamp', ')'],\n",
       " ['sodium', 'pour', 'injection', '(', 'jamp', ')'],\n",
       " ['jamp', 'lurasidone', '(', 'jamp', ')'],\n",
       " ['apo-eletriptan', '(', 'apotex', ')'],\n",
       " ['évaluations', 'récemment', 'publiées'],\n",
       " ['bicarbonate', 'de', 'sodium', 'pour', 'injection', '(', 'jamp', ')'],\n",
       " ['bicarbonate', 'de', 'sodium', 'darunavir'],\n",
       " ['dextrose', 'halycil'],\n",
       " ['bicarbonate', 'de', 'sodium', 'darunavir', '(', 'jamp', ')'],\n",
       " ['sodium', 'darunavir', '(', 'jamp', ')'],\n",
       " ['évaluations', 'récemment'],\n",
       " ['jamp', 'calcium', 'polystyrene', 'sulfonate', '(', 'jamp', ')'],\n",
       " ['calcium', 'polystyrene', 'sulfonate', '(', 'jamp', ')'],\n",
       " ['dextrose', 'injection', '(', 'oméga', ')'],\n",
       " ['darunavir', 'dextrose'],\n",
       " ['glycopyrrolate', '(', 'jamp', ')'],\n",
       " ['sodium', 'darunavir'],\n",
       " ['injection', 'de', 'glycopyrrolate', '(', 'jamp', ')'],\n",
       " ['injection', '(', 'oméga', ')'],\n",
       " ['evaluation', 'publiée'],\n",
       " ['darunavir', '(', 'jamp', ')'],\n",
       " ['citrate', 'liquid', '(', 'angita', ')'],\n",
       " ['sulfonate', '(', 'jamp', ')'],\n",
       " ['association'],\n",
       " ['adultes', 'atteints'],\n",
       " ['conditions'],\n",
       " ['efficacité'],\n",
       " ['demande', 'en', 'attente', \"d'\", 'évaluation'],\n",
       " ['attente', \"d'\", 'un', 'dépôt', 'pour', 'évaluation'],\n",
       " ['attente', \"d'\", 'un', 'dépôt'],\n",
       " ['dépôt', 'pour', 'évaluation'],\n",
       " ['type'],\n",
       " ['services', 'sociaux'],\n",
       " ['utilisation'],\n",
       " ['produit'],\n",
       " ['coût'],\n",
       " ['résultats'],\n",
       " ['risque'],\n",
       " ['traitement', 'des', 'patients'],\n",
       " ['cellules'],\n",
       " ['fabricants'],\n",
       " ['patients', 'adultes'],\n",
       " ['besoins'],\n",
       " ['pandémie'],\n",
       " ['système'],\n",
       " ['clinique'],\n",
       " ['enfants'],\n",
       " ['patients', 'adultes', 'atteints'],\n",
       " ['étude'],\n",
       " ['études'],\n",
       " ['réponse'],\n",
       " ['indication', 'reconnue'],\n",
       " ['trauma'],\n",
       " ['médicament', \"d'\", 'exception'],\n",
       " ['ligne'],\n",
       " ['ordonnances'],\n",
       " ['projet', 'aligné'],\n",
       " ['projet', 'aligné', 'inesss-acmts', 'santé', 'canada'],\n",
       " ['qualité'],\n",
       " ['méthode'],\n",
       " ['vie'],\n",
       " ['poumon'],\n",
       " ['connaissance'],\n",
       " ['msss'],\n",
       " ['cancer', 'du', 'poumon'],\n",
       " ['traitement', 'des', 'patients', 'adultes'],\n",
       " ['traitement', 'des', 'patients', 'adultes', 'atteints'],\n",
       " ['demande', 'en', 'attente', \"d'\", 'un', 'dépôt', 'pour', 'évaluation'],\n",
       " ['demande', 'en', 'attente', \"d'\", 'un', 'dépôt'],\n",
       " ['adulte'],\n",
       " ['extrait'],\n",
       " ['hospitalisation'],\n",
       " ['produits', 'de', 'connaissance'],\n",
       " ['auteur'],\n",
       " ['mois'],\n",
       " ['suivi'],\n",
       " ['traitement', 'du', 'cancer'],\n",
       " ['patients', 'atteints'],\n",
       " ['kio'],\n",
       " ['projet', 'auteur'],\n",
       " ['ordonnance'],\n",
       " ['réévaluation'],\n",
       " ['risques'],\n",
       " ['pré-ac', 'en', 'cours'],\n",
       " ['pré-ac', 'en', 'cours', \"d'\", 'évaluation'],\n",
       " ['pratiques'],\n",
       " ['ligne', 'evaluation', 'publiée'],\n",
       " ['ligne', 'evaluation'],\n",
       " ['prise'],\n",
       " ['extrait', 'de', \"l'\", 'avis', 'au', 'ministre'],\n",
       " ['réponse', 'rapide'],\n",
       " ['établissements'],\n",
       " ['trouble'],\n",
       " ['injury'],\n",
       " ['indications'],\n",
       " ['usage', 'optimal'],\n",
       " ['analyse'],\n",
       " ['médicaments', \"d'\", 'exception'],\n",
       " ['symptômes'],\n",
       " ['transfert'],\n",
       " ['cas'],\n",
       " ['outil'],\n",
       " ['sondage'],\n",
       " ['ajout'],\n",
       " ['ensemble'],\n",
       " ['soutien'],\n",
       " ['coordination'],\n",
       " ['protocole'],\n",
       " ['guide'],\n",
       " ['traumatologie'],\n",
       " ['description'],\n",
       " ['évolution'],\n",
       " ['pertinence'],\n",
       " ['fiche'],\n",
       " ['chronique'],\n",
       " ['processus'],\n",
       " ['besoins', 'hospitaliers'],\n",
       " ['refus'],\n",
       " ['régime'],\n",
       " ['dépistage'],\n",
       " ['collaboration'],\n",
       " ['coordination', 'scientifique'],\n",
       " ['diabète'],\n",
       " ['accès'],\n",
       " ['méthode', 'de', 'réponse'],\n",
       " ['listes', 'de', 'médicaments'],\n",
       " ['méthode', 'de', 'réponse', 'rapide'],\n",
       " ['projections'],\n",
       " ['cancer', 'du', 'poumon', 'non', 'à', 'petites', 'cellules'],\n",
       " ['cancérologie'],\n",
       " ['durée'],\n",
       " ['dose'],\n",
       " ['tériflunomide'],\n",
       " ['prophylaxie'],\n",
       " ['description', 'du', 'médicament'],\n",
       " ['modalités'],\n",
       " ['kio', 'autres', 'recommandations'],\n",
       " ['nom', 'commercial'],\n",
       " ['infection'],\n",
       " ['prévention'],\n",
       " ['rencontre'],\n",
       " ['général'],\n",
       " ['lymphome'],\n",
       " ['merck'],\n",
       " ['chimiothérapie'],\n",
       " ['critères'],\n",
       " ['aide'],\n",
       " ['réseau'],\n",
       " ['effets'],\n",
       " ['risques', \"d'\", 'hospitalisation'],\n",
       " ['conditions', 'à', 'venir'],\n",
       " ['troubles'],\n",
       " ['génériques'],\n",
       " ['innocuité'],\n",
       " ['stade'],\n",
       " ['cadre'],\n",
       " ['roche'],\n",
       " ['population'],\n",
       " ['électronique'],\n",
       " ['mesure'],\n",
       " ['pembrolizumab'],\n",
       " ['keytruda'],\n",
       " ['adalimumab'],\n",
       " ['soins', 'palliatifs'],\n",
       " ['brain'],\n",
       " ['demandes'],\n",
       " ['demande', \"d'\", 'inscription'],\n",
       " ['jeunes'],\n",
       " ['regard'],\n",
       " ['présente'],\n",
       " ['dépôt', 'électronique'],\n",
       " ['pembrolizumab', 'merck'],\n",
       " ['patient'],\n",
       " ['test'],\n",
       " ['évaluation', 'keytruda'],\n",
       " ['hypertension'],\n",
       " ['travaux'],\n",
       " ['care'],\n",
       " ['experts'],\n",
       " ['fins'],\n",
       " ['transfert', 'de', 'connaissances'],\n",
       " ['semaines'],\n",
       " ['sanis'],\n",
       " ['sang'],\n",
       " ['brain', 'injury'],\n",
       " ['protocole', 'médical'],\n",
       " ['traumatic'],\n",
       " ['traitement', 'adjuvant'],\n",
       " ['professionnels'],\n",
       " ['gène'],\n",
       " ['projections', 'des', 'besoins', 'hospitaliers'],\n",
       " ['projections', 'des', 'besoins'],\n",
       " ['pansement'],\n",
       " ['sandoz'],\n",
       " ['soins', 'intensifs'],\n",
       " ['hospitalisation', 'et', 'projections', 'des', 'besoins'],\n",
       " ['hospitalisation', 'et', 'projections'],\n",
       " ['hospitalisation', 'et', 'projections', 'des', 'besoins', 'hospitaliers'],\n",
       " ['risques', \"d'\", 'hospitalisation', 'et', 'projections'],\n",
       " ['raison'],\n",
       " ['régime', 'général'],\n",
       " ['jours'],\n",
       " ['liste', 'des', 'médicaments'],\n",
       " ['déficit'],\n",
       " ['portrait'],\n",
       " ['mise'],\n",
       " ['nombre'],\n",
       " ['liste', 'de', 'médicaments'],\n",
       " ['recherche'],\n",
       " ['investigation'],\n",
       " ['annexes'],\n",
       " ['médecins'],\n",
       " ['traitement', 'des', 'adultes'],\n",
       " ['solution'],\n",
       " ['atteintes'],\n",
       " ['pré-ac', 'en', 'attente', \"d'\", 'un', 'dépôt', 'pour', 'évaluation'],\n",
       " ['pré-ac', 'en', 'attente', \"d'\", 'un', 'dépôt'],\n",
       " ['adultes', 'atteints', \"d'\", 'un', 'cancer'],\n",
       " ['asthme'],\n",
       " ['tableau'],\n",
       " ['inhibiteur'],\n",
       " ['infections'],\n",
       " ['terme'],\n",
       " ['procédures'],\n",
       " ['québécois'],\n",
       " ['mesures'],\n",
       " ['diagnostic'],\n",
       " ['élaboration'],\n",
       " ['biosimilaire'],\n",
       " ['pratique'],\n",
       " ['références'],\n",
       " ['interventions'],\n",
       " ['traumatic', 'brain'],\n",
       " ['jour'],\n",
       " ['études', 'cliniques'],\n",
       " ['attente', \"d'\", 'évaluation', 'keytruda'],\n",
       " ['diabète', 'de', 'type'],\n",
       " ['groupe'],\n",
       " ['traumatic', 'brain', 'injury'],\n",
       " ['graves'],\n",
       " ['formule'],\n",
       " ['contexte', 'de', 'pandémie'],\n",
       " ['analyses'],\n",
       " ['ordonnance', 'collective'],\n",
       " ['évaluation', 'des', 'médicaments'],\n",
       " ['biologie'],\n",
       " ['biologie', 'médicale'],\n",
       " ['réadaptation'],\n",
       " ['modification'],\n",
       " ['azc'],\n",
       " ['documentation'],\n",
       " ['conseil', 'a', 'recommandé'],\n",
       " ['post-covid', '19'],\n",
       " ['implantation'],\n",
       " ['femmes'],\n",
       " ['ordonnances', 'collectives'],\n",
       " ['intervention'],\n",
       " ['rétablissement'],\n",
       " ['principaux'],\n",
       " ['échéancier'],\n",
       " ['contexte', 'de', 'la', 'covid-19'],\n",
       " ['affections'],\n",
       " ['study'],\n",
       " ['intention'],\n",
       " ['virus'],\n",
       " ['survie'],\n",
       " ['intérêt'],\n",
       " ['lyme'],\n",
       " ['demandes', \"d'\", 'inscription'],\n",
       " ['reprise'],\n",
       " ['ministère'],\n",
       " ['rapports'],\n",
       " ['formule', 'nutritive'],\n",
       " ['opdivo'],\n",
       " ['maladies'],\n",
       " ['produit', 'biosimilaire'],\n",
       " ['produit', 'du', 'système'],\n",
       " ['plan'],\n",
       " ['aspects'],\n",
       " ['réduction'],\n",
       " ['ajustement'],\n",
       " ['mutation'],\n",
       " ['littérature'],\n",
       " ['réévaluation', 'en', 'attente'],\n",
       " ['keytruda', 'pembrolizumab', 'merck'],\n",
       " ['produit', 'du', 'système', 'du', 'sang', 'traitement'],\n",
       " ['fins', \"d'\", 'inscription'],\n",
       " ['keytruda', 'pembrolizumab'],\n",
       " ['nom', 'commercial', 'à', 'venir'],\n",
       " ['évaluation', 'keytruda', 'pembrolizumab', 'merck'],\n",
       " ['évaluation', 'keytruda', 'pembrolizumab'],\n",
       " ['traitement',\n",
       "  'des',\n",
       "  'patients',\n",
       "  'adultes',\n",
       "  'atteints',\n",
       "  \"d'\",\n",
       "  'un',\n",
       "  'cancer'],\n",
       " ['sang', 'traitement'],\n",
       " ['patients', 'adultes', 'atteints', \"d'\", 'un', 'cancer'],\n",
       " ['produit', 'du', 'système', 'du', 'sang'],\n",
       " ['review'],\n",
       " ['système', 'du', 'sang', 'traitement'],\n",
       " ['système', 'du', 'sang'],\n",
       " ['sang'],\n",
       " ['nivolumab'],\n",
       " ['affections', 'post-covid', '19'],\n",
       " ['phase'],\n",
       " ['maladie', 'de', 'lyme'],\n",
       " ['lien'],\n",
       " ['syndrome'],\n",
       " ['note'],\n",
       " ['inspq'],\n",
       " ['alternatives'],\n",
       " ['notice'],\n",
       " ['médicaments', 'du', 'régime'],\n",
       " ['médicaments', 'du', 'régime', 'général'],\n",
       " ['immunoglobulines'],\n",
       " ['chirurgie'],\n",
       " ['santécom'],\n",
       " ['sites'],\n",
       " ['inhibiteurs'],\n",
       " ['assurance'],\n",
       " ['ventilation'],\n",
       " ['états'],\n",
       " ['entretien'],\n",
       " ['notice', 'santécom'],\n",
       " ['ministère', 'de', 'la', 'santé'],\n",
       " ['conclusion'],\n",
       " ['uetmis'],\n",
       " ['biosimilaires'],\n",
       " ['médecin'],\n",
       " ['semaine'],\n",
       " ['présentations'],\n",
       " ['recommandation', 'de', \"l'\", 'inesss', 'ajout'],\n",
       " ['traitement', \"d'\", 'entretien'],\n",
       " ['lilly'],\n",
       " ['hypertension', 'artérielle'],\n",
       " ['états', 'des', 'connaissances'],\n",
       " ['chaleur'],\n",
       " ['covid-19', 'au', 'québec'],\n",
       " ['oeuvre'],\n",
       " ['placebo'],\n",
       " ['treatment'],\n",
       " ['influenza'],\n",
       " ['temps'],\n",
       " ['études', 'cliniques', 'en', 'cours'],\n",
       " ['approche'],\n",
       " ['leucémie'],\n",
       " ['épidémie'],\n",
       " ['milieu'],\n",
       " ['systematic'],\n",
       " ['traitement', 'du', 'cancer', 'du', 'poumon'],\n",
       " ['traitements', 'en', 'contexte'],\n",
       " ['mise', 'en', 'oeuvre'],\n",
       " ['impact'],\n",
       " ['moment'],\n",
       " ['ventilation', 'assistée'],\n",
       " ['tumeurs'],\n",
       " ['coût', 'de', 'traitement'],\n",
       " ['pandémie', 'covid-19'],\n",
       " ['réponse', 'rapide', 'dans', 'le', 'contexte', 'de', 'la', 'covid-19'],\n",
       " ['échangeur', 'de', 'chaleur'],\n",
       " ['oeuvre', 'de', 'la', 'méthode', 'de', 'réponse', 'rapide'],\n",
       " ['vue'],\n",
       " ['élaboration', 'et', 'mise'],\n",
       " ['méthode', 'de', 'réponse', 'rapide', 'dans', 'le', 'contexte'],\n",
       " ['mise', 'en', 'oeuvre', 'de', 'la', 'méthode', 'de', 'réponse'],\n",
       " ['mise', 'en', 'oeuvre', 'de', 'la', 'méthode'],\n",
       " ['prophylaxie', 'et', 'traitement'],\n",
       " ['échangeur'],\n",
       " ['réponse', 'rapide', 'dans', 'le', 'contexte'],\n",
       " ['oeuvre', 'de', 'la', 'méthode', 'de', 'réponse'],\n",
       " ['oeuvre', 'de', 'la', 'méthode'],\n",
       " ['élaboration', 'et', 'mise', 'en', 'oeuvre', 'de', 'la', 'méthode'],\n",
       " ['monothérapie'],\n",
       " ['taux'],\n",
       " ['mise', 'en', 'oeuvre', 'de', 'la', 'méthode', 'de', 'réponse', 'rapide'],\n",
       " ['élaboration', 'et', 'mise', 'en', 'oeuvre'],\n",
       " ['réponses', 'rapides', 'disponibles', 'affections', 'post-covid', '19'],\n",
       " ['regard', 'sur', 'la', 'pandémie', 'covid-19', 'au', 'québec'],\n",
       " ['pandémie', 'covid-19', 'au', 'québec'],\n",
       " ['regard', 'sur', 'la', 'pandémie', 'covid-19'],\n",
       " ['projections', 'des', 'besoins', 'hospitaliers', 'traitements'],\n",
       " ['procédures', 'diagnostiques'],\n",
       " ['ministère', 'de', 'la', 'santé', 'et', 'des', 'services'],\n",
       " ['démarche'],\n",
       " ['réponses', 'rapides', 'disponibles', 'services', 'sociaux'],\n",
       " ['réponses', 'rapides', 'disponibles', 'regard'],\n",
       " ['sites', \"d'\", 'intérêt', 'visitez'],\n",
       " ['ministère', 'de', 'la', 'santé', 'et', 'des', 'services', 'sociaux'],\n",
       " ['traitements', 'spécifiques'],\n",
       " ['besoins', 'hospitaliers', 'traitements'],\n",
       " ['regard', 'sur', 'la', 'pandémie'],\n",
       " ['traitements', 'spécifiques', 'à', 'la', 'covid-19'],\n",
       " ['échangeur', 'de', 'chaleur', 'sites'],\n",
       " ['échangeur', 'de', 'chaleur', 'sites', \"d'\", 'intérêt'],\n",
       " ['traitement', 'ordonnances', 'collectives'],\n",
       " ['réponses', 'rapides', 'disponibles', 'rétablissement'],\n",
       " ['inspq', 'visitez'],\n",
       " ['intérêt', 'visitez'],\n",
       " ['niveau'],\n",
       " ['contributions', 'des', 'uetmis', 'soins'],\n",
       " ['contributions', 'des', 'uetmis'],\n",
       " ['contexte', 'de', 'la', 'covid-19', 'contributions'],\n",
       " ['contributions'],\n",
       " ['projections',\n",
       "  'des',\n",
       "  'besoins',\n",
       "  'hospitaliers',\n",
       "  'traitements',\n",
       "  'spécifiques'],\n",
       " ['rapports', 'disponibles'],\n",
       " ['alternatives', 'de', 'traitements'],\n",
       " ['réponses', 'rapides', 'disponibles', 'études', 'cliniques', 'en', 'cours'],\n",
       " ['alternatives', 'de', 'traitements', 'en', 'contexte'],\n",
       " ['réponses', 'rapides', 'disponibles', 'affections'],\n",
       " ['présentations', 'cliniques'],\n",
       " ['summary'],\n",
       " ['rétablissement', 'et', 'reprise'],\n",
       " ['réponses', 'rapides', 'disponibles', 'investigation'],\n",
       " ['réponses', 'rapides', 'disponibles', 'méthode'],\n",
       " ['contributions', 'des', 'uetmis', 'soins', 'intensifs'],\n",
       " ['réponses', 'rapides', 'disponibles', 'services'],\n",
       " ['réponses', 'rapides', 'disponibles', 'méthode', 'de', 'réponse'],\n",
       " ['traitement', 'ordonnances'],\n",
       " ['prophylaxie', 'et', 'traitement', 'ordonnances'],\n",
       " ['réponses', 'rapides', 'disponibles', 'méthode', 'de', 'réponse', 'rapide'],\n",
       " ['rapports', 'disponibles', 'présentations'],\n",
       " ['chaleur', 'sites'],\n",
       " ['besoins', 'hospitaliers', 'traitements', 'spécifiques'],\n",
       " ['rapports', 'disponibles', 'présentations', 'cliniques'],\n",
       " ['alternatives', 'de', 'traitements', 'en', 'contexte', 'de', 'pandémie'],\n",
       " ['traitements', 'en', 'contexte', 'de', 'pandémie'],\n",
       " ['réponses', 'rapides', 'disponibles', 'autres', 'traitements'],\n",
       " ['covid-19', 'longue'],\n",
       " ['réponses', 'rapides', 'disponibles', 'études', 'cliniques'],\n",
       " ['réponses', 'rapides', 'disponibles', 'cancérologie'],\n",
       " ['affections', 'post-covid', '19', '(', 'covid-19', 'longue', ')'],\n",
       " ['réponses', 'rapides', 'disponibles', 'études'],\n",
       " ['chaleur', 'sites', \"d'\", 'intérêt'],\n",
       " ['sites', \"d'\", 'intérêt'],\n",
       " ['plaques'],\n",
       " ['appoint'],\n",
       " ['constats'],\n",
       " ['situation'],\n",
       " ['médicaments', 'biosimilaires'],\n",
       " ['fer'],\n",
       " ['pfizer'],\n",
       " ['paladin'],\n",
       " ['glucose'],\n",
       " ['normes'],\n",
       " ['dépôt', 'électronique', \"d'\", 'une', 'demande', \"d'\", 'inscription'],\n",
       " ['sujets'],\n",
       " ['dépôt', 'électronique', \"d'\", 'une', 'demande'],\n",
       " ['sol'],\n",
       " ['base'],\n",
       " ['évolution', 'de', \"l'\", 'épidémie'],\n",
       " ['comprimé'],\n",
       " ['pharma'],\n",
       " ['épidémie', 'de', 'covid-19'],\n",
       " ['attention'],\n",
       " ['emergency'],\n",
       " ['projets'],\n",
       " ['santé', 'canada'],\n",
       " ['suivi', 'de', \"l'\", 'évolution'],\n",
       " ['protocole', 'médical', 'national'],\n",
       " ['suivi', 'de', \"l'\", 'évolution', 'de', \"l'\", 'épidémie'],\n",
       " ['suivi', 'de', \"l'\", 'évolution', 'de', \"l'\", 'épidémie', 'de', 'covid-19'],\n",
       " ['score'],\n",
       " ['évolution', 'de', \"l'\", 'épidémie', 'de', 'covid-19'],\n",
       " ['administration'],\n",
       " ['évaluation', 'nom'],\n",
       " ['évaluation', 'nom', 'commercial'],\n",
       " ['médicaments', 'évalués'],\n",
       " ['problèmes'],\n",
       " ['protocoles'],\n",
       " ['santé', 'mentale'],\n",
       " ['patients', 'âgés'],\n",
       " ['traitement', 'des', 'adultes', 'atteints'],\n",
       " ['bénéfices'],\n",
       " ['évaluation', 'nom', 'commercial', 'à', 'venir'],\n",
       " ['amélioration'],\n",
       " ['développement'],\n",
       " ['ministre', 'sur', 'les', 'génériques'],\n",
       " ['polyangéite'],\n",
       " ['pembrolizumab', 'merck', 'traitement'],\n",
       " ['réévaluation', 'en', 'attente', \"d'\", 'évaluation'],\n",
       " ['enfant'],\n",
       " ['radiothérapie'],\n",
       " ['jamp', 'inscription'],\n",
       " ['tests'],\n",
       " ['gsk'],\n",
       " ['lumière'],\n",
       " ['conformité'],\n",
       " ['besoin'],\n",
       " ['années'],\n",
       " ['oncologie'],\n",
       " ['point'],\n",
       " ['objet'],\n",
       " ['augmentation'],\n",
       " ['modérée'],\n",
       " ['action'],\n",
       " ['attente', \"d'\", 'évaluation', 'keytruda', 'pembrolizumab'],\n",
       " ['psoriasis'],\n",
       " ['application'],\n",
       " ['glycémie'],\n",
       " ['egfr'],\n",
       " ['échelle'],\n",
       " ['long'],\n",
       " ['prostate'],\n",
       " ['agent'],\n",
       " ['présence'],\n",
       " ['bandelette'],\n",
       " ['place'],\n",
       " ['progression'],\n",
       " ['centre'],\n",
       " ['insuline'],\n",
       " ['institut'],\n",
       " ['metformine'],\n",
       " ['effets', 'indésirables'],\n",
       " ['adolescents'],\n",
       " ['paiement'],\n",
       " ['doses'],\n",
       " ['stylo'],\n",
       " ['thérapie'],\n",
       " ['processus', \"d'\", 'évaluation'],\n",
       " ['demande', 'en', 'attente', \"d'\", 'évaluation', 'keytruda'],\n",
       " ['rosiglitazone'],\n",
       " ['liste', 'de', 'médicaments', 'du', 'régime', 'général'],\n",
       " ['alcool'],\n",
       " ['qualité', 'de', 'vie'],\n",
       " ['liste', 'de', 'médicaments', 'du', 'régime'],\n",
       " ['sclérose'],\n",
       " ['centres'],\n",
       " ['clientèle'],\n",
       " ['familles'],\n",
       " ['insuffisance'],\n",
       " ['autorisation'],\n",
       " ['techniques'],\n",
       " ['hormone'],\n",
       " ['indicateurs'],\n",
       " ['indications', 'reconnues'],\n",
       " ['premarin'],\n",
       " ['douleur'],\n",
       " ['référence'],\n",
       " ['monothérapie', 'pour', 'le', 'traitement'],\n",
       " ['sep'],\n",
       " ['systematic', 'review'],\n",
       " ['période'],\n",
       " ['modèle'],\n",
       " ['protocoles', 'médicaux'],\n",
       " ['année'],\n",
       " ['gestion'],\n",
       " ['statut'],\n",
       " ['agents'],\n",
       " ['guides'],\n",
       " ['colite'],\n",
       " ['complications'],\n",
       " ['guide', \"d'\", 'usage', 'optimal'],\n",
       " ['organisation'],\n",
       " ['colite', 'ulcéreuse'],\n",
       " ['traitement', 'des', 'patients', 'atteints'],\n",
       " ['liaison'],\n",
       " ['guide', \"d'\", 'usage'],\n",
       " ['exception', 'décision'],\n",
       " ['exception', 'décision', 'du', 'ministre'],\n",
       " ['objectif'],\n",
       " ['seringue'],\n",
       " ['standard'],\n",
       " ['consultation'],\n",
       " ['informations'],\n",
       " ['soulagement'],\n",
       " ['ordonnance', 'individuelle'],\n",
       " ['pioglitazone'],\n",
       " ['publication'],\n",
       " ['continu'],\n",
       " ['mutations'],\n",
       " ['marie-claude'],\n",
       " ['décès'],\n",
       " ['sédation'],\n",
       " ['coûts'],\n",
       " ['remboursement'],\n",
       " ['protocoles', 'médicaux', 'nationaux'],\n",
       " ['diminution'],\n",
       " ['fusion'],\n",
       " ['experts', 'consultés'],\n",
       " ['éléments'],\n",
       " ['travail'],\n",
       " ['uvéite'],\n",
       " ['sras-cov', '2'],\n",
       " ['services', 'sociaux', '(', 'msss', ')'],\n",
       " ['adultes', 'atteints', \"d'\", 'un', 'lymphome'],\n",
       " ['abbvie'],\n",
       " ['médicament', \"d'\", 'exception', 'décision', 'du', 'ministre'],\n",
       " ['traitement', 'de', 'la', 'colite', 'ulcéreuse'],\n",
       " ['documents'],\n",
       " ['médicament', \"d'\", 'exception', 'décision'],\n",
       " ['aspects', 'économique'],\n",
       " ['traitement', 'de', 'la', 'colite'],\n",
       " ['inj'],\n",
       " ['protection'],\n",
       " ['revue'],\n",
       " ['considérations'],\n",
       " ['topique'],\n",
       " ['rencontre', 'présoumission'],\n",
       " ['aigüe'],\n",
       " ['gonorrhoeae'],\n",
       " ['endomètre'],\n",
       " ['rgam'],\n",
       " ['cellules', 'métastatique'],\n",
       " ['présoumission'],\n",
       " ['comparaison'],\n",
       " ['attente', \"d'\", 'évaluation', 'nom'],\n",
       " ['gène', 'ret'],\n",
       " ['adultes', 'atteints', \"d'\", 'un', 'cancer', 'du', 'poumon'],\n",
       " ['abbvie', 'traitement'],\n",
       " ['asthme', 'sévère'],\n",
       " ['incertitude'],\n",
       " ['point', 'de', 'vue'],\n",
       " ['préavis'],\n",
       " ['évaluation', 'keytruda', 'pembrolizumab', 'merck', 'traitement'],\n",
       " ['traitement', 'de', \"l'\", 'uvéite'],\n",
       " ['paladin', 'traitement'],\n",
       " ['attente', \"d'\", 'évaluation', 'nom', 'commercial'],\n",
       " ['cancer', 'de', \"l'\", 'endomètre'],\n",
       " ['keytruda', 'pembrolizumab', 'merck', 'traitement'],\n",
       " ['médicaments', 'présentés'],\n",
       " ['ajout', 'aux', 'listes'],\n",
       " ['cardiovasculaire'],\n",
       " ['ministre', 'de', 'la', 'santé'],\n",
       " ['ministre', 'de', 'la', 'santé', 'et', 'des', 'services', 'sociaux'],\n",
       " ['mélanome'],\n",
       " ['marcan'],\n",
       " ['ajout', 'aux', 'listes', 'de', 'médicaments'],\n",
       " ['ministre', 'de', 'la', 'santé', 'et', 'des', 'services'],\n",
       " ['synthèse'],\n",
       " ['mandat'],\n",
       " ['rehabilitation'],\n",
       " ['réalisation'],\n",
       " ['répertoire'],\n",
       " ['indication', 'reconnue', 'aux', 'listes'],\n",
       " ['hyperactivité'],\n",
       " ['mcg'],\n",
       " ['inscrits'],\n",
       " ['version'],\n",
       " ['maladie', 'pulmonaire'],\n",
       " ['guise'],\n",
       " ['absence'],\n",
       " ['résultat'],\n",
       " ['conséquences'],\n",
       " ['public'],\n",
       " ['recommandation', 'de', \"l'\", 'inesss', 'ajout', 'aux', 'listes'],\n",
       " ['modification', \"d'\", 'une', 'indication'],\n",
       " ['mode'],\n",
       " ['maladie', 'pulmonaire', 'obstructive'],\n",
       " ['décisions'],\n",
       " ['caractéristiques'],\n",
       " ['maladie', 'pulmonaire', 'obstructive', 'chronique'],\n",
       " ['iii'],\n",
       " ['nouveautés'],\n",
       " ['carcinome'],\n",
       " ['système', 'de', 'santé'],\n",
       " ['principaux', 'experts', 'consultés'],\n",
       " ['liste', 'des', 'principaux', 'experts', 'consultés'],\n",
       " ['principaux', 'experts'],\n",
       " ['limite'],\n",
       " ['dispositifs'],\n",
       " ['bgp', 'pharma'],\n",
       " ['rétention'],\n",
       " ['chlamydia'],\n",
       " ['modification', \"d'\", 'une', 'indication', 'reconnue'],\n",
       " ['groupes'],\n",
       " ['liste', 'des', 'principaux'],\n",
       " ['lésions'],\n",
       " ['imagerie'],\n",
       " ['liste', 'des', 'principaux', 'experts'],\n",
       " ['bgp'],\n",
       " ['excellence'],\n",
       " ['algorithme'],\n",
       " ['pansements'],\n",
       " ['fiches'],\n",
       " ['candidose'],\n",
       " ['management'],\n",
       " ['biologie', 'médicale', 'et', 'génomique'],\n",
       " ['plaies'],\n",
       " ['institut', 'national'],\n",
       " ['préavis', 'obligatoire'],\n",
       " ['système', 'du', 'sang'],\n",
       " ['critère'],\n",
       " ['tsa'],\n",
       " ['évaluation', 'scientifique'],\n",
       " ['juge'],\n",
       " ['refus', \"d'\", 'inscription'],\n",
       " ['fin'],\n",
       " ['détresse'],\n",
       " ['performance'],\n",
       " ['produits', 'du', 'système'],\n",
       " ['ppb'],\n",
       " ['déficience'],\n",
       " ['mucosite'],\n",
       " ['fonction'],\n",
       " ['ipilimumab'],\n",
       " ['hospitalisations'],\n",
       " ['ppe'],\n",
       " ['acétate'],\n",
       " ['ordonnances', 'associées'],\n",
       " ['rencontre', 'postsoumission'],\n",
       " ['traumatisme'],\n",
       " ['famille'],\n",
       " ['condition'],\n",
       " ['utérus'],\n",
       " ['postsoumission'],\n",
       " ['enjeux'],\n",
       " ['option'],\n",
       " ['fièvre'],\n",
       " ['profil'],\n",
       " ['traitement', 'de', \"l'\", 'asthme'],\n",
       " ['programme'],\n",
       " ['relatives'],\n",
       " ['nausées'],\n",
       " ['fibrose'],\n",
       " ['diabetes'],\n",
       " ['cancer', 'de', 'la', 'prostate'],\n",
       " ['fentanyl'],\n",
       " ['produits', 'du', 'système', 'du', 'sang'],\n",
       " ['dermatite', 'atopique'],\n",
       " ['experts', 'consultés', 'autres', 'recommandations'],\n",
       " ['aide', 'à', 'la', 'décision'],\n",
       " ['nifédipine'],\n",
       " ['dermatite'],\n",
       " ['mucosite', 'oropharyngée'],\n",
       " ['guo'],\n",
       " ['amgevita'],\n",
       " ['adalimumab', 'amgen'],\n",
       " ['critères', 'économique'],\n",
       " ['tarification'],\n",
       " ['cancers'],\n",
       " ['transplantation'],\n",
       " ['trouble', 'lié'],\n",
       " ['bid'],\n",
       " ['chloroquine'],\n",
       " ['réactif'],\n",
       " ['réactif', 'quantitatif'],\n",
       " ['randomized'],\n",
       " ['médicaments', 'décision'],\n",
       " ['consensus'],\n",
       " ['médicaments', 'décision', 'du', 'ministre'],\n",
       " ['croissance'],\n",
       " ['exemption'],\n",
       " ['ordre'],\n",
       " ['attente', \"d'\", 'un', 'avis', 'de', 'conformité'],\n",
       " ['urgence'],\n",
       " ['cst'],\n",
       " ['naloxone'],\n",
       " ['produits', 'de', 'santé'],\n",
       " ['ensemble', 'des', 'critères'],\n",
       " ['candidose', 'buccale'],\n",
       " ['ostéoporose'],\n",
       " ['traitement', 'du', 'diabète'],\n",
       " ['élimination'],\n",
       " ['trouble', 'lié', 'à', \"l'\", 'usage'],\n",
       " ['calcipotriol'],\n",
       " ['sédation', 'palliative'],\n",
       " ['facteurs'],\n",
       " ['évaluation', 'des', 'médicaments', 'aux', 'fins'],\n",
       " ['davc'],\n",
       " ['médicaments', 'aux', 'fins', \"d'\", 'inscription'],\n",
       " ['évaluation', 'des', 'médicaments', 'aux', 'fins', \"d'\", 'inscription'],\n",
       " ['médicaments', 'aux', 'fins'],\n",
       " ['quality'],\n",
       " ['références', 'utilisées'],\n",
       " ['antidiabétique'],\n",
       " ['natalizumab'],\n",
       " ['ensemble', 'des', 'critères', 'prévus'],\n",
       " ['élimination', 'fécale'],\n",
       " ['critères', 'prévus'],\n",
       " ['liste', 'établissements'],\n",
       " ['formulation'],\n",
       " ['jamp', 'inscription', 'inscrire'],\n",
       " ['vitamine'],\n",
       " ['détection'],\n",
       " ['continuum'],\n",
       " ['médicaments', 'evaluation'],\n",
       " ['documentation', 'scientifique'],\n",
       " ['proches'],\n",
       " ['âge'],\n",
       " ['listes', 'des', 'médicaments', 'evaluation'],\n",
       " ['médicaments', 'evaluation', 'publiée'],\n",
       " ['classe'],\n",
       " ['preuve'],\n",
       " ['insuffisance', 'cardiaque'],\n",
       " ['santé', 'naturels'],\n",
       " ['produits', 'de', 'santé', 'naturels'],\n",
       " ['rencontre', 'présoumission', 'avec', 'les', 'fabricants'],\n",
       " ['sédation', 'palliative', 'continue'],\n",
       " ['mortalité'],\n",
       " ['dexcom'],\n",
       " ['présoumission', 'avec', 'les', 'fabricants'],\n",
       " ['modifications'],\n",
       " ['postsoumission', 'avec', 'les', 'fabricants'],\n",
       " ['rencontre', 'postsoumission', 'avec', 'les', 'fabricants'],\n",
       " ['troubles', 'neurocognitifs'],\n",
       " ['pertes'],\n",
       " ['évaluation', 'aux', 'fins', \"d'\", 'inscription'],\n",
       " ['fiche', 'synthèse'],\n",
       " ['trastuzumab'],\n",
       " ['technologies'],\n",
       " ['évaluation', 'aux', 'fins'],\n",
       " ['usage', \"d'\", 'alcool'],\n",
       " ['trouble', 'lié', 'à', \"l'\", 'usage', \"d'\", 'alcool'],\n",
       " ['infections', 'urinaires'],\n",
       " ['pharmacien'],\n",
       " ['candidose', 'buccale', 'chez', \"l'\", 'adulte'],\n",
       " ['institut', 'national', \"d'\", 'excellence', 'en', 'santé'],\n",
       " ['listes', 'de', 'médicaments', 'décision'],\n",
       " ['excellence', 'en', 'santé'],\n",
       " ['traitement', 'au', 'fer'],\n",
       " ['listes', 'de', 'médicaments', 'décision', 'du', 'ministre'],\n",
       " ['cliniciens'],\n",
       " ['institut', 'national', \"d'\", 'excellence'],\n",
       " ['associations'],\n",
       " ['pertes', 'vaginales'],\n",
       " ['laboratoire'],\n",
       " ['rétention', 'urinaire'],\n",
       " ['surveillance'],\n",
       " ['présent'],\n",
       " ['fabricants', 'avis', 'aux', 'fabricants'],\n",
       " ['outil', 'de', 'transfert'],\n",
       " ['médecins', 'signataires'],\n",
       " ['med'],\n",
       " ['préavis', 'obligatoire', 'demandé', 'aux', 'fabricants'],\n",
       " ['préavis', 'obligatoire', 'demandé'],\n",
       " ['signataires'],\n",
       " ['fer', 'intraveineux'],\n",
       " ['modalités', \"d'\", 'évaluation'],\n",
       " ['fibrose', 'kystique'],\n",
       " ['outil', 'de', 'transfert', 'de', 'connaissances'],\n",
       " ['femme'],\n",
       " ['fabricants', 'rencontre'],\n",
       " ['pompe'],\n",
       " ['comité'],\n",
       " ['traitement', \"d'\", 'appoint'],\n",
       " ['traitement', 'au', 'fer', 'intraveineux'],\n",
       " ['exon'],\n",
       " ['conditions', 'décision'],\n",
       " ['fer', 'intraveineux', 'chez', \"l'\", 'adulte'],\n",
       " ['frais'],\n",
       " ['traitement', 'au', 'fer', 'intraveineux', 'chez', \"l'\", 'adulte'],\n",
       " ['rétention', 'urinaire', 'aigüe'],\n",
       " ['demande', \"d'\", 'exemption'],\n",
       " ['conditions', 'décision', 'du', 'ministre'],\n",
       " ['intervenants'],\n",
       " ['pertes', 'vaginales', 'inhabituelles'],\n",
       " ['traitement', 'de', 'la', 'fibrose'],\n",
       " ['glaucome'],\n",
       " ['recommandation', 'de', \"l'\", 'inesss', 'médicaments'],\n",
       " ['estrogènes'],\n",
       " ['rédaction'],\n",
       " ['cpnpc'],\n",
       " ['thyroïde'],\n",
       " ['aide', 'médicale'],\n",
       " ['aide', 'médicale', 'à', 'mourir'],\n",
       " ['associés'],\n",
       " ['domicile'],\n",
       " ['corticothérapie'],\n",
       " ['écoulement'],\n",
       " ['prise', 'de', 'décision'],\n",
       " ['écoulement', 'urétral'],\n",
       " ['modes'],\n",
       " ['dermatite', 'atopique', 'modérée'],\n",
       " ['fresenius'],\n",
       " ['efficacy'],\n",
       " ['professionnels', 'de', 'la', 'santé'],\n",
       " ['algorithmes'],\n",
       " ['renseignements'],\n",
       " ['différence'],\n",
       " ['médicaments', 'génériques'],\n",
       " ['professionnel'],\n",
       " ['ordonnance', 'individuelle', \"d'\", 'ajustement'],\n",
       " ['lénalidomide'],\n",
       " ['itss'],\n",
       " ['heures'],\n",
       " ['eampoc'],\n",
       " ['gonadotrophines'],\n",
       " ['insomnie'],\n",
       " ['modalités', \"d'\", 'évaluation', 'des', 'médicaments'],\n",
       " ['institut',\n",
       "  'national',\n",
       "  \"d'\",\n",
       "  'excellence',\n",
       "  'en',\n",
       "  'santé',\n",
       "  'et',\n",
       "  'en',\n",
       "  'services'],\n",
       " ['conséquence'],\n",
       " ['excellence', 'en', 'santé', 'et', 'en', 'services', 'sociaux'],\n",
       " ['technologie'],\n",
       " ['congrès'],\n",
       " ['excellence', 'en', 'santé', 'et', 'en', 'services'],\n",
       " ['inscription', 'de', 'médicaments'],\n",
       " ['dernières'],\n",
       " ['res'],\n",
       " ['taro'],\n",
       " ['interféron'],\n",
       " ['essais'],\n",
       " ['trouble', 'déficitaire'],\n",
       " ['traitement', 'de', 'la', 'dermatite'],\n",
       " ['dupixent'],\n",
       " ['nucala'],\n",
       " ['gabarits'],\n",
       " ['choix'],\n",
       " ...]"
      ]
     },
     "execution_count": 127,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print(len(tokenized_queries))\n",
    "\n",
    "tokenized_queries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>retards liés</th>\n",
       "      <th>littérature scientifique</th>\n",
       "      <th>alk réévaluation</th>\n",
       "      <th>dav</th>\n",
       "      <th>mutations activatrices d'insertion</th>\n",
       "      <th>néphropathie chronique et de diabète</th>\n",
       "      <th>warfarine</th>\n",
       "      <th>stress</th>\n",
       "      <th>paramètres intermédiaires</th>\n",
       "      <th>registre des traumatismes</th>\n",
       "      <th>...</th>\n",
       "      <th>patients adultes atteints d'un cancer de l'endomètre</th>\n",
       "      <th>présoumission avec les fabricants préavis obligatoire</th>\n",
       "      <th>sécheresse vaginale</th>\n",
       "      <th>vraylar cariprazine abbvie traitement</th>\n",
       "      <th>cellules claires</th>\n",
       "      <th>nicolay ferrari</th>\n",
       "      <th>transition</th>\n",
       "      <th>folotyn</th>\n",
       "      <th>kio évaluations</th>\n",
       "      <th>summary</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.413841</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.709287</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.267082</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>3.071228</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.071228</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.308659</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.192352</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.132485</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.568860</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>3.160309</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.160309</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.173297</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1.771574</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.391556</td>\n",
       "      <td>1.771574</td>\n",
       "      <td>2.384877</td>\n",
       "      <td>2.707759</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.771574</td>\n",
       "      <td>0.694350</td>\n",
       "      <td>...</td>\n",
       "      <td>4.241023</td>\n",
       "      <td>0.0</td>\n",
       "      <td>4.241023</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5.024616</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>2.332044</td>\n",
       "      <td>2.647774</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.732329</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>3.204549</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.204549</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.261402</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>5.136411</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.580572</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2030</th>\n",
       "      <td>2.060277</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.294128</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.231825</td>\n",
       "      <td>...</td>\n",
       "      <td>4.169879</td>\n",
       "      <td>0.0</td>\n",
       "      <td>4.169879</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.938054</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1466</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>3.101687</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.101687</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.729494</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1468</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.313594</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.242277</td>\n",
       "      <td>...</td>\n",
       "      <td>4.192129</td>\n",
       "      <td>0.0</td>\n",
       "      <td>4.192129</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.678755</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1520</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>2.889684</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>3.001874</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.001874</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.741918</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1447</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2035 rows × 6025 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      retards liés  littérature scientifique  alk réévaluation       dav  \\\n",
       "0         0.000000                       0.0          1.413841  0.000000   \n",
       "1         0.000000                       0.0          3.192352  0.000000   \n",
       "2         1.771574                       0.0          2.391556  1.771574   \n",
       "3         0.000000                       0.0          0.000000  0.000000   \n",
       "4         0.000000                       0.0          0.000000  0.000000   \n",
       "...            ...                       ...               ...       ...   \n",
       "2030      2.060277                       0.0          2.294128  0.000000   \n",
       "1466      0.000000                       0.0          0.000000  0.000000   \n",
       "1468      0.000000                       0.0          2.313594  0.000000   \n",
       "1520      0.000000                       0.0          0.000000  0.000000   \n",
       "1447      0.000000                       0.0          0.000000  0.000000   \n",
       "\n",
       "      mutations activatrices d'insertion  \\\n",
       "0                               1.709287   \n",
       "1                               3.132485   \n",
       "2                               2.384877   \n",
       "3                               2.332044   \n",
       "4                               0.000000   \n",
       "...                                  ...   \n",
       "2030                            0.000000   \n",
       "1466                            0.000000   \n",
       "1468                            0.000000   \n",
       "1520                            0.000000   \n",
       "1447                            0.000000   \n",
       "\n",
       "      néphropathie chronique et de diabète  warfarine  stress  \\\n",
       "0                                 0.000000        0.0     0.0   \n",
       "1                                 0.000000        0.0     0.0   \n",
       "2                                 2.707759        0.0     0.0   \n",
       "3                                 2.647774        0.0     0.0   \n",
       "4                                 5.136411        0.0     0.0   \n",
       "...                                    ...        ...     ...   \n",
       "2030                              0.000000        0.0     0.0   \n",
       "1466                              0.000000        0.0     0.0   \n",
       "1468                              0.000000        0.0     0.0   \n",
       "1520                              2.889684        0.0     0.0   \n",
       "1447                              0.000000        0.0     0.0   \n",
       "\n",
       "      paramètres intermédiaires  registre des traumatismes  ...  \\\n",
       "0                      2.267082                   0.000000  ...   \n",
       "1                      2.568860                   0.000000  ...   \n",
       "2                      1.771574                   0.694350  ...   \n",
       "3                      1.732329                   0.000000  ...   \n",
       "4                      3.580572                   0.000000  ...   \n",
       "...                         ...                        ...  ...   \n",
       "2030                   0.000000                   1.231825  ...   \n",
       "1466                   0.000000                   0.000000  ...   \n",
       "1468                   0.000000                   1.242277  ...   \n",
       "1520                   0.000000                   0.000000  ...   \n",
       "1447                   0.000000                   0.000000  ...   \n",
       "\n",
       "      patients adultes atteints d'un cancer de l'endomètre  \\\n",
       "0                                              3.071228      \n",
       "1                                              3.160309      \n",
       "2                                              4.241023      \n",
       "3                                              3.204549      \n",
       "4                                              0.000000      \n",
       "...                                                 ...      \n",
       "2030                                           4.169879      \n",
       "1466                                           3.101687      \n",
       "1468                                           4.192129      \n",
       "1520                                           3.001874      \n",
       "1447                                           0.000000      \n",
       "\n",
       "      présoumission avec les fabricants préavis obligatoire  \\\n",
       "0                                                   0.0       \n",
       "1                                                   0.0       \n",
       "2                                                   0.0       \n",
       "3                                                   0.0       \n",
       "4                                                   0.0       \n",
       "...                                                 ...       \n",
       "2030                                                0.0       \n",
       "1466                                                0.0       \n",
       "1468                                                0.0       \n",
       "1520                                                0.0       \n",
       "1447                                                0.0       \n",
       "\n",
       "      sécheresse vaginale  vraylar cariprazine abbvie traitement  \\\n",
       "0                3.071228                                    0.0   \n",
       "1                3.160309                                    0.0   \n",
       "2                4.241023                                    0.0   \n",
       "3                3.204549                                    0.0   \n",
       "4                0.000000                                    0.0   \n",
       "...                   ...                                    ...   \n",
       "2030             4.169879                                    0.0   \n",
       "1466             3.101687                                    0.0   \n",
       "1468             4.192129                                    0.0   \n",
       "1520             3.001874                                    0.0   \n",
       "1447             0.000000                                    0.0   \n",
       "\n",
       "      cellules claires  nicolay ferrari  transition  folotyn  kio évaluations  \\\n",
       "0                  0.0              0.0         0.0      0.0         3.308659   \n",
       "1                  0.0              0.0         0.0      0.0         3.173297   \n",
       "2                  0.0              0.0         0.0      0.0         5.024616   \n",
       "3                  0.0              0.0         0.0      0.0         3.261402   \n",
       "4                  0.0              0.0         0.0      0.0         0.000000   \n",
       "...                ...              ...         ...      ...              ...   \n",
       "2030               0.0              0.0         0.0      0.0         2.938054   \n",
       "1466               0.0              0.0         0.0      0.0         2.729494   \n",
       "1468               0.0              0.0         0.0      0.0         0.678755   \n",
       "1520               0.0              0.0         0.0      0.0         3.741918   \n",
       "1447               0.0              0.0         0.0      0.0         0.000000   \n",
       "\n",
       "      summary  \n",
       "0         0.0  \n",
       "1         0.0  \n",
       "2         0.0  \n",
       "3         0.0  \n",
       "4         0.0  \n",
       "...       ...  \n",
       "2030      0.0  \n",
       "1466      0.0  \n",
       "1468      0.0  \n",
       "1520      0.0  \n",
       "1447      0.0  \n",
       "\n",
       "[2035 rows x 6025 columns]"
      ]
     },
     "execution_count": 128,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "metadata": {},
   "outputs": [],
   "source": [
    "#df.to_csv(base_path + titre + '_matrice-OkapiBM25.csv') # Si on veut avoir la matrice (mais le fichier peut être très volumineux)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "metadata": {},
   "outputs": [],
   "source": [
    "terms_okapi = {term: df[term].max() for term in df}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 131,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'retards liés': 3.444671729341301,\n",
       " 'littérature scientifique': 0.10701347960806883,\n",
       " 'alk réévaluation': 3.591974032304352,\n",
       " 'dav': 3.499849489030184,\n",
       " \"mutations activatrices d'insertion\": 4.7148847177222155,\n",
       " 'néphropathie chronique et de diabète': 5.257841174613827,\n",
       " 'warfarine': 6.132125678171774,\n",
       " 'stress': 0.08295426080042402,\n",
       " 'paramètres intermédiaires': 3.619849830471083,\n",
       " 'registre des traumatismes': 1.8630766781171442,\n",
       " 'brolucizumab novartis traitement': 3.402184291885258,\n",
       " 'agoniste': 2.7748876529897464,\n",
       " 'liquides': 4.473505741602462,\n",
       " 'injections de vitamine': 0.1086563179178894,\n",
       " 'erreurs innées': 0.08354895067069236,\n",
       " 'hypertension artérielle hypolipémiants infections urinaires': 9.14919009307234,\n",
       " 'kératose': 3.723853997531944,\n",
       " 'cétirizine (chlorhydrate de)': 3.6279987222684102,\n",
       " 'sclérose latérale amyotrophique': 0.17999355012521587,\n",
       " 'juge': 0.15565505521368278,\n",
       " 'degré': 0.15439718943768854,\n",
       " 'hemlibra': 0.16184688085957297,\n",
       " 'problèmes techniques': 5.082298585790713,\n",
       " 'traitement de la fibrose kystique chez les patients': 0.16184688085957297,\n",
       " 'récidive': 0.13021258422053672,\n",
       " \"patients en attente d'une coloscopie\": 3.817750040235679,\n",
       " 'évaluation nypozi': 0.16184688085957297,\n",
       " \"traitement du cancer de l'endomètre\": 5.791952067890312,\n",
       " 'problèmes de santé': 10.22830206496887,\n",
       " 'poids': 0.0,\n",
       " 'recommandations cliniques': 1.1909227332375343,\n",
       " 'nadeau coordination scientifique': 0.001974775189535625,\n",
       " 'rri': 12.950670551204096,\n",
       " \"attente d'évaluation oxlumo\": 0.0,\n",
       " 'cardiologie et maladies': 1.4506670705405191,\n",
       " 'fabricants des médicaments présentés': 1.9112385971343269,\n",
       " 'réponses rapides disponibles méthode de réponse rapide': 3.1734712126398974,\n",
       " 'traitement de la dermatite atopique modérée': 1.0357165449764754,\n",
       " \"recommandation de l'inesss inscription\": 0.011756238775863776,\n",
       " 'clostridium difficile': 14.048486027948634,\n",
       " 'sensibilité': 6.362128501867617,\n",
       " 'symptômes vasomoteurs': 3.0758998576011556,\n",
       " 'oncaspar pegaspargase servier': 4.326839766537728,\n",
       " 'prise': 1.838678084028478,\n",
       " \"attente d'évaluation nubeqa\": 2.9947157475159765,\n",
       " 'poumon à petites': 1.9509713115483853,\n",
       " 'schizophrénie pré-ac': 4.940948851678901,\n",
       " 'faricimab roche traitement': 2.2646454324013927,\n",
       " 'experts': 3.066547430075607,\n",
       " 'évaluation oncaspar pegaspargase servier': 6.66674878226684,\n",
       " 'nom commercial à venir finérénone': 9.627897375093411,\n",
       " 'documentation': 3.075174497789948,\n",
       " 'problématique': 3.2821759396108168,\n",
       " 'sécukinumab': 5.067550210718033,\n",
       " 'neisseria': 10.691248002766606,\n",
       " 'gamme': 13.708312417667173,\n",
       " 'daptomycine': 0.021599428565470234,\n",
       " \"attente d'évaluation vabysmo\": 0.06646180054138402,\n",
       " 'abbvie traitement de la colite': 8.468636892250146,\n",
       " 'cancer du sein triple': 0.044862371975913785,\n",
       " 'influenza': 0.009929559859132416,\n",
       " 'hypertension oculaire': 2.715497837674286,\n",
       " 'association avec la lénalidomide': 8.862389514411865,\n",
       " \"attente d'un dépôt pour évaluation nom\": 3.8546394095192866,\n",
       " 'régime général décision du ministre': 5.182579621801195,\n",
       " 'adulte dans le contexte de la covid-19': 4.0648237624645835,\n",
       " 'hulio adalimumab bgp pharma': 6.385892634293551,\n",
       " 'ravulizumab alexion': 2.5536946711018036,\n",
       " 'carfilzomib': 2.190410756208934,\n",
       " 'control': 0.22511127760815197,\n",
       " 'conclusion en conséquence': 3.232836283754668,\n",
       " 'rein': 9.960256363236013,\n",
       " 'aranesp': 2.4332043623908914,\n",
       " \"cours d'évaluation beovu\": 0.11822636920420067,\n",
       " 'évaluation en traumatologie et en soins': 8.553615376704368,\n",
       " \"schizophrénie pré-ac en cours d'évaluation\": 1.3735049747148582,\n",
       " 'oxybate': 2.928754966775022,\n",
       " 'seuils': 0.15419748745721462,\n",
       " 'lapatinib': 8.880108195312651,\n",
       " 'évaluation nom commercial à venir': 8.596763334031989,\n",
       " 'suivis': 3.116481671721916,\n",
       " 'rétablissement': 3.76042484653938,\n",
       " 'coordination scientifique sara beha': 0.0,\n",
       " 'hormone': 0.0,\n",
       " 'professionnelle scientifique': 0.13021258422053672,\n",
       " 'injury': 0.0,\n",
       " 'hommes': 3.799380930525711,\n",
       " 'chlorure': 0.0,\n",
       " 'angioedème héréditaire (aoh)': 0.244801141659997,\n",
       " 'enfant': 0.259070545741694,\n",
       " 'iii': 0.13021258422053672,\n",
       " 'ordonnances associées aide': 0.2364563982822454,\n",
       " \"critère d'utilisation\": 3.4183505427310417,\n",
       " 'services essentiels': 0.13021258422053672,\n",
       " 'traitement du lymphome': 0.08354895067069236,\n",
       " 'données scientifiques': 0.15260198987000143,\n",
       " 'head injury': 0.48753269995305326,\n",
       " 'poumon à petites cellules': 0.23605789086002085,\n",
       " 'knight traitement': 0.36067710225150534,\n",
       " \"attente d'évaluation tavneos avacopan\": 0.15260198987000143,\n",
       " 'magron': 0.26841289310110666,\n",
       " \"attente d'évaluation nucala mépolizumab gsk\": 7.089923003339504,\n",
       " 'albrioza phénylbutyrate': 0.39303210449259113,\n",
       " 'confiance': 12.644961789993978,\n",
       " 'cancer médullaire de la thyroïde': 2.403009457670467,\n",
       " 'évènements': 0.39919833109768554,\n",
       " 'spondylarthrite ankylosante évolutive réévaluation en cours': 0.18905187091215098,\n",
       " 'antidiabétiques': 3.4921156851861253,\n",
       " 'médicament le conseil': 0.36608402534976286,\n",
       " 'axicabtagène ciloleucel': 3.232836283754668,\n",
       " 'monde': 0.27992521819088034,\n",
       " \"attente d'évaluation retevmo\": 7.153631331626224,\n",
       " 'perspective': 3.9531349087893197,\n",
       " 'syrup odan chloral': 0.2920594650801097,\n",
       " \"refus d'introduction\": 4.036294493950405,\n",
       " 'objet du régime général': 0.3524709580298215,\n",
       " 'amifampridine': 0.1766765147289353,\n",
       " 'résidus abbott': 0.5945461795611221,\n",
       " 'maladie coronarienne préexistante': 0.4875326999530534,\n",
       " 'jama': 3.2214489512798865,\n",
       " 'citrate liquid calcium': 0.31624407029726154,\n",
       " 'équilibre bénéfices-risques': 0.2664073258044538,\n",
       " 'appoint du lupus érythémateux disséminé': 0.24923501260688943,\n",
       " 'hulio': 3.882540515686796,\n",
       " 'évaluation addnutriv': 3.1588124593982916,\n",
       " 'attention': 0.30239707306125035,\n",
       " \"pertinence de l'utilisation\": 0.259070545741694,\n",
       " 'stade': 3.6610738743081956,\n",
       " 'formule nutritive polymérique restreinte en résidus': 0.23407947428593112,\n",
       " 'troubles mentaux courants': 4.877667611393474,\n",
       " \"objet d'une évaluation\": 7.723511869972209,\n",
       " 'traitement de la manie': 3.7056186767313637,\n",
       " 'treat': 4.6830500270791005,\n",
       " 'traumatologie (cst)': 17.0655504428492,\n",
       " 'grippe saisonnière': 19.618554984195455,\n",
       " \"cours d'évaluation tepmetko\": 13.415376338468857,\n",
       " \"demande en cours d'évaluation yescarta\": 12.402489316475634,\n",
       " \"adultes atteints d'une infection à clostridium\": 4.073317081656214,\n",
       " 'azc pour le traitement du cancer': 3.643808546263263,\n",
       " 'pertinence et indications de transmission': 4.328785169832721,\n",
       " 'appui': 4.4717845827794145,\n",
       " 'assistance': 3.3324767811747367,\n",
       " 'mutations conduisant': 3.1234880754083973,\n",
       " 'fabricants des médicaments': 3.9999648665070393,\n",
       " 'arthrite': 8.44823952359765,\n",
       " 'score combiné': 5.377425113945263,\n",
       " 'évaluation kimmtrak tebentafusp': 6.530674214452407,\n",
       " 'œsophage': 5.9804343410236935,\n",
       " 'alendronate monosodique nora pms-teriflunomide': 3.9207853613461436,\n",
       " 'ménotropines': 4.617287337872244,\n",
       " 'niveau': 4.2875342402582355,\n",
       " 'hôpitaux': 2.715777447822187,\n",
       " 'priorisation des patients': 4.7023893963471695,\n",
       " 'perf': 9.377106444458175,\n",
       " 'rylaze': 4.613977561633508,\n",
       " 'ppe': 2.849995143043171,\n",
       " 'évaluation keytruda pembrolizumab': 3.868736404667045,\n",
       " 'nom du fabricant ach-teriflunomide': 2.9879174983953067,\n",
       " 'forme grave de la granulomatose avec polyangéite': 8.790441778275651,\n",
       " 'ministre des analyses de biologie médicale': 8.468636892250146,\n",
       " 'guide': 1.786620582714613,\n",
       " 'kamada': 3.6069683850545347,\n",
       " 'auteur': 6.305250140187746,\n",
       " 'type': 7.757847211720946,\n",
       " 'défini': 4.32699545393974,\n",
       " 'usage optimal usage optimal': 3.733888645130527,\n",
       " 'lenvatinib eisai': 4.731132305448728,\n",
       " 'myélome multiple pré-ac': 6.161659287239365,\n",
       " 'johnson produit du système': 1.874949974780314,\n",
       " 'preuves': 3.2513013638359634,\n",
       " 'lenvatinib': 13.265223530836002,\n",
       " 'tepotinib': 12.770260468186311,\n",
       " 'inhibiteurs': 16.16693257162079,\n",
       " 'formes': 27.534915333972314,\n",
       " 'sommaire de la littérature': 21.331736688245716,\n",
       " \"fabricant recommandation de l'inesss décision\": 7.168133995399182,\n",
       " 'pansement absorbant': 2.11818833742541,\n",
       " 'dépôt pour évaluation ruxience': 8.48811509598191,\n",
       " 'clientèle': 6.332112021529941,\n",
       " 'allergie aux protéines de lait': 0.0,\n",
       " 'lupus': 4.904292423111614,\n",
       " 'effets sur la durée': 4.752903474143408,\n",
       " 'problèmes de santé mentale': 10.156349341862548,\n",
       " 'évidence': 5.600762586577758,\n",
       " 'anesthésie': 2.0896318770190163,\n",
       " 'betamethasone': 1.838678084028478,\n",
       " 'endocrinothérapie pour le traitement': 6.185021402232274,\n",
       " 'dojolvi triheptanoïne': 5.237611765646231,\n",
       " \"endomètre pré-ac en cours d'évaluation cosentyx\": 3.5946522266036562,\n",
       " 'traitement des personnes avec un trouble déficitaire': 6.2706593499113845,\n",
       " 'patients atteints de glaucome': 9.28772376481195,\n",
       " 'indication de paiement': 3.7469700600172593,\n",
       " 'phuong hua': 2.0002861717164757,\n",
       " 'utérus intact avec intolérance': 1.8736467634879723,\n",
       " 'association avec le lenvatinib pour le traitement': 3.8815406431724555,\n",
       " 'marcan jamp levetiracetam': 12.485213227906176,\n",
       " \"portrait de l'usage des médicaments\": 7.936407502153927,\n",
       " 'réponse rapide inesss': 3.35614932814794,\n",
       " 'phases': 4.661923049947374,\n",
       " 'traitement des plaies': 10.433117642321001,\n",
       " 'croissance pré-ac': 4.760968281754293,\n",
       " 'services en vertu': 10.615860217847542,\n",
       " 'résultats obtenus': 4.955707833893832,\n",
       " 'citraflow citrate de sodium medxl': 11.947567540864672,\n",
       " 'partage': 4.528441542279748,\n",
       " 'défibrillateur cardiaque': 3.805426616557831,\n",
       " 'immunoglobulines en dermatologie': 3.8216909650593536,\n",
       " 'leuprolide': 5.828236414067289,\n",
       " 'prosigna': 2.6136283114067287,\n",
       " 'planification': 2.9927845169207314,\n",
       " 'terme des enfants': 5.506794947535107,\n",
       " \"muscle pré-ac en attente d'évaluation\": 4.085410555140192,\n",
       " 'adénocarcinome rénal': 2.4331381469492097,\n",
       " 'indication reconnue à la liste': 5.780718224304699,\n",
       " 'présence': 5.140464499348109,\n",
       " 'accès vasculaire': 7.8998802426887895,\n",
       " 'recherche pour trouver': 2.1860002596895622,\n",
       " 'évaluation de la pertinence': 8.373194646034188,\n",
       " 'philadelphie et atteints': 3.948078619798061,\n",
       " 'lésions': 6.7747040876635625,\n",
       " 'dexcom pour la surveillance du glucose': 4.674995297760275,\n",
       " \"coût d'acquisition\": 3.9666026357942386,\n",
       " 'ing': 8.656860129158662,\n",
       " 'nouveautés': 2.8147344235923044,\n",
       " \"médicaments biosimilaires évaluation d'une demande\": 3.656385240603867,\n",
       " \"traitement des patients adultes atteints d'un myélome\": 6.7491960946934295,\n",
       " 'regard sur la pandémie covid-19': 2.971434722995146,\n",
       " 'dextrose oméga inscription': 3.672969160917544,\n",
       " 'lymphome lymphoblastique': 5.712500090367941,\n",
       " \"attente d'une évaluation\": 5.7411136441501425,\n",
       " 'hypogonadotropic': 11.007484821660007,\n",
       " 'traitement du rhumatisme psoriasique actif': 8.816000548278755,\n",
       " 'cours': 15.07515591914689,\n",
       " 'pfizer produit': 4.829650072391983,\n",
       " 'capacités': 24.6257596571081,\n",
       " 'sodium pour injection bicarbonate de sodium': 4.389386332143355,\n",
       " 'trauma care': 4.433467323186666,\n",
       " \"risque d'icc\": 5.434953064297858,\n",
       " \"forme rémittente recommandation de l'inesss\": 4.693732175445573,\n",
       " 'système': 4.14805489866003,\n",
       " 'jamp lurasidone': 7.918376668076986,\n",
       " 'douleur': 4.641786220520127,\n",
       " \"retrait de l'indication reconnue\": 6.260189126843008,\n",
       " \"attente d'évaluation nom\": 4.305076608590974,\n",
       " 'leila': 5.641807839587572,\n",
       " 'regard sur la pandémie': 4.452289906527649,\n",
       " 'patientes': 6.3521291148448675,\n",
       " 'antipsychotiques': 3.540007116295801,\n",
       " 'système de santé': 5.952395489519717,\n",
       " 'donnée': 4.930514727530213,\n",
       " \"complications neurologiques graves à la suite d'un traumatisme\": 6.156104044175629,\n",
       " 'citrate liquid (angita)': 3.5540408089727142,\n",
       " 'traitement conventionnel': 4.511070543241955,\n",
       " 'vivant': 6.1798366017706705,\n",
       " 'suppléance fresenius agent': 5.053159729696635,\n",
       " 'comité': 9.842641185633205,\n",
       " 'moxifloxacin': 12.106093968264574,\n",
       " 'soya': 4.749030114984183,\n",
       " 'délais': 6.7154204130437805,\n",
       " 'cardiomyopathie': 6.614047163219011,\n",
       " 'postmenopausal': 5.321061012136867,\n",
       " 'traitement des adultes atteints de la forme grave': 3.82716203391508,\n",
       " 'tymlos': 4.38392994240309,\n",
       " 'sondage portant': 4.105280631972559,\n",
       " 'infarctus aigu du myocarde avec élévation du segment': 6.6208723545278145,\n",
       " 'évaluation dojolvi triheptanoïne': 4.3984319424782825,\n",
       " 'chlamydia trachomatis': 5.299472704739334,\n",
       " 'pertinence et indications de transmission des prélèvements chirurgicaux': 7.161694543209777,\n",
       " 'victimes de brûlures': 4.559999706480217,\n",
       " 'décision evaluation publiée': 8.801465242612037,\n",
       " 'déficit immunitaire combiné sévère': 9.727812741499832,\n",
       " 'terme des besoins hospitaliers': 4.734476368875924,\n",
       " 'acétylcystéine sandoz': 8.887231828388503,\n",
       " 'doses': 6.9700134596415735,\n",
       " 'type de cancer': 3.7180558711053666,\n",
       " 'long-term': 4.033031883815422,\n",
       " 'réponses rapides disponibles services': 13.28688735502104,\n",
       " 'caplacizumab sanofiaven traitement': 9.45986794955109,\n",
       " \"sondage portant sur l'état des pratiques\": 4.5436177930914505,\n",
       " 'inotersen': 5.718890889094548,\n",
       " 'conseil scientifique': 7.19614652638014,\n",
       " 'dépôt pour évaluation tremfya': 5.256471794973058,\n",
       " 'associations': 3.999116085624946,\n",
       " 'ppe mucosite oropharyngée naloxone': 7.259074430200878,\n",
       " \"traitement des adultes atteints d'une infection à clostridium difficile\": 4.113702124466582,\n",
       " 'traitement de la thrombose veineuse profonde pré-ac': 4.941631552747628,\n",
       " 'trousse': 9.64126254075159,\n",
       " 'contraceptif': 5.773553533670531,\n",
       " 'limite': 4.33663883457664,\n",
       " 'traitement de la somnolence diurne': 5.173798456772516,\n",
       " \"cours d'évaluation addnutriv\": 20.160930383820833,\n",
       " \"attente d'évaluation tecentriq atézolizumab\": 11.633439867349706,\n",
       " 'maladies cardiovasculaires': 9.752223587434418,\n",
       " 'cathéter': 9.999039638155658,\n",
       " 'critère': 4.318161662415028,\n",
       " 'coût annuel du traitement': 4.854370253432596,\n",
       " 'myocarde avec élévation du segment': 16.962935015038997,\n",
       " 'traitement du syndrome hémolytique et urémique': 12.22686024722648,\n",
       " 'insuline chez les patients atteints': 7.839105214715046,\n",
       " \"anifrolumab azc traitement d'appoint\": 6.920995424015077,\n",
       " 'type de demande': 6.507726129841121,\n",
       " 'canada pour le traitement des plaies': 18.31367221428684,\n",
       " 'dépenses additionnelles': 13.456659285617212,\n",
       " 'troubles mentaux': 21.99909807691945,\n",
       " \"déficit de l'attention\": 15.00459889741616,\n",
       " 'hypertension artérielle hypolipémiants infections': 3.610457463817672,\n",
       " 'produit du système du sang- traitement': 7.196392356899668,\n",
       " 'pandemic': 5.901108171984588,\n",
       " \"pré-ac en attente d'évaluation dojolvi triheptanoïne\": 8.924724014763527,\n",
       " 'décennies': 6.772318971619325,\n",
       " 'saignements': 6.029272458813898,\n",
       " 'défis': 2.8896090931926404,\n",
       " 'élexacaftor': 4.694415018230166,\n",
       " 'inhalation': 8.88751313486304,\n",
       " 'entrectinib roche traitement': 5.67557378227796,\n",
       " 'duranceau direction scientifique': 3.143323740718566,\n",
       " \"usage d'alcool troubles\": 4.513474009433441,\n",
       " 'plaques': 5.086834454374977,\n",
       " 'hyperoxalurie primitive': 11.117762333940068,\n",
       " 'alimentation': 4.852041803114164,\n",
       " 'vie des patients': 4.3950560068424895,\n",
       " \"pré-ac en attente d'évaluation orladeyo\": 23.11432668111709,\n",
       " 'therapy': 16.911148035390493,\n",
       " 'adénocarcinome rénal pré-ac en attente': 12.51197141587651,\n",
       " 'excellence en santé et en services sociaux': 6.690880838952087,\n",
       " 'somnolence diurne excessive': 5.544034300672828,\n",
       " 'covid-19 confirmée': 4.625641842055636,\n",
       " 'résultats des études': 5.5318614954057885,\n",
       " 'oxytrol': 4.46855572982277,\n",
       " 'capecitabine': 3.473170923617831,\n",
       " 'mellitus': 4.739692830091555,\n",
       " 'échographie': 5.911485586820106,\n",
       " 'pembrolizumab merck en monothérapie pour le traitement': 5.5356434613986405,\n",
       " 'nonacog bêta pégol': 3.956834416753902,\n",
       " 'excellence': 7.312660211569253,\n",
       " 'alnylam traitement de hyperoxalurie primitive': 4.4429434305429,\n",
       " \"demande en cours d'évaluation firdapse amifampridine\": 3.264912319336349,\n",
       " \"cours d'évaluation xydalba\": 6.527911850093495,\n",
       " 'ozanimod': 18.72019641429251,\n",
       " 'nom commercial à venir tézépélumab': 3.3999235837117343,\n",
       " 'rva': 4.482326545666374,\n",
       " 'mépolizumab gsk': 13.321219551785777,\n",
       " \"régie de l'assurance\": 13.021758180720626,\n",
       " 'fabricants rencontre': 5.661903823191301,\n",
       " 'sanis nat-teriflunomide': 28.68320029000332,\n",
       " 'méthode de réponse rapide': 5.519219370361422,\n",
       " 'médecin traitant': 6.579304354702235,\n",
       " 'autorisation': 10.068894609075908,\n",
       " 'services de santé': 7.224552120610457,\n",
       " 'emergency departments': 11.830778016562643,\n",
       " 'écoulement urétral élimination fécale': 10.153047997563572,\n",
       " 'interféron': 8.177407086574188,\n",
       " 'toronto': 13.52888288094586,\n",
       " 'rivaroxaban': 6.893069599943427,\n",
       " 'marie-france': 4.157779477437599,\n",
       " 'collaboration': 5.019123508416825,\n",
       " 'adultes atteints de néphropathie chronique': 4.089998190714552,\n",
       " 'oeuvre de la méthode': 8.041145498066712,\n",
       " 'cancer infectées': 3.6491371072975736,\n",
       " \"solution de rinçage pour les dispositifs d'accès vasculaire\": 6.1286726618061405,\n",
       " 'évaluation cosentyx sécukinumab novartis': 6.3268193943791475,\n",
       " 'atteintes': 7.623307751603567,\n",
       " 'irm': 7.017921660719856,\n",
       " 'paladin traitement de la somnolence': 4.940448446477461,\n",
       " 'publication': 3.3136224948065136,\n",
       " 'profils': 5.974366396057308,\n",
       " 'états-unis': 9.402074695481005,\n",
       " 'recommandations au ministre de la santé': 4.764923398511836,\n",
       " 'évaluation addnutriv agent de suppléance': 5.7186238410112,\n",
       " \"attente d'une évaluation scientifique par l'inesss\": 5.971424076611541,\n",
       " 'benzodiazépines': 5.106365162940642,\n",
       " 'gabarits protocoles médicaux': 6.44012789531971,\n",
       " 'traitement des adultes porteurs': 6.2258034401219735,\n",
       " 'nonacog bêta': 7.026670883287338,\n",
       " 'interférons': 8.240694227284223,\n",
       " 'réponses rapides disponibles affections': 3.9513550006784324,\n",
       " \"patients atteints d'un cancer du poumon\": 3.6739721824616844,\n",
       " 'doute': 3.63454113338468,\n",
       " \"patientes ménopausées avec l'utérus intact\": 12.844370565473156,\n",
       " 'biomarqueurs somatiques': 6.237030676500237,\n",
       " \"vie en centre d'hébergement\": 6.066388956760659,\n",
       " 'traitement du déficit congénital': 10.69926600522088,\n",
       " \"pré-ac en attente d'évaluation cablivi\": 11.211087840621293,\n",
       " 'carole-line nadeau coordination': 4.490662351421096,\n",
       " 'évaluation osphena': 3.7173408860065575,\n",
       " 'littérature grise': 4.473977286244357,\n",
       " 'pathologie': 9.71828131397405,\n",
       " 'recommandations au ministre de la santé et des services sociaux': 6.742941040369626,\n",
       " 'médicaments dans le but de faire': 4.868435399779966,\n",
       " 'filgrastim': 12.673566405019326,\n",
       " 'degarelix': 16.621562492760866,\n",
       " 'patient': 21.504192090416392,\n",
       " 'injection azithromycine jamp': 8.017866488650743,\n",
       " 'demande date limite pour commentaires rylaze': 12.030561529781673,\n",
       " 'traitements spécifiques à la covid-19': 13.327891850607909,\n",
       " 'diagnosis': 16.621562492760866,\n",
       " 'système de santé et de services sociaux': 12.030561529781673,\n",
       " 'citrate de fentanyl pour injection': 20.95318012817585,\n",
       " 'taro tenofovir ténofovir disoproxil': 7.590222038538438,\n",
       " 'ultomiris ravulizumab alexion traitement': 14.161770200226488,\n",
       " 'traitement du cancer des voies biliaires': 19.106753405300587,\n",
       " 'pioglitazone': 6.443865700915598,\n",
       " 'listes décision': 15.444130224397693,\n",
       " 'rsosi': 13.046691539281886,\n",
       " 'acétate': 5.173798456772516,\n",
       " 'recherche': 6.26830305091544,\n",
       " \"attente d'évaluation jardiance\": 6.74361786032166,\n",
       " 'conseil du médicament': 6.450466052242048,\n",
       " 'dépôt annoncé': 13.367926039740642,\n",
       " 'guides': 4.914922929372614,\n",
       " 'maladies neurovasculaires': 5.751279376942335,\n",
       " \"traitement de l'uvéite non infectieuse\": 3.073282878085917,\n",
       " 'sport': 2.308735736286895,\n",
       " \"processus synchronisé d'évaluation\": 4.028875652834808,\n",
       " 'transmission': 3.6061956925738325,\n",
       " 'darunavir (jamp)': 10.136150190151191,\n",
       " 'projet projet': 13.676157306446992,\n",
       " 'conciliation': 6.732389918084057,\n",
       " 'duchesnay traitement de la dyspareunie': 5.767494090036532,\n",
       " 'dépression': 3.641878333809941,\n",
       " \"processus d'évaluation modalités d'évaluation\": 3.288218868455464,\n",
       " \"dispositifs d'accès\": 5.313282944589573,\n",
       " 'jamp m-teriflunomide tériflunomide mantra mar-teriflunomide': 7.762721549812311,\n",
       " 'troubles neurocognitifs': 4.026000576898556,\n",
       " 'lovastatine': 3.8223678194925887,\n",
       " 'hospitalisation pour les personnes infectées par le sras-cov-2': 0.0,\n",
       " 'amivantamab janssen traitement': 7.248074026383774,\n",
       " \"dépôt électronique d'une demande\": 11.152535829487157,\n",
       " 'poussées': 3.296657421311475,\n",
       " 'densité mammographique': 3.2924838681067117,\n",
       " 'tableaux': 6.258164872639619,\n",
       " 'mésothéliome': 5.670935780318555,\n",
       " 'évaluation beovu': 7.2798236319053755,\n",
       " 'gmf': 3.0950141934368323,\n",
       " 'autorisations': 9.960256363236013,\n",
       " \"recommandation de l'inesss maintien\": 3.444671729341301,\n",
       " 'évaluation du synvisc': 4.939895486039112,\n",
       " 'moreault': 11.078293733180542,\n",
       " 'virus': 8.566182019111043,\n",
       " 'liste des médicaments couverts par le régime': 3.9956666272718526,\n",
       " 'présoumission avec les fabricants préavis': 4.432717528968919,\n",
       " 'données disponibles': 3.966781898305454,\n",
       " 'monothérapie pour le traitement adjuvant des patients': 6.142056975940183,\n",
       " 'asthme éosinophile': 5.830786275834971,\n",
       " 'leucémie lymphoblastique': 8.306929692096473,\n",
       " 'facteur': 4.288505300633656,\n",
       " 'organisations': 9.929079211440179,\n",
       " 'grille': 4.589836551343958,\n",
       " 'jamp fluconazole-150 fluconazole sanis': 6.7937946770413005,\n",
       " 'brentuximab': 3.2913536687195237,\n",
       " 'verzenio abémaciclib lilly': 7.175622492833174,\n",
       " 'préalable': 5.4726340901317485,\n",
       " 'garde': 19.340568510779107,\n",
       " 'coordination scientifique marie-france': 8.471333634902397,\n",
       " 'déficit acquis en fibrinogène': 9.287219169297652,\n",
       " 'choix': 4.531702613041319,\n",
       " 'épidémie de covid-19': 3.8249542783023247,\n",
       " 'infarctus aigu du myocarde': 7.60965762755682,\n",
       " 'technologies innovantes': 5.765290817067097,\n",
       " 'ruxolitinib novartis': 10.076555335750658,\n",
       " 'plaques (sep)': 4.617287337872244,\n",
       " 'abbvie': 22.71851136296127,\n",
       " \"processus d'évaluation\": 11.429015152114966,\n",
       " 'présentation': 25.000696604054966,\n",
       " 'évaluation cosentyx sécukinumab': 4.477101688577893,\n",
       " 'taro taro-lenalidomide lénalidomide taro': 9.519213902508241,\n",
       " 'tyrosine kinase': 22.787298764116972,\n",
       " \"sang- traitement d'entretien\": 26.51028406753939,\n",
       " 'initiatives': 19.432861813841804,\n",
       " 'responsabilités': 10.660561524432875,\n",
       " 'merck en association avec une chimiothérapie': 4.036204882207857,\n",
       " 'eptinezumab lundbeck traitement': 15.648550347124008,\n",
       " 'estime': 21.189846796547194,\n",
       " 'tafasitamab incyte en association avec la lénalidomide': 14.112424542849606,\n",
       " \"démarche d'évaluation\": 26.73496337886055,\n",
       " 'analgésique': 5.115029561221774,\n",
       " 'association avec une endocrinothérapie pour le traitement': 5.414959264133542,\n",
       " 'formulation': 30.321133875047163,\n",
       " 'démarche utilisée': 16.589320734316395,\n",
       " \"recommandation de l'inesss médicament\": 19.50236591194193,\n",
       " 'cancer infectées par le sras-cov-2': 17.89656619471255,\n",
       " 'résultat': 8.118610995959733,\n",
       " 'moelle osseuse': 14.075137068321322,\n",
       " 'services de réadaptation présentant': 17.501711916587812,\n",
       " 'colloques': 6.371943073179462,\n",
       " 'évaluation rozlytrek entrectinib': 18.737574002037157,\n",
       " 'matériel': 4.145288195035172,\n",
       " 'établissements': 15.655207778936022,\n",
       " 'polyangéite microscopique': 16.54700074770073,\n",
       " 'zafirlukast': 7.6340518284263075,\n",
       " 'cariprazine abbvie traitement de la schizophrénie': 19.96268611509189,\n",
       " 'justesse du prix décision': 6.53130320857403,\n",
       " 'lenvima lenvatinib': 9.195637030707477,\n",
       " 'nom commercial dénomination': 14.075137068321322,\n",
       " 'myélome multiple pré-ac en cours': 12.783400877956382,\n",
       " 'refus décision': 14.480388658233693,\n",
       " 'patients hospitalisés': 14.480388658233693,\n",
       " 'système du sang-': 9.432428313035441,\n",
       " 'human': 17.395188191142335,\n",
       " 'hypogonadism': 4.6586341390149135,\n",
       " 'localisation': 6.2258034401219735,\n",
       " 'indications de paiement': 5.166541977059374,\n",
       " 'méthode': 11.150621249105008,\n",
       " 'ordonnance': 9.447156932898881,\n",
       " 'population pédiatrique': 12.124284141624832,\n",
       " \"traitement des adultes atteints d'un cancer\": 3.1578792329485945,\n",
       " 'contexte pandémique': 17.790141271817323,\n",
       " 'ase': 6.235109139347322,\n",
       " 'ipsen': 9.759814549263824,\n",
       " 'insomnie': 22.42850885698163,\n",
       " 'traitement cancer': 15.368003153048445,\n",
       " 'pegaspargase servier traitement des patients': 17.155591070006956,\n",
       " 'médicaments évalués': 4.902566941541863,\n",
       " 'ménopause': 5.172977461479959,\n",
       " 'réévaluation': 12.150615615296534,\n",
       " 'densité': 15.999978522650773,\n",
       " \"demande en cours d'évaluation mvasi bévacizumab\": 16.322184115185664,\n",
       " 'lymphome à grandes': 14.863553254732633,\n",
       " 'elvium traitement': 14.007748735408034,\n",
       " 'études randomisées': 23.493662957014685,\n",
       " 'ministre': 5.844160873189839,\n",
       " 'capox': 13.456254311890932,\n",
       " 'compagnon': 27.561334054501568,\n",
       " \"demande en attente d'évaluation keytruda\": 8.844275619001573,\n",
       " \"données d'efficacité\": 7.047040133390579,\n",
       " 'coût unitaire': 10.599651138587069,\n",
       " \"suivi de l'évolution de l'épidémie de covid-19\": 10.651828367106603,\n",
       " 'proactive': 22.7654321716805,\n",
       " 'prévention des rechutes': 15.906089840134188,\n",
       " 'lien avec la covid-19': 17.761163747101957,\n",
       " 'adalimumab amgen': 5.192603753150768,\n",
       " 'évaluations récemment publiées': 16.778198984686494,\n",
       " 'fluconazole-150': 15.62160070107747,\n",
       " 'jim boulanger direction scientifique elisabeth': 6.999130862707357,\n",
       " 'hyperkaliémie chez les patients atteints': 14.970646236581462,\n",
       " 'jardiance empagliflozine': 7.047040133390579,\n",
       " 'pertinence du dépistage néonatal': 6.2258034401219735,\n",
       " 'réponse rapide dans le contexte': 5.065170031027521,\n",
       " 'pratique': 0.9096663504338759,\n",
       " 'abaloparatide paladin traitement': 4.167032544164969,\n",
       " 'évaluation ngenla somatrogon': 5.299643575355569,\n",
       " 'aide-mémoire': 9.54637956640924,\n",
       " \"modification d'une indication reconnue\": 5.902615030697112,\n",
       " 'bévacizumab amgen traitement des patients': 4.879400947316643,\n",
       " \"demande en cours d'évaluation keytruda\": 4.349293887368153,\n",
       " 'cst nouveautés': 5.982430503985838,\n",
       " 'changements': 6.40224858913197,\n",
       " 'erreurs innées du métabolisme': 23.50790315737081,\n",
       " 'highly': 6.013122240547016,\n",
       " 'évaluation des systèmes': 20.147395161027617,\n",
       " 'exercice du collège des médecins du québec': 5.629771325924354,\n",
       " 'abaloparatide paladin': 5.406698081428013,\n",
       " 'dextrose injection': 11.9986448110634,\n",
       " 'services de réadaptation': 4.325904641729005,\n",
       " 'médecins signataires': 4.9904883780871,\n",
       " 'zanubrutinib': 6.865793127404709,\n",
       " 'guardian': 5.962205662003976,\n",
       " 'sélection': 10.393655604143701,\n",
       " 'lisinopril sanis': 6.112929870861557,\n",
       " 'marcan jamp levetiracetam tablets lévétiracétam': 4.972926927573176,\n",
       " 'groupe recevant': 16.75154828520681,\n",
       " \"mandat d'évaluer des demandes\": 16.468008742950545,\n",
       " 'évaluation yescarta': 20.376998450236023,\n",
       " 'congress': 24.002448615265237,\n",
       " 'analyse de la littérature': 5.066735152697923,\n",
       " 'médicaments en attente': 15.624094976092614,\n",
       " 'protection de la jeunesse': 8.238286364193794,\n",
       " 'sulfonate polystyrène': 3.591974032304352,\n",
       " 'association': 7.189252019674774,\n",
       " 'tête': 7.526649599304424,\n",
       " 'retard': 5.214954699339486,\n",
       " 'appréciation rapide de la pertinence': 5.452710352955989,\n",
       " 'jamp bicalutamide bicalutamide sanis cephalexin': 8.892412350874341,\n",
       " 'réaction': 5.892266109042227,\n",
       " 'version': 14.513337997134828,\n",
       " 'brolucizumab': 4.260616285522622,\n",
       " 'suivi': 16.334310945597007,\n",
       " \"cours d'évaluation firdapse\": 5.973464387238769,\n",
       " 'listes des médicaments-': 6.513920272416459,\n",
       " 'mésothéliome pleural malin': 17.33288232171202,\n",
       " 'immunologie': 2.82685963620548,\n",
       " 'protons': 12.043017244632164,\n",
       " 'bgp pharma': 15.690630819919893,\n",
       " 'justesse': 6.9231005084113,\n",
       " 'évaluation ruxience': 6.959669045818492,\n",
       " 'lettre': 4.551896966690842,\n",
       " 'economic': 6.958483021264878,\n",
       " 'méthadone': 4.508560088894315,\n",
       " 'mesures': 3.3780831379392278,\n",
       " 'cessation du tabagisme': 5.533240075903981,\n",
       " 'évaluation de la pertinence du dépistage': 4.756247753887662,\n",
       " 'système du sang en vue': 4.53352498098044,\n",
       " 'capteur': 4.757432572983478,\n",
       " 'alternatives de traitements en contexte': 4.559185114561084,\n",
       " 'professionnels impliqués': 5.335784119739857,\n",
       " 'affiche': 6.306241248184848,\n",
       " 'mandats recherche': 5.23392473820649,\n",
       " 'argent coloplast': 6.853021498787737,\n",
       " 'cémiplimab sanofiaven traitement du cancer du poumon': 17.419064937047263,\n",
       " 'clientèles': 7.201137833172408,\n",
       " 'analyse des besoins': 5.57095551869524,\n",
       " 'sclérose en plaques de forme': 6.149648154534296,\n",
       " \"régime général d'assurance médicaments\": 6.567074594026853,\n",
       " 'vagues de la pandémie': 7.151359276232781,\n",
       " 'guselkumab': 4.766594916661458,\n",
       " 'boivin': 6.6555065320061795,\n",
       " 'follitropine bêta': 4.729848632544957,\n",
       " 'sang- traitement du déficit': 4.938740199694565,\n",
       " \"services menant à l'évaluation diagnostique\": 5.8989323111154945,\n",
       " 'protocole de recherche': 3.9476181062904625,\n",
       " 'ondansétron': 5.883148061557639,\n",
       " \"mutations activatrices d'insertion de l'exon\": 6.073507432797347,\n",
       " 'utérus': 7.6889226844441625,\n",
       " \"pré-ac en attente d'évaluation nucala\": 7.966933621747145,\n",
       " 'respect': 8.729888281215931,\n",
       " \"demande en attente d'évaluation kimmtrak\": 8.640710488486492,\n",
       " 'rylaze crisantaspase recombinante': 5.004647990171429,\n",
       " 'établissements de santé pour le traitement': 5.487091379854233,\n",
       " \"profil d'effets indésirables\": 6.265491436320424,\n",
       " 'traitement des patients adultes': 10.507473738087867,\n",
       " 'maladie pulmonaire obstructive chronique': 5.360905569777513,\n",
       " \"régime général d'assurance\": 6.3581581936413425,\n",
       " 'finérénone': 21.230278089341468,\n",
       " 'comportement': 10.899311977396696,\n",
       " 'réévaluation fiche': 19.19654781629411,\n",
       " 'igiv': 0.0,\n",
       " \"guide d'exercice du collège des médecins\": 12.675410280224884,\n",
       " 'insuline': 15.65654069999831,\n",
       " 'dipropionate': 5.439895868352161,\n",
       " 'évolution': 6.335460136609061,\n",
       " 'principes directeurs': 7.7216508393834395,\n",
       " 'expertise': 7.610518374737643,\n",
       " 'infarction': 6.693250486746967,\n",
       " 'forme grave': 7.301528333802055,\n",
       " 'ajout aux listes de médicaments': 4.781470510434593,\n",
       " 'individus': 5.956072166775998,\n",
       " \"patients atteints d'un carcinome\": 7.726354854909639,\n",
       " 'hypertension pulmonaire': 9.924475886030987,\n",
       " 'médicaments accessibles': 6.103493075704925,\n",
       " 'familles': 7.764629830599971,\n",
       " 'évaluation en traumatologie': 5.652498266130218,\n",
       " 'rencontre postsoumission avec les fabricants': 13.707598574618238,\n",
       " 'head': 7.720679564353647,\n",
       " 'prestation': 11.683314277683959,\n",
       " 'entretien': 5.4121906876533545,\n",
       " 'particuliers': 5.510249374131405,\n",
       " 'absence': 10.496444850715294,\n",
       " 'dépôt électronique temporaire pour les demandes': 4.922996398026565,\n",
       " \"cours d'évaluation bryhali\": 6.6513610760165545,\n",
       " 'exception de la liste': 6.234720679848864,\n",
       " \"unité d'évaluation en traumatologie\": 6.4313194491379075,\n",
       " 'trajectoires de services menant': 6.040824416959144,\n",
       " 'oia': 5.070431316367184,\n",
       " 'heure': 6.019087581655428,\n",
       " 'troubles neurodéveloppementaux chez les enfants': 14.892456694771596,\n",
       " 'ordonnance individuelle préimprimée': 6.716744304337641,\n",
       " 'conseil recommande': 10.042689680921324,\n",
       " 'listes': 11.84042762033464,\n",
       " 'kio autres recommandations': 6.224036072202552,\n",
       " 'lumakras': 9.493210196893937,\n",
       " 'voies': 8.468636892250146,\n",
       " 'biosimilaires': 12.60659813783321,\n",
       " 'mélanome uvéal': 4.49460955968397,\n",
       " 'syndrome hémolytique et urémique': 5.061549655083654,\n",
       " 'période': 5.367268487840429,\n",
       " \"demande en attente d'évaluation vyepti\": 5.836066420612806,\n",
       " 'cpnpc': 5.634521975636405,\n",
       " 'knight traitement des symptômes vasomoteurs': 5.055339033912501,\n",
       " 'philadelphie': 11.077199351018265,\n",
       " 'jours': 11.05097575886908,\n",
       " 'mandat': 4.736587408404884,\n",
       " 'estrogènes oraux': 6.803250140041871,\n",
       " 'adalimumab amgen traitement': 4.269388318852498,\n",
       " 'refus': 0.0,\n",
       " 'normes de qualité': 6.413426162859349,\n",
       " 'dayvigo': 6.55398958347906,\n",
       " 'manière': 4.059237204517029,\n",
       " 'cible': 6.012133194162616,\n",
       " 'retrait': 15.393110348208486,\n",
       " 'système du sang- traitement': 6.092330872258202,\n",
       " 'antécédent de cancer': 3.0060272606357583,\n",
       " 'pfizer traitement de la dermatite atopique': 6.75398543204602,\n",
       " \"cours d'évaluation mvasi bévacizumab amgen\": 4.590896989210262,\n",
       " \"traitement de l'œdème maculaire diabétique pré-ac\": 5.097907952547301,\n",
       " 'scientific': 4.636025283006447,\n",
       " 'association avec la lénalidomide pour le traitement': 1.6616731265342526,\n",
       " 'inscription -avec': 5.785623555051602,\n",
       " 'rebinyn': 12.030620741876671,\n",
       " 'jamp fluconazole-150': 2.772373295985705,\n",
       " 'alk réévaluation en cours': 12.60659813783321,\n",
       " 'thérapies': 18.37385426181362,\n",
       " 'kamrab': 6.20690789091246,\n",
       " 'folfox': 8.468636892250146,\n",
       " 'titre': 6.221635255715887,\n",
       " 'résultats démontrent': 13.618556840244382,\n",
       " 'évaluation bijuva': 6.699369511121291,\n",
       " 'colite': 7.361605963724689,\n",
       " 'gliclazide': 5.484051460362205,\n",
       " 'bolen': 5.402923407531684,\n",
       " 'cancer du sein triple négatif au stade': 6.114334309869245,\n",
       " 'expérientielles': 12.241862627147063,\n",
       " 'bouloux': 6.060104469686304,\n",
       " 'brolucizumab novartis': 6.299318364792395,\n",
       " 'castration métastatique pré-ac en attente': 0.0,\n",
       " 'évaluation fiche': 5.601526452403154,\n",
       " 'résonance': 8.149013260381206,\n",
       " 'entrectinib roche': 5.9464701636630295,\n",
       " 'trastuzumab deruxtecan': 4.628950170331273,\n",
       " 'souche': 9.158030029850806,\n",
       " 'dépôt électronique': 5.61150005712468,\n",
       " 'durée': 19.263369337227566,\n",
       " 'résonance magnétique': 6.1752710406747955,\n",
       " 'évaluation des systèmes de pompes': 10.019004077527569,\n",
       " 'dépistage néonatal du déficit immunitaire': 5.823749014186735,\n",
       " 'majorité': 12.457075576818166,\n",
       " 'rituximab pfizer produit biosimilaire': 6.10631723597742,\n",
       " 'bupropion': 19.239163771012304,\n",
       " 'mar-ondansetron odt': 10.982644909257434,\n",
       " \"réévaluation en attente d'évaluation\": 6.835131792749524,\n",
       " 'partenaires': 13.321377697846547,\n",
       " 'segment': 7.3115138757258915,\n",
       " 'technique': 16.621562492760866,\n",
       " 'fabricant contribue': 5.702019370634938,\n",
       " 'tanvex produit': 7.388840784084149,\n",
       " \"mutation d'un gène brca\": 9.415540976076247,\n",
       " 'soutien': 10.86077518759547,\n",
       " 'carcinome urothélial infiltrant le muscle': 19.743880871088482,\n",
       " 'ministre sur iclusig': 5.252156695643187,\n",
       " 'outil': 4.032166810536365,\n",
       " 'chimiothérapie': 13.840160950828087,\n",
       " 'cohort': 18.42572139062739,\n",
       " 'hémophilie de type': 5.604232628306305,\n",
       " 'œil': 4.470393420277627,\n",
       " 'collaboration avec un groupe': 6.524052973002606,\n",
       " 'verio': 4.827894436014245,\n",
       " 'dextrose': 8.734144448573337,\n",
       " 'mutation kras': 7.119821452658359,\n",
       " 'pandémie de covid-19': 5.665071976220754,\n",
       " 'sandoz teriflunomide tériflunomide sandoz': 6.662896514712711,\n",
       " 'réadaptation pour les enfants': 4.419785734466836,\n",
       " 'fiche synthèse': 6.0582266050094,\n",
       " 'infections urinaires inhibiteurs': 7.168447645324823,\n",
       " 'traitement de hyperoxalurie primitive': 5.935858238067318,\n",
       " 'ovulation': 6.7376243081302505,\n",
       " 'lymphœdème secondaire': 5.595154535597381,\n",
       " 'xydalba dalbavancine paladin traitement': 5.252089029452693,\n",
       " 'patients atteints du diabète': 5.353083305468592,\n",
       " 'jamp teriflunomide tériflunomide jamp': 12.798366222723592,\n",
       " 'réduction de la pression': 6.908615732988435,\n",
       " 'gonorrhoeae davc eampoc': 6.048584003238465,\n",
       " 'semaines avant le dépôt annoncé': 12.70980345418285,\n",
       " 'registre des traumatismes évaluation': 5.441711007550713,\n",
       " 'johnson produit du système du sang-': 5.120793235131833,\n",
       " 'sars-cov-2': 17.160269762161356,\n",
       " 'médicaments evaluation publiée': 6.3699015159686985,\n",
       " 'cariprazine': 8.182162290846918,\n",
       " 'médicaments du québec': 5.220024855705483,\n",
       " 'ultomiris': 8.579169565775624,\n",
       " 'berotralstat biocryst traitement': 7.204363287123248,\n",
       " 'archives': 12.401394262652818,\n",
       " 'complexe': 5.849368390956965,\n",
       " 'intégration': 5.59319072283976,\n",
       " 'élaboration': 6.338196371648705,\n",
       " 'bioéquivalence': 5.334565380798926,\n",
       " \"suivi de l'évolution\": 6.212578844913015,\n",
       " 'centre': 6.582318661081033,\n",
       " 'vitro': 9.169006340450403,\n",
       " 'sécurité': 5.866892124032403,\n",
       " 'lupus érythémateux disséminé': 7.440892841736053,\n",
       " 'installations de soins aigus': 6.749578769308711,\n",
       " 'questionnaire': 7.8932627620673035,\n",
       " 'besoins des enfants': 9.855402775410496,\n",
       " 'services externes intensifs': 2.2904845206820803,\n",
       " 'réponse aux besoins': 5.287014068775042,\n",
       " 'pfizer traitement à long terme': 7.766607118428061,\n",
       " 'glycémie recommandation': 11.677156924500633,\n",
       " 'triheptanoïne ultragenyx traitement': 8.097574508366502,\n",
       " 'médicaments du régime général décision': 6.801601109759972,\n",
       " 'pandémie de la covid-19': 7.410387816251061,\n",
       " 'dostarlimab gsk traitement du cancer': 23.05692037485521,\n",
       " 'recherche pour trouver un médicament': 6.779792034307077,\n",
       " 'institut': 11.901175955583891,\n",
       " 'cabozantinib ipsen': 11.133134445170445,\n",
       " 'bgp pharma inscription': 13.046691539281886,\n",
       " 'décision evaluation': 5.043044438648622,\n",
       " 'option': 8.530238131601289,\n",
       " 'ménopayse chez la femme': 4.836327288179133,\n",
       " \"liaison à l'attention du pharmacien\": 3.903281251154087,\n",
       " 'administration': 5.841148080753954,\n",
       " \"recours à l'imagerie\": 6.695907408250869,\n",
       " 'qualité méthodologique': 6.394108699975487,\n",
       " 'portrait': 7.182645879577905,\n",
       " 'méthode de réponse rapide dans le contexte': 9.246398057224226,\n",
       " 'produits de santé': 11.388106527190317,\n",
       " 'critères prévus': 8.043060615817522,\n",
       " 'knight traitement des symptômes': 6.762509462214217,\n",
       " 'cord': 4.48652170392871,\n",
       " 'baisse de prix des génériques': 7.253720602832194,\n",
       " 'gènes': 8.255720057262867,\n",
       " 'brimonidine': 6.634131206489621,\n",
       " 'gonorrhoeae': 1.4345264515217384,\n",
       " 'intégration des données': 7.9118974642803925,\n",
       " 'économies': 11.461042232054579,\n",
       " 'éradication': 7.30985000964555,\n",
       " 'perfusion intraveineuse': 6.562617816867967,\n",
       " 'muscle': 4.945185325080234,\n",
       " \"dupilumab sanofiaven traitement de l'asthme\": 0.0,\n",
       " 'assurance maladie': 5.218612101740968,\n",
       " 'réadaptation présentant une déficience': 5.65347997724786,\n",
       " 'évaluation nucala mepolizumab': 4.398343994620596,\n",
       " 'génération (sng)': 5.839373285725053,\n",
       " 'abbvie traitement de la manie': 5.2586662365017975,\n",
       " 'otsuka can traitement': 12.756555600529502,\n",
       " 'forme rémittente recommandation': 6.328417299649761,\n",
       " 'décisions': 5.563302767634358,\n",
       " 'mpai-4': 6.526448850548045,\n",
       " \"guide d'usage optimal\": 6.19501154377048,\n",
       " 'indication reconnue pour le traitement': 9.767591408581344,\n",
       " 'merck forme': 17.30809189756234,\n",
       " 'phénotype éosinophilique': 6.422883961875948,\n",
       " 'pegvaliase biomarin': 18.005555356247875,\n",
       " 'injection bicarbonate': 14.800198577223346,\n",
       " 'ritonavir': 8.174661295255508,\n",
       " 'délai': 12.437272320468136,\n",
       " 'présentes': 4.933161336774973,\n",
       " \"attente d'évaluation kimmtrak\": 7.400099288611673,\n",
       " 'veille': 13.601665174335581,\n",
       " 'ministère de la santé': 8.416432728376487,\n",
       " 'intrarosa prasterone lupin': 2.268256649327495,\n",
       " 'évaluation palynziq pegvaliase biomarin': 8.036798855936379,\n",
       " 'résistance': 6.998246338509418,\n",
       " 'récepteurs hormonaux': 5.730653658143027,\n",
       " 'régie': 7.305100517382088,\n",
       " 'icp': 9.874854639823903,\n",
       " \"glycémie recommandation de l'inesss\": 9.265655189819915,\n",
       " 'reviews': 11.835096700826359,\n",
       " 'apotex inscription': 5.987300444468387,\n",
       " 'évaluation des technologies': 4.360934250198017,\n",
       " 'évaluation keytruda pembrolizumab merck traitement': 8.915597893022095,\n",
       " 'jamp nifedipine': 4.955216222312664,\n",
       " 'ajustement professionnels': 6.137477181787071,\n",
       " \"demande en cours d'évaluation nucala\": 5.624588544177567,\n",
       " 'jamp fluconazole-150 fluconazole': 11.78788370936719,\n",
       " 'paladin traitement de la somnolence diurne': 6.757669083448814,\n",
       " \"adultes atteints d'un lymphome à grandes cellules\": 7.693097105496548,\n",
       " 'lopinavir': 4.981180004773725,\n",
       " 'dextrose halycil': 17.580839029603716,\n",
       " 'allergie aux protéines': 5.409458834417696,\n",
       " 'cancer des voies biliaires (cvb)': 8.558199578179314,\n",
       " 'practices': 6.488145602066935,\n",
       " 'bevacizumab': 6.032701691533988,\n",
       " 'évaluations en mode': 10.98899911218215,\n",
       " 'fardeau économique sur le système': 13.5274808967701,\n",
       " 'calcium polystyrene': 6.156706518951021,\n",
       " 'yannick': 10.788758139520468,\n",
       " 'medison inscription': 6.761215283932738,\n",
       " 'maribavir takeda traitement': 15.189031921079685,\n",
       " 'cablivi caplacizumab sanofiaven': 8.00344333674963,\n",
       " 'anifrolumab': 13.238508994114124,\n",
       " 'accu-chek': 5.428561745238355,\n",
       " 'cabozantinib': 18.388519609568256,\n",
       " 'hémoglobinurie': 6.856052146191629,\n",
       " 'médicaments génériques': 14.811556036937985,\n",
       " 'iic pré-ac': 21.464754545471372,\n",
       " 'screening': 11.73532110103487,\n",
       " 'épisode': 6.32020006725604,\n",
       " 'ministre sur esbriet': 5.976914347422822,\n",
       " 'nom du fabricant ach-teriflunomide tériflunomide': 6.224631044594849,\n",
       " 'young': 11.89905359710115,\n",
       " 'solution ophtalmique': 10.98899911218215,\n",
       " 'insuline glargine bgp pharma': 13.608105447565023,\n",
       " 'pandémie covid-19 au québec': 5.838918926978324,\n",
       " 'tcc': 5.369556025692232,\n",
       " 'pediatric': 7.016927495097157,\n",
       " 'néphropathie chronique réévaluation': 7.428485628176778,\n",
       " \"sang- traitement d'entretien du déficit\": 8.53243107292244,\n",
       " 'infertilité': 6.859430127423643,\n",
       " \"réévaluation en cours d'évaluation\": 7.497685861821159,\n",
       " \"mandat d'évaluer\": 3.499849489030184,\n",
       " 'mcgill': 5.125689177056778,\n",
       " 'fabricants demande': 6.110359414060698,\n",
       " 'intention de traitement': 7.91828577413201,\n",
       " 'trauma centers': 8.862389514411865,\n",
       " 'réflexion': 3.5907593186751074,\n",
       " 'infarctus aigu': 4.346197842131608,\n",
       " 'alendronate monosodique nora': 6.706104765600869,\n",
       " 'zepzelca lurbinectédine jazz': 10.380947643282362,\n",
       " 'enfant pré-ac en attente': 7.835585132788975,\n",
       " 'formules nutritives monomériques': 12.702411690150988,\n",
       " 'tamiflu': 21.876515120279286,\n",
       " 'immunodéficience humaine': 18.202195912332545,\n",
       " 'lucy': 6.993797667574749,\n",
       " 'évaluation wakix': 6.397191871627915,\n",
       " 'projets': 15.85729958681473,\n",
       " 'évaluation du réseau documentation': 5.073774452520492,\n",
       " 'chsld': 14.8093422241073,\n",
       " \"traitement des adultes atteints d'une infection à clostridium\": 20.823739459828595,\n",
       " 'capsules cdm': 9.53320706798006,\n",
       " 'jeunesse': 6.197326055208774,\n",
       " 'medison traitement des patients': 14.481812950555854,\n",
       " 'jugées': 10.91210833439192,\n",
       " 'conformité de santé': 6.3034879150231635,\n",
       " 'organon inscription': 7.011838199302154,\n",
       " 'ajinomoto': 11.40557801465274,\n",
       " 'réponses rapides disponibles autres traitements': 5.182579621801195,\n",
       " 'alexandre paré': 15.189031921079685,\n",
       " 'chiens': 11.920870468635055,\n",
       " 'appoint du lupus': 5.522909534404363,\n",
       " 'blessures': 14.519606400736889,\n",
       " 'épisodes hémorragiques': 21.30214242803118,\n",
       " \"liaison à l'attention\": 10.789332933470849,\n",
       " \"médicaments d'exception de la liste\": 9.40096647244729,\n",
       " 'pertes vaginales inhabituelles premarin': 12.526416402849335,\n",
       " 'corticothérapie orale': 16.65042246762447,\n",
       " 'éplérénone': 5.822331648976646,\n",
       " 'mort': 17.18819002435893,\n",
       " 'budget des établissements de santé': 6.210616663400851,\n",
       " 'ordonnances individuelles': 12.586998305897609,\n",
       " 'cablivi caplacizumab': 7.701522704462141,\n",
       " 'vertex traitement': 12.596693812947398,\n",
       " 'sodium darunavir': 6.840281226273911,\n",
       " \"médicaments évalués par l'inesss\": 4.708200109187936,\n",
       " 'poussée clinique aiguë': 18.01520442054445,\n",
       " 'traitement des tumeurs solides extracrâniennes': 13.067068568898497,\n",
       " 'endomètre': 11.271849369756097,\n",
       " 'dénomination commune nom': 4.823345659523342,\n",
       " 'situation de négligence': 22.943278614183125,\n",
       " \"québec's\": 13.273647808186645,\n",
       " 'alexion pour le traitement du syndrome hémolytique': 6.18501491538112,\n",
       " 'traitement des personnes diabétiques de type': 12.567723844364611,\n",
       " 'mutations activatrices': 7.703086187872616,\n",
       " 'pharmacien': 12.851833577752188,\n",
       " 'lisinopril': 18.79698356798025,\n",
       " 'atézolizumab': 5.285716897366016,\n",
       " 'avc': 12.549889747916968,\n",
       " 'dojolvi triheptanoïne ultragenyx traitement': 5.428547459229288,\n",
       " 'évaluation des médicaments biosimilaires évaluation': 5.372629268579482,\n",
       " \"demande d'inscription\": 4.320780729314051,\n",
       " 'mucosite oropharyngée naloxone': 19.191525216516837,\n",
       " 'inesss a développé': 8.647030613976742,\n",
       " 'mint-quetiapine': 5.477655766147548,\n",
       " 'traitement au fer': 13.728724543223592,\n",
       " 'élévation du segment': 10.05278736861824,\n",
       " 'mpoc': 20.18819734628242,\n",
       " 'mantra mar-teriflunomide tériflunomide marcan mometasone': 18.6567982826337,\n",
       " 'projet auteur': 8.774349146723965,\n",
       " \"modèle d'ordonnance\": 11.489146440339178,\n",
       " 'diseases': 5.319460235171641,\n",
       " 'génotypage du rhd': 18.901844675879133,\n",
       " 'besoins': 15.400095262639127,\n",
       " 'pandémie covid-19': 7.020382955134204,\n",
       " 'conclusion': 11.08617018409658,\n",
       " 'évaluation cablivi caplacizumab sanofiaven traitement': 10.234953171026643,\n",
       " 'modifications apportées': 3.8086825879272395,\n",
       " 'évaluation jemperli dostarlimab gsk': 9.989878469815363,\n",
       " 'inscription décision': 5.498595036555404,\n",
       " 'oméga': 8.288816403040311,\n",
       " \"modification d'une indication reconnue aux listes\": 16.949766095332247,\n",
       " 'phase de rétablissement': 4.356581667661111,\n",
       " 'patients atteints de néphropathie chronique': 7.188060084111752,\n",
       " 'répercussions': 6.356094964429463,\n",
       " 'yervoy': 6.517652165429965,\n",
       " 'cours échéancier': 10.226476595348963,\n",
       " 'cliniques': 13.18449452907537,\n",
       " 'décès en lien': 6.6998284712732765,\n",
       " 'évaluations en appui': 19.97497198929391,\n",
       " 'utilisation en contexte québécois des inhibiteurs': 4.567341886782344,\n",
       " 'jamp calcium': 4.66836929156726,\n",
       " 'sous-groupe': 12.078970384774788,\n",
       " 'eampoc écoulement urétral': 8.594360387252987,\n",
       " 'durvalumab azc pour le traitement': 3.6326584130731407,\n",
       " 'anticoagulants': 5.677539169910409,\n",
       " \"modification d'une indication reconnue par le conseil\": 9.097918212103524,\n",
       " 'quétiapine (fumarate de)': 8.828240628308016,\n",
       " \"cours d'évaluation opdivo\": 17.35399855047322,\n",
       " \"pré-ac en attente d'évaluation foquest méthylphénidate\": 3.679157605644962,\n",
       " 'ventilation assistée': 5.554788714603898,\n",
       " 'caplacizumab sanofiaven': 6.524127203289167,\n",
       " 'retevmo selpercatinib lilly pour le traitement': 6.1295203450615166,\n",
       " 'fibrose kystique chez les patients': 9.015129864144122,\n",
       " 'méta-analyses': 7.497310518137532,\n",
       " 'prednisone': 14.686027782788134,\n",
       " 'issue': 28.7398826221567,\n",
       " \"produits d'hormonothérapie\": 3.8009562305259954,\n",
       " 'plans': 17.711077969193425,\n",
       " 'olaparib azc pour le traitement': 6.30400060250274,\n",
       " 'connaissances outil': 6.911136309799362,\n",
       " 'tériflunomide teva': 16.83870666657281,\n",
       " 'fumarate': 10.990641976607002,\n",
       " 'régime général': 4.314748061154854,\n",
       " 'plaies complexes': 6.316100426500193,\n",
       " 'pédiatrie': 2.7703195822062545,\n",
       " 'severe': 7.293124118736669,\n",
       " \"demande en cours d'évaluation beovu\": 6.413185533485266,\n",
       " 'morbidité': 8.588521263994688,\n",
       " 'ipp': 17.045677944080058,\n",
       " 'commentaire sur un médicament': 2.7998753173696924,\n",
       " 'pression intraoculaire': 7.429689501881876,\n",
       " 'troubles': 4.565563661286524,\n",
       " 'accès': 5.194170673793311,\n",
       " ...}"
      ]
     },
     "execution_count": 131,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "terms_okapi"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 132,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Terme</th>\n",
       "      <th>OkapiBM25</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>retards liés</td>\n",
       "      <td>3.444672</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>littérature scientifique</td>\n",
       "      <td>0.107013</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>alk réévaluation</td>\n",
       "      <td>3.591974</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>dav</td>\n",
       "      <td>3.499849</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>mutations activatrices d'insertion</td>\n",
       "      <td>4.714885</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6020</th>\n",
       "      <td>nicolay ferrari</td>\n",
       "      <td>5.809825</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6021</th>\n",
       "      <td>transition</td>\n",
       "      <td>10.636027</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6022</th>\n",
       "      <td>folotyn</td>\n",
       "      <td>9.754495</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6023</th>\n",
       "      <td>kio évaluations</td>\n",
       "      <td>7.470046</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6024</th>\n",
       "      <td>summary</td>\n",
       "      <td>12.577386</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6025 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                   Terme  OkapiBM25\n",
       "0                           retards liés   3.444672\n",
       "1               littérature scientifique   0.107013\n",
       "2                       alk réévaluation   3.591974\n",
       "3                                    dav   3.499849\n",
       "4     mutations activatrices d'insertion   4.714885\n",
       "...                                  ...        ...\n",
       "6020                     nicolay ferrari   5.809825\n",
       "6021                          transition  10.636027\n",
       "6022                             folotyn   9.754495\n",
       "6023                     kio évaluations   7.470046\n",
       "6024                             summary  12.577386\n",
       "\n",
       "[6025 rows x 2 columns]"
      ]
     },
     "execution_count": 132,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tab = DataFrame(terms_okapi.items(), columns=['Terme', 'OkapiBM25'])\n",
    "tab"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 133,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Terme</th>\n",
       "      <th>OkapiBM25</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5003</th>\n",
       "      <td>itinérance</td>\n",
       "      <td>47.329810</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5048</th>\n",
       "      <td>hormone de croissance pré-ac en cours</td>\n",
       "      <td>47.082489</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5046</th>\n",
       "      <td>opdivo</td>\n",
       "      <td>43.677060</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5612</th>\n",
       "      <td>activité</td>\n",
       "      <td>42.626487</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5002</th>\n",
       "      <td>embryons</td>\n",
       "      <td>41.894857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4470</th>\n",
       "      <td>actikerall</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5242</th>\n",
       "      <td>influenza chez l'enfant et l'adulte</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1776</th>\n",
       "      <td>pembrolizumab</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>attente d'évaluation oxlumo</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2568</th>\n",
       "      <td>médicament d'exception evaluation</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6025 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                      Terme  OkapiBM25\n",
       "5003                             itinérance  47.329810\n",
       "5048  hormone de croissance pré-ac en cours  47.082489\n",
       "5046                                 opdivo  43.677060\n",
       "5612                               activité  42.626487\n",
       "5002                               embryons  41.894857\n",
       "...                                     ...        ...\n",
       "4470                             actikerall   0.000000\n",
       "5242    influenza chez l'enfant et l'adulte   0.000000\n",
       "1776                          pembrolizumab   0.000000\n",
       "33              attente d'évaluation oxlumo   0.000000\n",
       "2568      médicament d'exception evaluation   0.000000\n",
       "\n",
       "[6025 rows x 2 columns]"
      ]
     },
     "execution_count": 133,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tab.sort_values([\"OkapiBM25\"], \n",
    "                    axis=0,\n",
    "                    ascending=[False], \n",
    "                    inplace=True)\n",
    "\n",
    "tab"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 134,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Terme</th>\n",
       "      <th>Structure syntaxique</th>\n",
       "      <th>Fréquence (TF)</th>\n",
       "      <th>LLR</th>\n",
       "      <th>p-value</th>\n",
       "      <th>Fréquence documentaire (DF)</th>\n",
       "      <th>isMeSHTerm</th>\n",
       "      <th>isTaxoTerm</th>\n",
       "      <th>Terme formatté</th>\n",
       "      <th>TF (sklearn)</th>\n",
       "      <th>DF (sklearn)</th>\n",
       "      <th>TF-IDF</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>traitement</td>\n",
       "      <td>NOM</td>\n",
       "      <td>7872</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1218</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>traitement</td>\n",
       "      <td>7864</td>\n",
       "      <td>1180</td>\n",
       "      <td>0.233696</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>jamp</td>\n",
       "      <td>NOM</td>\n",
       "      <td>7296</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>992</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>jamp</td>\n",
       "      <td>2556</td>\n",
       "      <td>992</td>\n",
       "      <td>0.299247</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>évaluation</td>\n",
       "      <td>NOM</td>\n",
       "      <td>6785</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1396</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>évaluation</td>\n",
       "      <td>1694</td>\n",
       "      <td>324</td>\n",
       "      <td>0.207417</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>médicaments</td>\n",
       "      <td>NOM</td>\n",
       "      <td>5448</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>1206</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>médicaments</td>\n",
       "      <td>5451</td>\n",
       "      <td>1206</td>\n",
       "      <td>0.398131</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>demande</td>\n",
       "      <td>NOM</td>\n",
       "      <td>3662</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>280</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>demande</td>\n",
       "      <td>3662</td>\n",
       "      <td>240</td>\n",
       "      <td>0.558081</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6020</th>\n",
       "      <td>degré</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>14</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>degré</td>\n",
       "      <td>16</td>\n",
       "      <td>14</td>\n",
       "      <td>0.143549</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6021</th>\n",
       "      <td>foam</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>8</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>foam</td>\n",
       "      <td>16</td>\n",
       "      <td>8</td>\n",
       "      <td>0.486611</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6022</th>\n",
       "      <td>coque</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>22</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>coque</td>\n",
       "      <td>16</td>\n",
       "      <td>12</td>\n",
       "      <td>0.448285</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6023</th>\n",
       "      <td>médicaments du québec</td>\n",
       "      <td>NOM PRP:det NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>88.74281960037526</td>\n",
       "      <td>4.496265284875781e-21</td>\n",
       "      <td>13</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>médicaments du québec</td>\n",
       "      <td>16</td>\n",
       "      <td>13</td>\n",
       "      <td>0.119791</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6024</th>\n",
       "      <td>lmc</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>5</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>lmc</td>\n",
       "      <td>14</td>\n",
       "      <td>2</td>\n",
       "      <td>0.396506</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6025 rows × 12 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                      Terme Structure syntaxique  Fréquence (TF)  \\\n",
       "0                traitement                  NOM            7872   \n",
       "1                      jamp                  NOM            7296   \n",
       "2                évaluation                  NOM            6785   \n",
       "3               médicaments                  NOM            5448   \n",
       "4                   demande                  NOM            3662   \n",
       "...                     ...                  ...             ...   \n",
       "6020                  degré                  NOM              16   \n",
       "6021                   foam                  NOM              16   \n",
       "6022                  coque                  NOM              16   \n",
       "6023  médicaments du québec      NOM PRP:det NOM              16   \n",
       "6024                    lmc                  NOM              16   \n",
       "\n",
       "                    LLR                p-value  Fréquence documentaire (DF)  \\\n",
       "0                     -                      -                         1218   \n",
       "1                     -                      -                          992   \n",
       "2                     -                      -                         1396   \n",
       "3                     -                      -                         1206   \n",
       "4                     -                      -                          280   \n",
       "...                 ...                    ...                          ...   \n",
       "6020                  -                      -                           14   \n",
       "6021                  -                      -                            8   \n",
       "6022                  -                      -                           22   \n",
       "6023  88.74281960037526  4.496265284875781e-21                           13   \n",
       "6024                  -                      -                            5   \n",
       "\n",
       "      isMeSHTerm  isTaxoTerm         Terme formatté  TF (sklearn)  \\\n",
       "0          False        True             traitement          7864   \n",
       "1          False       False                   jamp          2556   \n",
       "2          False       False             évaluation          1694   \n",
       "3          False        True            médicaments          5451   \n",
       "4          False       False                demande          3662   \n",
       "...          ...         ...                    ...           ...   \n",
       "6020       False       False                  degré            16   \n",
       "6021       False       False                   foam            16   \n",
       "6022       False        True                  coque            16   \n",
       "6023       False       False  médicaments du québec            16   \n",
       "6024       False       False                    lmc            14   \n",
       "\n",
       "      DF (sklearn)    TF-IDF  \n",
       "0             1180  0.233696  \n",
       "1              992  0.299247  \n",
       "2              324  0.207417  \n",
       "3             1206  0.398131  \n",
       "4              240  0.558081  \n",
       "...            ...       ...  \n",
       "6020            14  0.143549  \n",
       "6021             8  0.486611  \n",
       "6022            12  0.448285  \n",
       "6023            13  0.119791  \n",
       "6024             2  0.396506  \n",
       "\n",
       "[6025 rows x 12 columns]"
      ]
     },
     "execution_count": 134,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "terms_weighted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 135,
   "metadata": {},
   "outputs": [],
   "source": [
    "tab = pd.merge(terms_weighted, tab, on=\"Terme\")\n",
    "tab.sort_values([\"OkapiBM25\"], \n",
    "                    axis=0,\n",
    "                    ascending=[False], \n",
    "                    inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 136,
   "metadata": {},
   "outputs": [],
   "source": [
    "base_path = '../05-transformation/'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 137,
   "metadata": {},
   "outputs": [],
   "source": [
    "if tag:\n",
    "    file_path = base_path + acteur + '_' + tag + '_weighting_OKapiBM25.csv'\n",
    "\n",
    "else: \n",
    "    file_path = base_path + acteur  + '_weighting_OKapiBM25.csv'\n",
    "tab.to_csv(file_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 138,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Terme</th>\n",
       "      <th>Structure syntaxique</th>\n",
       "      <th>Fréquence (TF)</th>\n",
       "      <th>LLR</th>\n",
       "      <th>p-value</th>\n",
       "      <th>Fréquence documentaire (DF)</th>\n",
       "      <th>isMeSHTerm</th>\n",
       "      <th>isTaxoTerm</th>\n",
       "      <th>Terme formatté</th>\n",
       "      <th>TF (sklearn)</th>\n",
       "      <th>DF (sklearn)</th>\n",
       "      <th>TF-IDF</th>\n",
       "      <th>OkapiBM25</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4287</th>\n",
       "      <td>itinérance</td>\n",
       "      <td>NOM</td>\n",
       "      <td>30</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>15</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>itinérance</td>\n",
       "      <td>12</td>\n",
       "      <td>8</td>\n",
       "      <td>0.472798</td>\n",
       "      <td>47.329810</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2536</th>\n",
       "      <td>hormone de croissance pré-ac en cours</td>\n",
       "      <td>NOM PRP NOM NOM PRP NOM</td>\n",
       "      <td>44</td>\n",
       "      <td>534.9832950178793</td>\n",
       "      <td>2.3271021680629744e-118</td>\n",
       "      <td>44</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>hormone de croissance pré_ac en cours</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>0.006176</td>\n",
       "      <td>47.082489</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>379</th>\n",
       "      <td>opdivo</td>\n",
       "      <td>NOM</td>\n",
       "      <td>226</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>88</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>opdivo</td>\n",
       "      <td>214</td>\n",
       "      <td>86</td>\n",
       "      <td>0.429815</td>\n",
       "      <td>43.677060</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1520</th>\n",
       "      <td>activité</td>\n",
       "      <td>NOM</td>\n",
       "      <td>71</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>374</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>activité</td>\n",
       "      <td>28</td>\n",
       "      <td>28</td>\n",
       "      <td>0.094159</td>\n",
       "      <td>42.626487</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5994</th>\n",
       "      <td>embryons</td>\n",
       "      <td>NOM</td>\n",
       "      <td>16</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>7</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>embryons</td>\n",
       "      <td>16</td>\n",
       "      <td>7</td>\n",
       "      <td>0.505658</td>\n",
       "      <td>41.894857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5561</th>\n",
       "      <td>jim boulanger direction scientifique elisabeth...</td>\n",
       "      <td>NOM ADJ NOM ADJ NOM VER:pper</td>\n",
       "      <td>18</td>\n",
       "      <td>382.1569619377114</td>\n",
       "      <td>4.2204638905297015e-85</td>\n",
       "      <td>18</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>jim boulanger direction scientifique elisabeth...</td>\n",
       "      <td>18</td>\n",
       "      <td>18</td>\n",
       "      <td>0.088114</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5237</th>\n",
       "      <td>pansements de base</td>\n",
       "      <td>NOM PRP NOM</td>\n",
       "      <td>20</td>\n",
       "      <td>321.0270241228294</td>\n",
       "      <td>8.653548940266297e-72</td>\n",
       "      <td>4</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>pansements de base</td>\n",
       "      <td>20</td>\n",
       "      <td>4</td>\n",
       "      <td>0.382036</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4992</th>\n",
       "      <td>actikerall</td>\n",
       "      <td>NOM</td>\n",
       "      <td>22</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>10</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>actikerall</td>\n",
       "      <td>22</td>\n",
       "      <td>10</td>\n",
       "      <td>0.581519</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>890</th>\n",
       "      <td>sédation palliative continue</td>\n",
       "      <td>NOM ADJ ADJ</td>\n",
       "      <td>106</td>\n",
       "      <td>-inf</td>\n",
       "      <td>1.0</td>\n",
       "      <td>88</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>sédation palliative continue</td>\n",
       "      <td>106</td>\n",
       "      <td>88</td>\n",
       "      <td>0.285686</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>injury</td>\n",
       "      <td>NOM</td>\n",
       "      <td>466</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>14</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>injury</td>\n",
       "      <td>464</td>\n",
       "      <td>14</td>\n",
       "      <td>0.332691</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6025 rows × 13 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  Terme  \\\n",
       "4287                                         itinérance   \n",
       "2536              hormone de croissance pré-ac en cours   \n",
       "379                                              opdivo   \n",
       "1520                                           activité   \n",
       "5994                                           embryons   \n",
       "...                                                 ...   \n",
       "5561  jim boulanger direction scientifique elisabeth...   \n",
       "5237                                 pansements de base   \n",
       "4992                                         actikerall   \n",
       "890                        sédation palliative continue   \n",
       "199                                              injury   \n",
       "\n",
       "              Structure syntaxique  Fréquence (TF)                LLR  \\\n",
       "4287                           NOM              30                  -   \n",
       "2536       NOM PRP NOM NOM PRP NOM              44  534.9832950178793   \n",
       "379                            NOM             226                  -   \n",
       "1520                           NOM              71                  -   \n",
       "5994                           NOM              16                  -   \n",
       "...                            ...             ...                ...   \n",
       "5561  NOM ADJ NOM ADJ NOM VER:pper              18  382.1569619377114   \n",
       "5237                   NOM PRP NOM              20  321.0270241228294   \n",
       "4992                           NOM              22                  -   \n",
       "890                    NOM ADJ ADJ             106               -inf   \n",
       "199                            NOM             466                  -   \n",
       "\n",
       "                      p-value  Fréquence documentaire (DF)  isMeSHTerm  \\\n",
       "4287                        -                           15       False   \n",
       "2536  2.3271021680629744e-118                           44       False   \n",
       "379                         -                           88       False   \n",
       "1520                        -                          374       False   \n",
       "5994                        -                            7       False   \n",
       "...                       ...                          ...         ...   \n",
       "5561   4.2204638905297015e-85                           18       False   \n",
       "5237    8.653548940266297e-72                            4       False   \n",
       "4992                        -                           10       False   \n",
       "890                       1.0                           88       False   \n",
       "199                         -                           14       False   \n",
       "\n",
       "      isTaxoTerm                                     Terme formatté  \\\n",
       "4287        True                                         itinérance   \n",
       "2536       False              hormone de croissance pré_ac en cours   \n",
       "379        False                                             opdivo   \n",
       "1520       False                                           activité   \n",
       "5994       False                                           embryons   \n",
       "...          ...                                                ...   \n",
       "5561       False  jim boulanger direction scientifique elisabeth...   \n",
       "5237       False                                 pansements de base   \n",
       "4992       False                                         actikerall   \n",
       "890        False                       sédation palliative continue   \n",
       "199         True                                             injury   \n",
       "\n",
       "      TF (sklearn)  DF (sklearn)    TF-IDF  OkapiBM25  \n",
       "4287            12             8  0.472798  47.329810  \n",
       "2536            44            44  0.006176  47.082489  \n",
       "379            214            86  0.429815  43.677060  \n",
       "1520            28            28  0.094159  42.626487  \n",
       "5994            16             7  0.505658  41.894857  \n",
       "...            ...           ...       ...        ...  \n",
       "5561            18            18  0.088114   0.000000  \n",
       "5237            20             4  0.382036   0.000000  \n",
       "4992            22            10  0.581519   0.000000  \n",
       "890            106            88  0.285686   0.000000  \n",
       "199            464            14  0.332691   0.000000  \n",
       "\n",
       "[6025 rows x 13 columns]"
      ]
     },
     "execution_count": 138,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tab"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3.9.12 ('base')",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "a33210152f7d2bd255fb16656f372b633dbf298ed202bbbac20290b0375cadb7"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
